,Approval,Class,Drug Class,Drug Name,EntryName,Gene,INDEX,Indication(s),LigandType,Phase,Status,Subfamily,Target class,Target_novelty,Trial name,Uniprot,index
0,-,Class B1 (Secretin),small molecule,561679,crfr1_human,CRHR1,543,Anti-depressant,Peptide ,,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,crf-1 antagonist,P34998,0
1,-,Class B1 (Secretin),small molecule,768974,pth1r_human,PTH1R,10,Anti-osteoporotic agent,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"768974, parathyroid hormone analog",Q03431,1
2,-,Class A (Rhodopsin),peptide,abarelix,gnrhr_human,GNRHR,19,Antineoplastic agent,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"abarelix, plenaxis",P30968,2
3,-,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r1_human,PTGER1,29,dental ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P34995,3
4,-,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r2_human,PTGER2,29,periodontal ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P43116,4
5,-,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r3_human,PTGER3,29,periodontal ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P43115,5
6,-,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r4_human,PTGER4,29,periodontal ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P35408,6
7,-,Class C (Glutamate) ,small molecule,acamprosate,grm5_human,GRM5,34,Antineoplastic agent,Amino acid ,,approved,Metabotropic glutamate receptors,GPCR;Glutamate,established,"acamprosate,campral",P41594,7
8,1984,Class A (Rhodopsin),small molecule,acebutolol,adrb1_human,ADRB1,NRDD001,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,8
9,-,Class A (Rhodopsin),small molecule,aceprometazine,hrh1_human,HRH1,NRDD003,Hypnotics and Sedatives,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,9
10,1961,Class A (Rhodopsin),small molecule,acetophenazine,drd1_human,DRD1,NRDD006,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,10
11,1961,Class A (Rhodopsin),small molecule,acetophenazine,drd2_human,DRD2,NRDD006,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,11
12,2012,Class A (Rhodopsin),small molecule,aclidinium,acm1_human,CHRM1,44,Bronchodilator agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P11229,12
13,2012,Class A (Rhodopsin),small molecule,aclidinium,acm2_human,CHRM2,44,Bronchodilator agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08172,13
14,2012,Class A (Rhodopsin),small molecule,aclidinium,acm3_human,CHRM3,44,Bronchodilator agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P20309,14
15,2012,Class A (Rhodopsin),small molecule,aclidinium,acm4_human,CHRM4,44,Bronchodilator agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08173,15
16,2012,Class A (Rhodopsin),small molecule,aclidinium,acm5_human,CHRM5,44,Bronchodilator agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08912,16
17,2012,Class A (Rhodopsin),small molecule,aclidinium,acm2_human,CHRM2,MMAmay2016_0039,Bronchodilator agent; COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P08172,17
18,2012,Class A (Rhodopsin),small molecule,aclidinium,acm4_human,CHRM4,MMAmay2016_0040,Bronchodilator agent; COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P08173,18
19,2012,Class A (Rhodopsin),small molecule,aclidinium,acm5_human,CHRM5,MMAmay2016_0041,Bronchodilator agent; COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P08912,19
20,2012,Class A (Rhodopsin),small molecule,aclidinium,acm1_human,CHRM1,MMAmay2016_0042,Bronchodilator agent; COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P11229,20
21,2012,Class A (Rhodopsin),small molecule,aclidinium,acm3_human,CHRM3,MMAmay2016_0043,Bronchodilator agent; COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P20309,21
22,-,Class A (Rhodopsin),small molecule,acp-104,acm1_human,CHRM1,47,Antipsychotic agent,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,acp-104,P11229,22
23,-,Class A (Rhodopsin),small molecule,acp-104,drd2_human,DRD2,47,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,acp-104,P14416,23
24,-,Class A (Rhodopsin),small molecule,acp-104,drd3_human,DRD3,47,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,acp-104,P35462,24
25,-,Class A (Rhodopsin),small molecule,acp-104,5ht2a_human,HTR2A,47,Antipsychotic agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,acp-104,P28223,25
26,2015,Class A (Rhodopsin),small molecule,act-333679,pi2r_human,PTGIR,MMAmay2016_0747,Antihypertensive agent; treat pulmonary arterial hypertension,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,selixipag,P43119,26
27,1989,Class A (Rhodopsin),small molecule,adenosine,aa1r_human,ADORA1,2267,Analgesics;postoperative pain,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P30542,27
28,1989,Class A (Rhodopsin),small molecule,adenosine,aa2ar_human,ADORA2A,2267,Analgesics;postoperative pain,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P29274,28
29,1989,Class A (Rhodopsin),small molecule,adenosine,aa2br_human,ADORA2B,2267,Analgesics;postoperative pain,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P29275,29
30,1989,Class A (Rhodopsin),small molecule,adenosine,aa3r_human,ADORA3,2267,Analgesics;postoperative pain,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P0DMS8,30
31,-,Class A (Rhodopsin),small molecule,adl5747,oprd_human,OPRD1,55,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,adl5747,P41143,31
32,-,Class A (Rhodopsin),small molecule,adl5859,oprd_human,OPRD1,56,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"adl5859, pf-04856880",P41143,32
33,-,Class A (Rhodopsin),small molecule,adl5945,oprm_human,OPRM1,57,motilitant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,adl5945,P35372,33
34,-,Class A (Rhodopsin),small molecule,adl7445,oprm_human,OPRM1,58,motilitant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,adl7445,P35372,34
35,-,Class C (Glutamate) ,small molecule,adx10059,grm5_human,GRM5,62,Anti-migraine Agents; for treatment of gastroesophageal reflux disease,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,adx10059,P41594,35
36,-,Class A (Rhodopsin),small molecule,adx415,ada2a_human,ADRA2A,63,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,adx415,P08913,36
37,-,Class C (Glutamate) ,small molecule,adx-48621,grm5_human,GRM5,2472,Antiparkinson agents,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,adx-48621,P41594,37
38,-,Class C (Glutamate) ,small molecule,adx-71149,grm2_human,GRM2,64,Antipsychotic agent; Anti-depressant; anxiolytic,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,adx-71149,Q14416,38
39,-,Class C (Glutamate) ,small molecule,adx71441,gabr1_human,GABBR1,MMAmay2016_0243,for treatment of neurologic disorders,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,adx71441,Q9UBS5,39
40,-,Class C (Glutamate) ,small molecule,adx71441,gabr2_human,GABBR2,MMAmay2016_0244,for treatment of neurologic disorders,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,adx71441,O75899,40
41,-,Class A (Rhodopsin),small molecule,afamelanotide,mshr_human,MC1R,73,dermatological agent,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,afamelanotide,Q01726,41
42,-,Class A (Rhodopsin),small molecule,agn-214868,ada1a_human,ADRA1A,85,Analgesics; neuralgia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,agn-214868,P35348,42
43,-,Class A (Rhodopsin),small molecule,agn-214868,ada1b_human,ADRA1B,85,Analgesics; neuralgia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,agn-214868,P35368,43
44,-,Class A (Rhodopsin),small molecule,agn-214868,ada1d_human,ADRA1D,85,Analgesics; neuralgia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,agn-214868,P25100,44
45,-,Class A (Rhodopsin),small molecule,agn-214868,ada2a_human,ADRA2A,85,Analgesics; neuralgia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,agn-214868,P08913,45
46,-,Class A (Rhodopsin),small molecule,agn-214868,ada2b_human,ADRA2B,85,Analgesics; neuralgia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,agn-214868,P18089,46
47,-,Class A (Rhodopsin),small molecule,agn-214868,ada2c_human,ADRA2C,85,Analgesics; neuralgia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,agn-214868,P18825,47
48,-,Class A (Rhodopsin),small molecule,agomelatine,mtr1b_human,MTNR1B,86,Anti-depressant,Melatonin ,,in trial,Melatonin,GPCR;Rhodopsin,established,"agomelatine , ago178c, s-20098,valdoxan, thymanax",P49286,48
49,-,Class A (Rhodopsin),small molecule,agomelatine,5ht2b_human,HTR2B,87,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"agomelatine, ago178c, s-20098,valdoxan, thymanax",P41595,49
50,-,Class A (Rhodopsin),small molecule,agomelatine,5ht2c_human,HTR2C,87,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"agomelatine, ago178c, s-20098,valdoxan, thymanax",P28335,50
51,-,Class A (Rhodopsin),small molecule,agomelatine,mtr1a_human,MTNR1A,87,Anti-depressant,Melatonin ,,in trial,Melatonin,GPCR;Rhodopsin,established,"agomelatine, ago178c, s-20098,valdoxan, thymanax",P48039,51
52,-,Class A (Rhodopsin),small molecule,aiko-150,oprm_human,OPRM1,92,opioid antagonist,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,aiko-150,P35372,52
53,-,Class A (Rhodopsin),small molecule,ajulemic acid,cnr1_human,CNR1,2361,Analgesics;neuropathic pain,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"ip 751, ct-3",P21554,53
54,-,Class A (Rhodopsin),small molecule,ajulemic acid,cnr2_human,CNR2,2361,Analgesics;neuropathic pain,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"ip 751, ct-3",P34972,54
55,-,Class A (Rhodopsin),small molecule,ajulemic acid,cnr2_human,CNR2,MMA2016_0031,Anti-inflammatory agent; systemic schlerosis,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,resunab,P34972,55
56,-,Class B1 (Secretin),small molecule,akl-0707,ghrhr_human,GHRH,96,hormone replacement,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"akl-0707, ghrh analog",Q02643,56
57,-,Class A (Rhodopsin),small molecule,akp-11,s1pr1_human,S1PR1,MMA2016_0028,psoriasis,Lipid ,,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,akp-11,P21453,57
58,-,Class A (Rhodopsin),small molecule,alb-127158(a),mshr_human,MC1R,100,Anti-obesity agent,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,alb-127158(a),Q01726,58
59,-,Class B1 (Secretin),protein,albiglutide,glp1r_human,GLP1R,101,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,"albiglutide, gsk716155,syncria",P43220,59
60,2010,Class A (Rhodopsin),small molecule,alcaftadine,hrh1_human,HRH1,NRDD011,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,60
61,1986,Class A (Rhodopsin),small molecule,alfentanil,oprm_human,OPRM1,NRDD015,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,61
62,1986,Class A (Rhodopsin),small molecule,alfentanil,oprm_human,OPRM1,MMAmay2016_0108,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox51,  sublingual alfentanil",P35372,62
63,-,Class A (Rhodopsin),small molecule,alfuzosin,ada1a_human,ADRA1A,107,for treatment of benign prostatic hyperplasia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alfuzosin,uroxatral",P35348,63
64,-,Class A (Rhodopsin),small molecule,alfuzosin,ada1b_human,ADRA1B,107,for treatment of benign prostatic hyperplasia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alfuzosin,uroxatral",P35368,64
65,-,Class A (Rhodopsin),small molecule,alfuzosin,ada1d_human,ADRA1D,107,for treatment of benign prostatic hyperplasia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alfuzosin,uroxatral",P25100,65
66,-,Class A (Rhodopsin),small molecule,alks 33,oprd_human,OPRD1,115,for treatment of alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 29,P41143,66
67,-,Class A (Rhodopsin),small molecule,alks 33,oprk_human,OPRK1,115,for treatment of alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 29,P41145,67
68,-,Class A (Rhodopsin),small molecule,alks 33,oprm_human,OPRM1,115,for treatment of alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 29,P35372,68
69,-,Class A (Rhodopsin),small molecule,alks 33,oprd_human,OPRD1,116,for treatment of alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 33,P41143,69
70,-,Class A (Rhodopsin),small molecule,alks 33,oprk_human,OPRK1,116,for treatment of alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 33,P41145,70
71,-,Class A (Rhodopsin),small molecule,alks 33,oprm_human,OPRM1,116,for treatment of alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 33,P35372,71
72,-,Class A (Rhodopsin),small molecule,alks 33,oprd_human,OPRD1,118,for treatment of alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 5461,P41143,72
73,-,Class A (Rhodopsin),small molecule,alks 33,oprk_human,OPRK1,118,for treatment of alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 5461,P41145,73
74,-,Class A (Rhodopsin),small molecule,alks 33,oprm_human,OPRM1,118,for treatment of alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 5461,P35372,74
75,-,Class A (Rhodopsin),small molecule,"alks 33, samidorphan",oprd_human,OPRD1,MMAmay2016_0184,Anti-obesity agent; for antipsychotic-related metabolic weight gain,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P41143,75
76,-,Class A (Rhodopsin),small molecule,"alks 33, samidorphan",oprk_human,OPRK1,MMAmay2016_0184,Anti-obesity agent; for antipsychotic-related metabolic weight gain,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P41145,76
77,-,Class A (Rhodopsin),small molecule,"alks 33, samidorphan",oprm_human,OPRM1,MMAmay2016_0184,Anti-obesity agent; for antipsychotic-related metabolic weight gain,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35372,77
78,-,Class A (Rhodopsin),small molecule,alks 37,oprd_human,OPRD1,117,motilitant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 37,P41143,78
79,-,Class A (Rhodopsin),small molecule,alks 37,oprk_human,OPRK1,117,motilitant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 37,P41145,79
80,-,Class A (Rhodopsin),small molecule,alks 37,oprm_human,OPRM1,117,motilitant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 37,P35372,80
81,-,Class A (Rhodopsin),small molecule,almorexant,ox1r_human,HCRTR1,119,sleep disorder treatment ,Peptide ,,in trial,Orexin receptors,GPCR;Rhodopsin,established,"almorexant, act-078573",O43613,81
82,-,Class A (Rhodopsin),small molecule,almorexant,ox2r_human,HCRTR2,119,sleep disorder treatment ,Peptide ,,in trial,Orexin receptors,GPCR;Rhodopsin,established,"almorexant, act-078573",O43614,82
83,-,Class A (Rhodopsin),small molecule,almotriptan,5ht1b_human,HTR1B,120,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"almotriptan,axert, almogran, amignul",P28222,83
84,-,Class A (Rhodopsin),small molecule,almotriptan,5ht1d_human,HTR1D,120,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"almotriptan,axert, almogran, amignul",P28221,84
85,-,Class A (Rhodopsin),small molecule,alprenolol,adrb1_human,ADRB1,NRDD019,Anti-Arrhythmia Agents; Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,85
86,-,Class A (Rhodopsin),small molecule,alprenolol,adrb2_human,ADRB2,NRDD019,Anti-Arrhythmia Agents; Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,86
87,-,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,128,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,alista",P34995,87
88,-,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,128,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,alista",P43116,88
89,-,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,129,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,femprox",P34995,89
90,-,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,129,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,femprox",P43116,90
91,-,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,130,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,topiglan",P34995,91
92,-,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,130,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,topiglan",P43116,92
93,-,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,MMAapril2016_0157,for treatment of Raynaud's Disease,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"rayva, alprostadil + ddaip.hcl",P34995,93
94,-,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,MMAapril2016_0158,for treatment of Raynaud's Disease,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"rayva, alprostadil + ddaip.hcl",P43116,94
95,-,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,2039,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"topical alprostadil cream,alprox-td, befar, vitaros",P34995,95
96,-,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,2039,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"topical alprostadil cream,alprox-td, befar, vitaros",P43116,96
97,2008,Class A (Rhodopsin),small molecule,alvimopan,oprm_human,OPRM1,NRDD021,Opiate Antagonists,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,97
98,2008,Class A (Rhodopsin),small molecule,alvimopan,oprm_human,MOR,2549,for treatment of opioid-induced bowel dysfunction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,entereg,P35372,98
99,-,Class A (Rhodopsin),antibody,"alx- 0651, biparatopic nanobody",cxcr4_human,CXCR4,MMAmay2016_0267,Antineoplastic agent,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"alx- 0651, biparatopic nanobody",P61073,99
100,-,Class B1 (Secretin),protein,alx1-11,pth1r_human,PTH1R,1646,Anti-osteoporotic agent,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,preos,Q03431,100
101,-,Class B1 (Secretin),protein,alx1-11,pth2r_human,PTH2R,1646,Anti-osteoporotic agent,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,preos,P49190,101
102,-,Class A (Rhodopsin),small molecule,am1030,5ht2b_human,HTR2B,MMAmar2016_0116,Anti-inflammatory agent; atopic dermatitis,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,am1030,P41595,102
103,-,Class A (Rhodopsin),small molecule,am-152,lpar1_human,LPAR1,144,Anti-inflammatory agent; antifibrotic agent,Lipid ,,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,am-152,Q92633,103
104,-,Class A (Rhodopsin),small molecule,am-211,pd2r2_human,GPR44,145,Anti-inflammatory agent; antiallergy agent,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,am-211,Q9Y5Y4,104
105,-,Class A (Rhodopsin),small molecule,am-461,pd2r_human,PTGDR,146,Anti-inflammatory agent,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,am-461,Q13258,105
106,-,Class A (Rhodopsin),small molecule,am-831,acm1_human,CHRM1,MMAmay2016_0047,Antipsychotic agent; schizophrenia,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,am-831,P11229,106
107,-,Class A (Rhodopsin),small molecule,am-831,drd2_human,DRD2,MMAmay2016_0048,Antipsychotic agent; schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,am-831,P14416,107
108,-,Class A (Rhodopsin),small molecule,am-831,5ht2a_human,HTR2A,MMAmay2016_0049,Antipsychotic agent; schizophrenia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,am-831,P28223,108
109,-,Class A (Rhodopsin),small molecule,amantadine hcl,drd2_human,DRD2,MMAmay2016_0242, for levodopa-induced dyskinesia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"ads-5102, amantadine hcl extended release",P14416,109
110,-,Class A (Rhodopsin),small molecule,amap102,5ht2b_human,HTR2B,148,Anti-inflammatory agent; DMARD,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,amap102,P41595,110
111,-,Class A (Rhodopsin),small molecule,amap102,5ht2c_human,HTR2C,148,Anti-inflammatory agent; DMARD,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,amap102,P28335,111
112,-,Class A (Rhodopsin),small molecule,ambrisentan,ednra_human,EDNRA,1111,Antihypertensive agent,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,letairis,P25101,112
113,-,Class A (Rhodopsin),small molecule,ambrisentan,ednrb_human,EDNRB,1111,Antihypertensive agent,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,letairis,P24530,113
114,-,Class A (Rhodopsin),small molecule,amd-070,cxcr4_human,CXCR4,150,antiviral agent; HIV,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,amd-070,P61073,114
115,-,Class B1 (Secretin),antibody,amg 334,calrl_human,CALCRL,MMAapril2016_0116,Anti-migraine Agents,Peptide ,,in trial,Calcitonin receptors,GPCR;Secretin,not established,amg 334,Q16602,115
116,-,Class A (Rhodopsin),small molecule,amibegron,adrb3_human,ADRB3,158,Anti-depressant,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"amibegron, sr 58611",P13945,116
117,-,Class A (Rhodopsin),small molecule,amiodarone,ada1a_human,ADRA1A,160,Anti-Arrhythmia Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"amiodarone hcl,amio-aqueous iv",P35348,117
118,-,Class A (Rhodopsin),small molecule,amiodarone,adrb1_human,ADRB1,160,Anti-Arrhythmia Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"amiodarone hcl,amio-aqueous iv",P08588,118
119,-,Class A (Rhodopsin),small molecule,amisulpride,drd2_human,DRD2,161,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"amisulpride,solian",P14416,119
120,-,Class A (Rhodopsin),small molecule,amisulpride,drd3_human,DRD3,161,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"amisulpride,solian",P35462,120
121,-,Class A (Rhodopsin),small molecule,amisulpride,drd2_human,DRD2,MMAmay2016_0704,Antiemetics; chemotherapy induced nausea and vomiting,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,apd403,P14416,121
122,-,Class A (Rhodopsin),small molecule,amisulpride,drd3_human,DRD3,MMAmay2016_0705,Antiemetics; chemotherapy induced nausea and vomiting,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,apd403,P35462,122
123,-,Class A (Rhodopsin),small molecule,amitriptyline,5ht2a_human,HTR2A,1491,Analgesics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,oms-103hp,P28223,123
124,-,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,413,for treatment of cognitive dysfunction; for treatment of ADHD,Aminergic ,,approved,Trace amine receptors,GPCR;Rhodopsin,established,"c105, levo-amphetamine sulfate",Q96RJ0,124
125,-,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,MMAmay2016_0357,for treatment of cognitive dysfunction; for treatment of ADHD,Aminergic ,,approved,Trace amine receptors,GPCR;Rhodopsin,established,d-amphetamine transdermal system (d-ats),Q96RJ0,125
126,-,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,MMAmay2016_0658,for treatment of cognitive dysfunction; for treatment of ADHD,Aminergic ,,approved,Trace amine receptors,GPCR;Rhodopsin,established,"hld-100, reformulated amphetamine",Q96RJ0,126
127,-,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,1862,for treatment of cognitive dysfunction; for treatment of ADHD,Aminergic ,,approved,Trace amine receptors,GPCR;Rhodopsin,established,"sli 381, spd 465,adderall, adderall xr, adderall ir",Q96RJ0,127
128,-,Class A (Rhodopsin),small molecule,anamorelin,ghsr_human,GHSR,175,Appetite stimulant,Peptide ,,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,"anamorelin, rc-1291",Q92847,128
129,-,Class A (Rhodopsin),small molecule,anatibant,bkrb2_human,BDKRB2,177,for treatment of traumatic brain injury,Peptide ,,in trial,Bradykinin receptors,GPCR;Rhodopsin,established,anatibant,P30411,129
130,-,Class A (Rhodopsin),small molecule,anileridine,oprm_human,OPRM1,NRDD027,Analgesics; Narcotics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,130
131,-,Class A (Rhodopsin),small molecule,anisotropine methylbromide,acm1_human,CHRM1,NRDD029,Antispasmodics; Anti-ulcer Agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,131
132,-,Class A (Rhodopsin),small molecule,anisotropine methylbromide,acm2_human,CHRM2,NRDD029,Antispasmodics; Anti-ulcer Agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,132
133,-,Class A (Rhodopsin),small molecule,anisotropine methylbromide,acm3_human,CHRM3,NRDD029,Antispasmodics; Anti-ulcer Agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,133
134,-,Class A (Rhodopsin),small molecule,ap-1034,mshr_human,MC1R,189,Anti-obesity agent,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap1030,Q01726,134
135,-,Class A (Rhodopsin),small molecule,ap-1034,mc4r_human,MC4R,189,Anti-obesity agent,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap1030,P32245,135
136,-,Class A (Rhodopsin),peptide,ap214,mshr_human,MC1R,2538,for treatment of post-surgical kidney injury,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,Q01726,136
137,-,Class A (Rhodopsin),peptide,ap214,mc3r_human,MC3R,2538,for treatment of post-surgical kidney injury,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,P41968,137
138,-,Class A (Rhodopsin),peptide,ap214,mc4r_human,MC4R,2538,for treatment of post-surgical kidney injury,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,P32245,138
139,-,Class A (Rhodopsin),peptide,ap214,mc5r_human,MC5R,2538,for treatment of post-surgical kidney injury,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,P33032,139
140,-,Class A (Rhodopsin),small molecule,apd125,5ht2a_human,HTR2A,192,for treatment of insomnia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,apd125,P28223,140
141,-,Class A (Rhodopsin),small molecule,apd334,s1pr1_human,S1PR1,MMAmay2016_0282,for autoimmune disorders,Lipid ,,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,apd334,P21453,141
142,-,Class A (Rhodopsin),small molecule,apd421,drd2_human,DRD2,193,Antiemetics,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,apd421,P14416,142
143,-,Class A (Rhodopsin),small molecule,apd597,gp119_human,GPR119,2469,Antidiabetic,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,apd597,Q8TDV5,143
144,-,Class A (Rhodopsin),small molecule,apd668,gp119_human,GPR119,194,Antidiabetic,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,apd668,Q8TDV5,144
145,-,Class A (Rhodopsin),small molecule,apd791,5ht2a_human,HTR2A,195,antithrombotic,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,apd791,P28223,145
146,-,Class A (Rhodopsin),small molecule,apd811,pi2r_human,PTGIR,MMAmay2016_0283,Antihypertensive agent,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,apd811,P43119,146
147,-,Class A (Rhodopsin),small molecule,apd916,hrh3_human,HRH3,196,for treatment of sleep disorders; narcolepsy,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,apd916,Q9Y5N1,147
148,-,Class A (Rhodopsin),peptide,apelin,apj_human,APLNR,MMAjun2016_0045,Cardiovascular disorders; Insulin sensitivity,Peptide ,,in trial,Apelin receptors,GPCR;Rhodopsin,not established,apelin,P35414,148
149,-,Class A (Rhodopsin),small molecule,"api246,  srx246",v1ar_human,AVPR1A,MMAjun2016_0005,Treatment of affective and anger disorders,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"api246,  srx246",P37288,149
150,-,Class A (Rhodopsin),small molecule,aplindore,drd2_human,DRD2,203,Antiparkinson agent; for treatment of restlegs legs syndrome,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"aplindore, dab-452",P14416,150
151,-,Class A (Rhodopsin),small molecule,apomorphine,drd2_human,DRD2,206,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hcl,uprima, ixense",P14416,151
152,-,Class A (Rhodopsin),small molecule,apomorphine,drd3_human,DRD3,206,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hcl,uprima, ixense",P35462,152
153,-,Class A (Rhodopsin),small molecule,apomorphine,drd4_human,DRD4,206,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hcl,uprima, ixense",P21917,153
154,-,Class A (Rhodopsin),small molecule,apomorphine,drd2_human,DRD2,207,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hydrochloride,apokyn, apo-go",P14416,154
155,-,Class A (Rhodopsin),small molecule,apomorphine,drd3_human,DRD3,207,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hydrochloride,apokyn, apo-go",P35462,155
156,-,Class A (Rhodopsin),small molecule,apomorphine,drd4_human,DRD4,207,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hydrochloride,apokyn, apo-go",P21917,156
157,-,Class A (Rhodopsin),small molecule,apomorphine,drd2_human,DRD2,976,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",P14416,157
158,-,Class A (Rhodopsin),small molecule,apomorphine,drd3_human,DRD3,976,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",P35462,158
159,-,Class A (Rhodopsin),small molecule,apomorphine,drd4_human,DRD4,976,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",P21917,159
160,-,Class A (Rhodopsin),small molecule,apomorphine,drd2_human,DRD2,1009,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,intranasal apomorphine,P14416,160
161,-,Class A (Rhodopsin),small molecule,apomorphine,drd3_human,DRD3,1009,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,intranasal apomorphine,P35462,161
162,-,Class A (Rhodopsin),small molecule,apomorphine,drd4_human,DRD4,1009,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,intranasal apomorphine,P21917,162
163,1987,Class A (Rhodopsin),small molecule,apraclonidine,ada2a_human,ADRA2A,NRDD032,Antiglaucomic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,163
164,-,Class A (Rhodopsin),small molecule,aprepitant,nk1r_human,TACR1,209,Antiemetics,Peptide ,,approved,Tachykinin receptors,GPCR;Rhodopsin,established,"aprepitant, mk-869, fosaprepitant dimeglumine, mk-0517,emend",P25103,164
165,-,Class C (Glutamate) ,small molecule,arbaclofen,gabr1_human,GABBR1,216,symptomatic treatment for fragile X syndrome,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,arbaclofen,Q9UBS5,165
166,-,Class C (Glutamate) ,small molecule,arbaclofen,gabr2_human,GABBR2,216,symptomatic treatment for fragile X syndrome,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,arbaclofen,O75899,166
167,1997,Class A (Rhodopsin),small molecule,arbutamine,adrb1_human,ADRB1,NRDD034,Cardiotonic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,167
168,2006,Class A (Rhodopsin),small molecule,arformoterol,adrb2_human,ADRB2,NRDD036,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,168
169,-,Class A (Rhodopsin),small molecule,arformoterol,adrb2_human,ADRB2,2276,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,brovana,P07550,169
170,-,Class A (Rhodopsin),small molecule,ari-3037mo,hcar2_human,HCAR2,226,Vitamin B analog; for treatment for hyperlipidemia,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,ari-3037mo,Q8TDS4,170
171,-,Class A (Rhodopsin),small molecule,ari-3037mo,hcar3_human,HCAR3,226,Vitamin B analog; for treatment for hyperlipidemia,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,ari-3037mo,P49019,171
172,-,Class A (Rhodopsin),small molecule,aripiprazole,drd2_human,DRD2,22,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,abilify,P14416,172
173,-,Class A (Rhodopsin),small molecule,aripiprazole,5ht1a_human,HTR1A,22,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,abilify,P08908,173
174,-,Class A (Rhodopsin),small molecule,aripiprazole,5ht2a_human,HTR2A,22,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,abilify,P28223,174
175,-,Class A (Rhodopsin),small molecule,aripiprazole,5ht1a_human,HTR1A,MMAmay2016_0260,Antipsychotic agent; schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 9070,P08908,175
176,-,Class A (Rhodopsin),small molecule,aripiprazole,drd2_human,DRD2,MMAmay2016_0261,Antipsychotic agent; schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 9070,P14416,176
177,-,Class A (Rhodopsin),small molecule,aripiprazole,5ht2a_human,HTR2A,MMAmay2016_0262,Antipsychotic agent; schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 9070,P28223,177
178,-,Class A (Rhodopsin),small molecule,arry-502,pd2r2_human,GPR44,MMAapril2016_0314,Anti-Allergic Agents,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,arry-502,Q9Y5Y4,178
179,-,Class A (Rhodopsin),small molecule,asenapine,ada1a_human,ADRA1A,250,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,asenapine,P35348,179
180,-,Class A (Rhodopsin),small molecule,asenapine,ada2a_human,ADRA2A,250,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,asenapine,P08913,180
181,-,Class A (Rhodopsin),small molecule,asenapine,ada2b_human,ADRA2B,250,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,asenapine,P18089,181
182,-,Class A (Rhodopsin),small molecule,asenapine,ada2c_human,ADRA2C,250,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,asenapine,P18825,182
183,-,Class A (Rhodopsin),small molecule,asenapine,drd1_human,DRD1,250,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,asenapine,P21728,183
184,-,Class A (Rhodopsin),small molecule,asenapine,drd2_human,DRD2,250,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,asenapine,P14416,184
185,-,Class A (Rhodopsin),small molecule,asenapine,drd3_human,DRD3,250,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,asenapine,P35462,185
186,-,Class A (Rhodopsin),small molecule,asenapine,drd4_human,DRD4,250,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,asenapine,P21917,186
187,-,Class A (Rhodopsin),small molecule,asenapine,hrh1_human,HRH1,250,Antipsychotic agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,asenapine,P35367,187
188,-,Class A (Rhodopsin),small molecule,asenapine,hrh2_human,HRH2,250,Antipsychotic agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,asenapine,P25021,188
189,-,Class A (Rhodopsin),small molecule,asenapine,5ht1a_human,HTR1A,250,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P08908,189
190,-,Class A (Rhodopsin),small molecule,asenapine,5ht1b_human,HTR1B,250,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P28222,190
191,-,Class A (Rhodopsin),small molecule,asenapine,5ht2a_human,HTR2A,250,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P28223,191
192,-,Class A (Rhodopsin),small molecule,asenapine,5ht2b_human,HTR2B,250,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P41595,192
193,-,Class A (Rhodopsin),small molecule,asenapine,5ht2c_human,HTR2C,250,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P28335,193
194,-,Class A (Rhodopsin),small molecule,asenapine,5ht5a_human,HTR5A,250,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P47898,194
195,-,Class A (Rhodopsin),small molecule,asenapine,5ht6r_human,HTR6,250,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P50406,195
196,-,Class A (Rhodopsin),small molecule,asenapine,5ht7r_human,HTR7,250,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P34969,196
197,-,Class A (Rhodopsin),small molecule,asimadoline,oprk_human,OPRK1,253,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,asimadoline,P41145,197
198,-,Class A (Rhodopsin),small molecule,asm-024,adrb2_human,ADRB2,MMAmay2016_0687,for asthma and COPD,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,asm-024,P07550,198
199,1988,Class A (Rhodopsin),small molecule,astemizole,hrh1_human,HRH1,NRDD037,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,199
200,1981,Class A (Rhodopsin),small molecule,atenolol,adrb1_human,ADRB1,NRDD038,Anti-Arrhythmia Agents; Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,200
201,-,Class A (Rhodopsin),small molecule,athx-105,5ht2c_human,HTR2C,263,Anti-obesity agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,athx-105,P28335,201
202,-,Class A (Rhodopsin),small molecule,ati-7505,5ht4r_human,HTR4,265,Parasympathomimetic,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ati-7505,Q13639,202
203,-,Class A (Rhodopsin),small molecule,ati-9242,drd2_human,DRD2,2423,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,ati-9242,P14416,203
204,-,Class A (Rhodopsin),small molecule,ati-9242,5ht2a_human,HTR2A,2423,Antipsychotic agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ati-9242,P28223,204
205,-,Class A (Rhodopsin),small molecule,atrasentan,ednra_human,EDNRA,270,Antineoplastic agent,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"atrasentan, abt-627,xinlay",P25101,205
206,-,Class A (Rhodopsin),small molecule,atropine,acm1_human,CHRM1,977,nerve agent antidote,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P11229,206
207,-,Class A (Rhodopsin),small molecule,atropine,acm2_human,CHRM2,977,nerve agent antidote,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P08172,207
208,-,Class A (Rhodopsin),small molecule,atropine,acm3_human,CHRM3,977,nerve agent antidote,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P20309,208
209,-,Class A (Rhodopsin),small molecule,atropine,acm4_human,CHRM4,977,nerve agent antidote,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P08173,209
210,-,Class A (Rhodopsin),small molecule,atropine,acm5_human,CHRM5,977,nerve agent antidote,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P08912,210
211,-,Class A (Rhodopsin),small molecule,av608,nk1r_human,TACR1,278,Anti-depressant; for treatment of irritable bowel syndrome; antispasmodic,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,av608,P25103,211
212,-,Class A (Rhodopsin),small molecule,ave-1625,cnr1_human,CNR1,284,Anti-obesity agent; for treatment for Alzheimer's disease,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,ave-1625,P21554,212
213,-,Class A (Rhodopsin),vaccine,avicine,lshr_human,LHCGR,563,Antineoplastic agent; vaccine,Protein ,,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"ctp-37,avicine",P22888,213
214,-,Class A (Rhodopsin),small molecule,avn-101,5ht6r_human,HTR6,290,for treatment of Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,avn-101,P50406,214
215,-,Class A (Rhodopsin),small molecule,avn-211,5ht6r_human,HTR6,291,Antipsychotic agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,avn-211,P50406,215
216,-,Class A (Rhodopsin),small molecule,avn-322,5ht6r_human,HTR6,292,for treatment of Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,avn-322,P50406,216
217,-,Class A (Rhodopsin),small molecule,avn-397,5ht6r_human,HTR6,2490,anxiolytic;for treatment of Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,avn-397,P50406,217
218,-,Class A (Rhodopsin),small molecule,avosentan,ednra_human,EDNRA,295,Antihypertensive agent,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"avosentan, spp 301",P25101,218
219,-,Class A (Rhodopsin),peptide nucleic acid,avr118,aa2ar_human,ADORA2A,2269,wound healing accelerant,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,avr123,P29274,219
220,-,Class A (Rhodopsin),peptide nucleic acid,avr118,aa2br_human,ADORA2B,2269,wound healing accelerant,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,avr123,P29275,220
221,-,Class A (Rhodopsin),peptide nucleic acid,avr118,aa3r_human,ADORA3,2269,wound healing accelerant,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,avr123,P0DMS8,221
222,1977,Class A (Rhodopsin),small molecule,azatadine,hrh1_human,HRH1,NRDD041,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,222
223,-,Class C (Glutamate) ,small molecule,azd2066,grm5_human,GRM5,308,Analgesics; for treatment of gastroesophageal reflux disease,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,azd2066,P41594,223
224,-,Class A (Rhodopsin),small molecule,azd2423,ccr2_human,CCR2,2331,for treatment of chronic obstructive pulmonary disorder;Analgesics; neuropathic pain,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,azd2423,P41597,224
225,-,Class A (Rhodopsin),small molecule,azd2820,mc4r_human,MC4R,MMAmay2016_0297,Anti-obesity agent,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,azd2820,P32245,225
226,-,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,313,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,azelastine,P35367,226
227,-,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,314,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"azelastine hydrochloride nasal spray,astepro",P35367,227
228,-,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,456,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"cdx-313, budesonide + azelastine nasal spray",P35367,228
229,-,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,MMAmay2016_0366,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"dymista, azelastine hydrochloride + fluticasone propionate",P35367,229
230,-,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,679,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"dymista, azelastine hydrochloride + fluticasone propionate, mp29-02",P35367,230
231,-,Class A (Rhodopsin),small molecule,azilsartan,agtr1_human,AGTR1,315,Antihypertensive agent,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"azilsartan medoxomil, tak-491",P30556,231
232,-,Class A (Rhodopsin),small molecule,azilsartan,agtr1_human,AGTR1,MMAmay2016_0371,Antihypertensive agent,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"edarbyclor, azilsartan medoxomil + chlorthalidone",P30556,232
233,-,Class A (Rhodopsin),peptide,"azp-531, unacylated ghrelin",ghsr_human,GHSR,MMAapril2016_0315,Antidiabetic agent,Peptide ,,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,"azp-531, unacylated ghrelin",Q92847,233
234,-,Class C (Glutamate) ,small molecule,baclofen,gabr1_human,GABBR1,115,for treatment of alcohol dependance,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,alks 29,Q9UBS5,234
235,-,Class C (Glutamate) ,small molecule,baclofen,gabr2_human,GABBR2,115,for treatment of alcohol dependance,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,alks 29,O75899,235
236,-,Class C (Glutamate) ,small molecule,baclofen,gabr2_human,GABBR2,MMAmay2016_0071,for type 1A Charcot-Marie-Tooth disease,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,"pxt3003, baclofen + naltrexone + sorbitol",O75899,236
237,-,Class C (Glutamate) ,small molecule,baclofen,gabr1_human,GABBR1,MMAmay2016_0072,for type 1A Charcot-Marie-Tooth disease,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,"pxt3003, baclofen + naltrexone + sorbitol",Q9UBS5,237
238,-,Class C (Glutamate) ,small molecule,bci-838,grm2_human,GRM2,MMAmay2016_0306,Anti-depressant,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,bci-838,Q14416,238
239,-,Class C (Glutamate) ,small molecule,bci-838,grm3_human,GRM3,MMAmay2016_0307,Anti-depressant,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,bci-838,Q14832,239
240,1960,Class A (Rhodopsin),small molecule,benzphetamine,ada1a_human,ADRA1A,NRDD046,Central Nervous System Stimulants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,240
241,1960,Class A (Rhodopsin),small molecule,benzphetamine,ada2a_human,ADRA2A,NRDD046,Central Nervous System Stimulants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,241
242,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm1_human,CHRM1,NRDD047,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,242
243,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm2_human,CHRM2,NRDD047,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,243
244,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm3_human,CHRM3,NRDD047,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,244
245,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm4_human,CHRM4,NRDD047,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,245
246,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm5_human,CHRM5,NRDD047,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,246
247,1974,Class A (Rhodopsin),small molecule,benzquinamide,hrh1_human,HRH1,NRDD047,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,247
248,1954,Class A (Rhodopsin),small molecule,benztropine,acm1_human,CHRM1,NRDD049,Antiparkinson agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,248
249,-,Class A (Rhodopsin),small molecule,bepotastine,hrh1_human,HRH1,336,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"bepotastine besilate,bepreve, talion",P35367,249
250,-,Class A (Rhodopsin),small molecule,beraprost,pi2r_human,PTGIR,337,Antihypertensive agent,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,beraprost,P43119,250
251,-,Class A (Rhodopsin),small molecule,betahistine,hrh1_human,HRH1,MMAmay2016_0919,for treatment of vertigo,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,betahistine,P35367,251
252,-,Class A (Rhodopsin),small molecule,betahistine,hrh3_human,HRH3,MMAmay2016_0920,for treatment of vertigo,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,betahistine,Q9Y5N1,252
253,-,Class A (Rhodopsin),small molecule,betahistine,hrh1_human,HRH1,1464,Anti-obesity agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"obe101,histalean,anti-obesity agent",P35367,253
254,-,Class A (Rhodopsin),small molecule,betahistine,hrh3_human,HRH3,1464,Anti-obesity agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"obe101,histalean,anti-obesity agent",Q9Y5N1,254
255,-,Class A (Rhodopsin),small molecule,betanechol,acm2_human,CHRM2,648,Antidiabetic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dm-71,P08172,255
256,1985,Class A (Rhodopsin),small molecule,betaxolol,adrb1_human,ADRB1,NRDD052,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,256
257,-,Class A (Rhodopsin),small molecule,betazole,hrh2_human,HRH2,NRDD053,Diagnostic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P25021,257
258,-,Class A (Rhodopsin),small molecule,bethanechol,acm1_human,CHRM1,NRDD054,Parasympathomimetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,258
259,-,Class A (Rhodopsin),small molecule,bethanidine,ada1a_human,ADRA1A,NRDD055,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,259
260,-,Class A (Rhodopsin),small molecule,bethanidine,ada1b_human,ADRA1B,NRDD055,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,260
261,-,Class A (Rhodopsin),small molecule,bethanidine,ada1d_human,ADRA1D,NRDD055,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,261
262,-,Class A (Rhodopsin),small molecule,bethanidine,ada2a_human,ADRA2A,NRDD055,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,262
263,-,Class A (Rhodopsin),small molecule,bethanidine,ada2b_human,ADRA2B,NRDD055,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089,263
264,-,Class A (Rhodopsin),small molecule,bethanidine,ada2c_human,ADRA2C,NRDD055,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18825,264
265,-,Class A (Rhodopsin),small molecule,bevantolol,adrb1_human,ADRB1,NRDD056,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,265
266,-,Class A (Rhodopsin),small molecule,bf-1,5ht2b_human,HTR2B,343,Anti-migraine Agents,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,bf-1,P41595,266
267,-,Class A (Rhodopsin),small molecule,bg-9928,aa1r_human,ADORA1,345,for treatment of congestive heart failure,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,bg-9928,P30542,267
268,-,Class A (Rhodopsin),small molecule,bgc20-1531 ,pe2r4_human,PTGER4,347,Anti-migraine Agents,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,bgc20-1531,P35408,268
269,-,Class A (Rhodopsin),small molecule,bifeprunox,drd2_human,DRD2,356,Antipsychotic agent; Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P14416,269
270,-,Class A (Rhodopsin),small molecule,bifeprunox,drd3_human,DRD3,356,Antipsychotic agent; Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P35462,270
271,-,Class A (Rhodopsin),small molecule,bifeprunox,5ht1a_human,HTR1A,356,Antipsychotic agent; Antiparkinson agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P08908,271
272,-,Class A (Rhodopsin),small molecule,bifeprunox,5ht2a_human,HTR2A,356,Antipsychotic agent; Antiparkinson agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P28223,272
273,-,Class A (Rhodopsin),small molecule,bifeprunox,5ht2c_human,HTR2C,356,Antipsychotic agent; Antiparkinson agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P28335,273
274,-,Class A (Rhodopsin),small molecule,bifeprunox,5ht7r_human,HTR7,356,Antipsychotic agent; Antiparkinson agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P34969,274
275,-,Class A (Rhodopsin),small molecule,biib014,aa2ar_human,ADORA2A,2164,Antiparkinson agent,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,vipadenantis,P29274,275
276,-,Class A (Rhodopsin),small molecule,bim23a760,drd2_human,DRD2,358,Antineoplastic agent; treatment for acromegaly,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,bim23a760,P14416,276
277,-,Class A (Rhodopsin),small molecule,bim23a760,ssr2_human,SSTR2,358,Antineoplastic agent; treatment for acromegaly,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,bim23a760,P30874,277
278,-,Class A (Rhodopsin),small molecule,bim23a760,ssr5_human,SSTR5,358,Antineoplastic agent; treatment for acromegaly,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,bim23a760,P35346,278
279,-,Class A (Rhodopsin),small molecule,bimatoprost,pe2r1_human,PTGER1,359,Antiglaucomic Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"bimatoprost,  agn 192024,lumigan",P34995,279
280,-,Class A (Rhodopsin),small molecule,bimatoprost,pe2r3_human,PTGER3,359,Antiglaucomic Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"bimatoprost,  agn 192024,lumigan",P43115,280
281,-,Class A (Rhodopsin),small molecule,bimatoprost,pf2r_human,PTGFR,359,Antiglaucomic Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"bimatoprost,  agn 192024,lumigan",P43088,281
282,-,Class A (Rhodopsin),small molecule,bimatoprost,pe2r1_human,PTGER1,MMAmar2016_0296,Antiglaucomic Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"helios insert, bimatoprost ocular insert",P34995,282
283,-,Class A (Rhodopsin),small molecule,bimatoprost,pf2r_human,PTGFR,MMAmar2016_0297,Antiglaucomic Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"helios insert, bimatoprost ocular insert",P43088,283
284,-,Class A (Rhodopsin),small molecule,bimatoprost,pe2r3_human,PTGER3,MMAmar2016_0298,Antiglaucomic Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"helios insert, bimatoprost ocular insert",P43115,284
285,-,Class A (Rhodopsin),small molecule,binodenoson,aa2ar_human,ADORA2A,363,Diagnostic Agents,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"binodenoson, mre 0470,corvue",P29274,285
286,1959,Class A (Rhodopsin),small molecule,biperiden,acm1_human,CHRM1,NRDD057,Antidyskinetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,286
287,1992,Class A (Rhodopsin),small molecule,bisoprolol,adrb1_human,ADRB1,NRDD058,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,287
288,-,Class A (Rhodopsin),small molecule,bl-1020,drd2_human,DRD2,2424,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,bl-1020,P14416,288
289,-,Class A (Rhodopsin),small molecule,bl-1020,hrh1_human,HRH1,2424,Antipsychotic agent,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,bl-1020,P35367,289
290,-,Class A (Rhodopsin),small molecule,bl-1020,5ht2a_human,HTR2A,2424,Antipsychotic agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,bl-1020,P28223,290
291,-,Class A (Rhodopsin),peptide,bl-8040,cxcr4_human,CXCR4,APR13_0001,Antineoplastic agent,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,bl-8040,P61073,291
292,-,Class A (Rhodopsin),antibody,bms 936564,cxcr4_human,CXCR4,369,Antineoplastic agent,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"bms 936564, mdx-1338",P61073,292
293,-,Class A (Rhodopsin),small molecule,bosentan,ednra_human,EDNRA,2053,for treatment of pulmonary arterial hypertension,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,tracleer,P25101,293
294,-,Class A (Rhodopsin),small molecule,bosentan,ednrb_human,EDNRB,2053,for treatment of pulmonary arterial hypertension,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,tracleer,P24530,294
295,-,Class A (Rhodopsin),small molecule,"boxaban, hepatoren, vasculan, ifetroban",ta2r_human,TBXA2R,MMAjun2016_0011,Treatment of asystemic scleroderma; hepatorenal syndrome; asthma,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"boxaban, hepatoren, vasculan, ifetroban",P21731,295
296,-,Class A (Rhodopsin),peptide,bremelanotide,mshr_human,MC1R,383,for treatment of sexual dysfunction,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,bremelanotide,Q01726,296
297,-,Class A (Rhodopsin),peptide,bremelanotide,mc4r_human,MC4R,383,for treatment of sexual dysfunction,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,bremelanotide,P32245,297
298,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2a_human,ADRA2A,385,for treatment of glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate,alphagan",P08913,298
299,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2b_human,ADRA2B,385,for treatment of glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate,alphagan",P18089,299
300,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2c_human,ADRA2C,385,for treatment of glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate,alphagan",P18825,300
301,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2a_human,ADRA2A,386,for treatment of glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P08913,301
302,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2b_human,ADRA2B,386,for treatment of glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P18089,302
303,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2c_human,ADRA2C,386,for treatment of glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P18825,303
304,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2a_human,ADRA2A,2274,for treatment of erythema,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"cd07805/47, sansrosa, col-118",P08913,304
305,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2b_human,ADRA2B,2274,for treatment of erythema,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"cd07805/47, sansrosa, col-118",P18089,305
306,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2c_human,ADRA2C,2274,for treatment of erythema,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"cd07805/47, sansrosa, col-118",P18825,306
307,-,Class A (Rhodopsin),small molecule,bromocriptine,drd2_human,DRD2,389,Antidiabetic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"bromocriptine mesylate,cycloset, ergoset",P14416,307
308,-,Class A (Rhodopsin),small molecule,bromocriptine,drd3_human,DRD3,389,Antidiabetic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"bromocriptine mesylate,cycloset, ergoset",P35462,308
309,-,Class A (Rhodopsin),small molecule,bromodiphenhydramine,hrh1_human,HRH1,NRDD062,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,309
310,-,Class A (Rhodopsin),small molecule,brompheniramine,hrh1_human,HRH1,NRDD063,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,310
311,-,Class A (Rhodopsin),small molecule,bucindolol,adrb1_human,ADRB1,396,for treatment of heart failure,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"bucindolol hydrochloride,gencaro",P08588,311
312,-,Class A (Rhodopsin),small molecule,bucindolol,adrb2_human,ADRB2,396,for treatment of heart failure,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"bucindolol hydrochloride,gencaro",P07550,312
313,-,Class A (Rhodopsin),small molecule,buclizine,acm1_human,CHRM1,NRDD064,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,313
314,-,Class A (Rhodopsin),small molecule,buclizine,hrh1_human,HRH1,NRDD064,Antiemetics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,314
315,-,Class A (Rhodopsin),small molecule,budiodarone,adrb1_human,ADRB1,404,Anti-Arrhythmia Agents,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"budiodarone, ati-2042",P08588,315
316,-,Class A (Rhodopsin),small molecule,buprenorphine,oprd_human,OPRD1,118,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,alks 5461,P41143,316
317,-,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,118,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,alks 5461,P41145,317
318,-,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,333,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"bema buprenorphine, buccal mucosa adhesive",P41145,318
319,-,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,333,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"bema buprenorphine, buccal mucosa adhesive",P35372,319
320,-,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,405,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P41145,320
321,-,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,405,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P35372,321
322,-,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,406,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P41145,322
323,-,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,406,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P35372,323
324,-,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,407,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine subcutaneous implant,probuphine",P41145,324
325,-,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,407,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine subcutaneous implant,probuphine",P35372,325
326,-,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,408,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine sublingual tablet,subutex",P41145,326
327,-,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,408,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine sublingual tablet,subutex",P35372,327
328,-,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,MMAmar2016_0045,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"butab, rel-1028, oral, enteric-coated buprenorphine",P35372,328
329,-,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,MMAmar2016_0047,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"butab, rel-1028, oral, enteric-coated buprenorphine",P41145,329
330,-,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,409,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",P41145,330
331,-,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,409,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",P35372,331
332,-,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,422,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,cam2038,P41145,332
333,-,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,422,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,cam2038,P35372,333
334,-,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,MMAmay2016_0514,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P35372,334
335,-,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,MMAmay2016_0516,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P41145,335
336,-,Class A (Rhodopsin),small molecule,buprenorphine,oprd_human,OPRD1,2109,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,v1003,P41143,336
337,-,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,2109,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,v1003,P41145,337
338,-,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,2109,Anti-depressant; Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,v1003,P35372,338
339,1986,Class A (Rhodopsin),small molecule,buspirone,drd2_human,DRD2,NRDD066,Anti-anxiety Agents,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,339
340,1986,Class A (Rhodopsin),small molecule,buspirone,5ht1a_human,HTR1A,NRDD066,Anti-anxiety Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P08908,340
341,1978,Class A (Rhodopsin),small molecule,butorphanol,oprd_human,OPRD1,NRDD070,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41143,341
342,1978,Class A (Rhodopsin),small molecule,butorphanol,oprk_human,OPRK1,NRDD070,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,342
343,1978,Class A (Rhodopsin),small molecule,butorphanol,oprm_human,OPRM1,NRDD070,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,343
344,-,Class A (Rhodopsin),small molecule,bvt.115959,aa2ar_human,ADORA2A,411,Analgesics,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,bvt.115959,P29274,344
345,-,Class A (Rhodopsin),small molecule,bvt.28949,5ht2a_human,HTR2A,412,for treatment of glaucoma,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,bvt.28949,P28223,345
346,1996,Class A (Rhodopsin),small molecule,cabergoline,drd2_human,DRD2,NRDD071,Antiparkinson agents,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,346
347,-,Class A (Rhodopsin),small molecule,caffeine,aa1r_human,ADORA1,NRDD072,Central Nervous System Stimulants,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,-,P30542,347
348,-,Class A (Rhodopsin),small molecule,caffeine,aa2ar_human,ADORA2A,NRDD072,Central Nervous System Stimulants,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,-,P29274,348
349,-,Class A (Rhodopsin),cell therapy,"cal-1, autologous t cell and blood stem cell therapy",ccr5_human,CCR5,MMAapril2016_0320,antiviral agent; HIV,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"cal-1, autologous t cell and blood stem cell therapy",P51681,349
350,-,Class B1 (Secretin),small molecule,calcitonin,calcr_human,CALCR,376,Anti-osteoporotic agent,Peptide ,,approved,Calcitonin receptors,GPCR;Secretin,established,"bn-002,capsitonin",P30988,350
351,-,Class B1 (Secretin),small molecule,calcitonin,calcr_human,CALCR,2154,Anti-osteoporotic agent,Peptide ,,approved,Calcitonin receptors,GPCR;Secretin,established,viaderm-calcitonin,P30988,351
352,-,Class A (Rhodopsin),small molecule,candesartan,agtr1_human,AGTR1,427,Antihypertensive agent,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"candesartan cilexetil,atacand",P30556,352
353,2015,Class A (Rhodopsin),small molecule,cangrelor,p2y12_human,P2RY12,428,antithrombotic,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,"cangrelor, ar69931",Q9H244,353
354,-,Class A (Rhodopsin),small molecule,cannabidiol,cnr1_human,CNR1,MMAmar2016_0268,for treatment of epilepsy,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,cannabidiol,P21554,354
355,-,Class A (Rhodopsin),small molecule,cannabidiol,cnr2_human,CNR2,MMAmar2016_0269,for treatment of epilepsy,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,cannabidiol,P34972,355
356,-,Class A (Rhodopsin),small molecule,cannabidiol,cnr1_human,CNR1,MMAmar2016_0270,for treatment of epilepsy,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"epidiolex, oral liquid cannabidiol",P21554,356
357,-,Class A (Rhodopsin),small molecule,cannabidiol,cnr2_human,CNR2,MMAmar2016_0271,for treatment of epilepsy,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"epidiolex, oral liquid cannabidiol",P34972,357
358,-,Class A (Rhodopsin),small molecule,cannabidiol (cbd),cnr1_human,CNR1,MMAapril2016_0328,for ulcerative colitis and schizophrenia,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,gwp42003,P21554,358
359,-,Class A (Rhodopsin),small molecule,cannabidiol (cbd),cnr2_human,CNR2,MMAapril2016_0328,for ulcerative colitis and schizophrenia,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,gwp42003,P34972,359
360,-,Class A (Rhodopsin),small molecule,cannabidivarin,cnr1_human,CNR1,MMAmay2016_0402,for treatment of epilepsy,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,gwp42006,P21554,360
361,-,Class A (Rhodopsin),small molecule,cannabidivarin,cnr2_human,CNR2,MMAmay2016_0403,for treatment of epilepsy,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,gwp42006,P34972,361
362,-,Class A (Rhodopsin),small molecule,"cannabinoids,  thc + cbd",cnr1_human,CNR1,MMAmay2016_0720,Antineoplastic agent; for glioma,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"cannabinoids,  thc + cbd",P21554,362
363,-,Class A (Rhodopsin),small molecule,"cannabinoids,  thc + cbd",cnr2_human,CNR2,MMAmay2016_0721,Antineoplastic agent; for glioma,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"cannabinoids,  thc + cbd",P34972,363
364,1972,Class A (Rhodopsin),small molecule,carbachol,acm1_human,CHRM1,NRDD077,Antiglaucomic Agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,364
365,1972,Class A (Rhodopsin),small molecule,carbachol,acm2_human,CHRM2,NRDD077,Antiglaucomic Agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,365
366,-,Class A (Rhodopsin),small molecule,carbetocin,oxyr_human,OXTR,NRDD078,Labor Inducing Agents,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P30559,366
367,-,Class A (Rhodopsin),small molecule,carbinoxamine,acm1_human,CHRM1,NRDD080,Anti-Allergic Agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,367
368,-,Class A (Rhodopsin),small molecule,carbinoxamine,hrh1_human,HRH1,NRDD080,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,368
369,1979,Class A (Rhodopsin),small molecule,carboprost tromethamine,pe2r1_human,PTGER1,NRDD081,Abortifacient Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P34995,369
370,2015,Class A (Rhodopsin),small molecule,cariprazine,drd2_human,DRD2,433,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"cariprazine, rgh-188",P14416,370
371,2015,Class A (Rhodopsin),small molecule,cariprazine,drd3_human,DRD3,433,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"cariprazine, rgh-188",P35462,371
372,-,Class A (Rhodopsin),small molecule,carphenazine,drd1_human,DRD1,NRDD082,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,372
373,-,Class A (Rhodopsin),small molecule,carphenazine,drd2_human,DRD2,NRDD082,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,373
374,-,Class A (Rhodopsin),small molecule,carphenazine,drd5_human,DRD5,NRDD082,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21918,374
375,1988,Class A (Rhodopsin),small molecule,carteolol,adrb1_human,ADRB1,NRDD084,Antiglaucomic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,375
376,-,Class A (Rhodopsin),small molecule,carvedilol,ada1a_human,ADRA1A,434,for treatment of congestive heart failure,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"carvedilol, coreg",P35348,376
377,-,Class A (Rhodopsin),small molecule,carvedilol,adrb1_human,ADRB1,435,cardiovascular agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"carvedilol,coreg",P08588,377
378,-,Class A (Rhodopsin),small molecule,carvedilol,adrb2_human,ADRB2,435,cardiovascular agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"carvedilol,coreg",P07550,378
379,-,Class A (Rhodopsin),small molecule,casopitant,nk1r_human,TACR1,436,Antiemetics,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"casopitant mesilate, 679769,rezonic, zunrisa",P25103,379
380,-,Class A (Rhodopsin),protein,ccl2-lpm,ccr2_human,CCR2,445,Anti-inflammatory agent,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccl2-lpm,P41597,380
381,-,Class A (Rhodopsin),small molecule,ccx025,ccr9_human,CCR9,446,Anti-inflammatory agent,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx025,P51686,381
382,-,Class A (Rhodopsin),small molecule,ccx140,ccr2_human,CCR2,447,Anti-inflammatory agent; Antidiabetic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx140,P41597,382
383,-,Class A (Rhodopsin),small molecule,ccx168,c5ar1_human,C5AR1,448,Anti-inflammatory agent; for treatment for autoimmune disease,Peptide ,,in trial,Complement peptide receptors,GPCR;Rhodopsin,not established,ccx168,P21730,383
384,-,Class A (Rhodopsin),small molecule,ccx282,ccr9_human,CCR9,449,Anti-inflammatory agent; for treatment of Crohn's disease; for treatment of ulceraite colitis,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"ccx282, traficet-en",P51686,384
385,-,Class A (Rhodopsin),small molecule,ccx354,ccr1_human,CCR1,450,Anti-inflammatory agent; DMARD,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx354,P32246,385
386,-,Class A (Rhodopsin),small molecule,ccx507,ccr9_human,CCR9,MMAmay2016_0216,for treatment of ulcerative colitis; inflammatory bowel disease,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx507,P51686,386
387,-,Class A (Rhodopsin),small molecule,ccx832,cml1_human,CMKLR1,451,Anti-inflammatory agent; for treatment for autoimmune disease,Protein ,,in trial,Chemerin receptor,GPCR;Rhodopsin,not established,ccx832,Q99788,387
388,-,Class A (Rhodopsin),small molecule,ccx872,ccr2_human,CCR2,MMAapril2016_0147,Antineoplastic agent; pancreatic cancer,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx872,P41597,388
389,-,Class A (Rhodopsin),small molecule: combination,cer627,hcar3_human,HCAR3,MMA2015_0071,Dyslipidemia with low HDL,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,P49019,389
390,-,Class A (Rhodopsin),small molecule: combination,cer627,hcar2_human,HCAR2,MMA2015_0072,Dyslipidemia with low HDL,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,Q8TDS4,390
391,-,Class A (Rhodopsin),small molecule,"cerc-501, ly2456302",oprk_human,OPRK1,MMAfeb2016_0074,Substance use disorders,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,"cerc-501, ly2456302",P41145,391
392,-,Class A (Rhodopsin),small molecule,ceruletide,cckar_human,CCKAR,NRDD085,Diagnostic Agents,Peptide ,,approved,Cholecystokinin receptors,GPCR;Rhodopsin,established,-,P32238,392
393,-,Class A (Rhodopsin),small molecule,cetirizine,hrh1_human,HRH1,471,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"cetirizine hcl,zyrtec",P35367,393
394,-,Class A (Rhodopsin),peptide,cetrorelix,gnrhr_human,GNRHR,472,Antineoplastic agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"cetrorelix,cetrotide",P30968,394
395,2000,Class A (Rhodopsin),small molecule,cevimeline,acm1_human,CHRM1,NRDD086,Parasympathomimetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,395
396,2000,Class A (Rhodopsin),small molecule,cevimeline,acm3_human,CHRM3,NRDD086,Parasympathomimetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,396
397,-,Class A (Rhodopsin),small molecule,cf-101,aa3r_human,ADORA3,473,Anti-inflammatory agent; DMARD,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cf-101,P0DMS8,397
398,-,Class A (Rhodopsin),small molecule,cf-102,aa3r_human,ADORA3,474,Antineoplastic agent,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cf-102,P0DMS8,398
399,-,Class A (Rhodopsin),small molecule,cf602,aa3r_human,ADORA3,MMAapril2016_0230,for treatment of sexual dysfunction,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cf602,P0DMS8,399
400,-,Class B1 (Secretin),peptide,cgrp,calrl_human,CALCRL,477,Anti-Asthmatic Agents,Peptide ,,in trial,Calcitonin receptors,GPCR;Secretin,not established,cgrp,Q16602,400
401,-,Class A (Rhodopsin),small molecule,chlophedianol,hrh1_human,HRH1,NRDD087,Antitussive Agents,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,401
402,-,Class A (Rhodopsin),small molecule,chlorpheniramine,hrh1_human,HRH1,NRDD094,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,402
403,-,Class A (Rhodopsin),small molecule,chlorprothixene,drd1_human,DRD1,NRDD096,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,403
404,-,Class A (Rhodopsin),small molecule,chlorprothixene,drd2_human,DRD2,NRDD096,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,404
405,-,Class A (Rhodopsin),small molecule,chlorprothixene,drd3_human,DRD3,NRDD096,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P35462,405
406,-,Class A (Rhodopsin),small molecule,chlorprothixene,hrh1_human,HRH1,NRDD096,Antipsychotic agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,406
407,-,Class A (Rhodopsin),small molecule,chlorprothixene,5ht2a_human,HTR2A,NRDD096,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,407
408,-,Class A (Rhodopsin),small molecule,chlorprothixene,5ht2b_human,HTR2B,NRDD096,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P41595,408
409,-,Class A (Rhodopsin),small molecule,chlorprothixene,5ht2c_human,HTR2C,NRDD096,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,409
410,2000,Class A (Rhodopsin),protein,choriogonadotropin alfa,fshr_human,FSHR,NRDD099,Fertility Agents,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945,410
411,2000,Class A (Rhodopsin),protein,choriogonadotropin alfa,lshr_human,LHCGR,NRDD099,Fertility Agents,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P22888,411
412,-,Class A (Rhodopsin),protein,chorionic gonadotropin (hcg),lshr_human,LHCGR,2529,Antineoplastic agent,Protein ,,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,ml-04,P22888,412
413,-,Class A (Rhodopsin),small molecule,cicletanine ,ada1a_human,ADRA1A,2271,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P35348,413
414,-,Class A (Rhodopsin),small molecule,cicletanine ,ada1d_human,ADRA1D,2271,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P25100,414
415,-,Class A (Rhodopsin),small molecule,cicletanine ,ada2a_human,ADRA2A,2271,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P08913,415
416,-,Class A (Rhodopsin),small molecule,cicletanine ,ada2b_human,ADRA2B,2271,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P18089,416
417,-,Class A (Rhodopsin),small molecule,cicletanine ,ada2c_human,ADRA2C,2271,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P18825,417
418,-,Class A (Rhodopsin),small molecule,cicletanine ,adrb2_human,ADRB2,2271,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P07550,418
419,1979,Class A (Rhodopsin),small molecule,cimetidine,hrh2_human,HRH2,NRDD104,GI Anti-Ulcer Agents; antihistamines,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P25021,419
420,1979,Class A (Rhodopsin),small molecule,cimetidine,hrh2_human,HRH2,MMAmay2016_0601,Antihistamines,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"tl-118, hamsa-1, cyclophosphamide + diclofenac + sulfasalazine + cimetidine",P25021,420
421,2004,Class C (Glutamate) ,small molecule,cinacalcet,casr_human,CASR,NRDD105,Calcimimetics,Ion ,,approved,Calcium-sensing receptors,GPCR;Glutamate,established,-,P41180,421
422,-,Class C (Glutamate) ,small molecule,cinacalcet,casr_human,CASR,2327,for treatment of hyperparathyroidism,Ion ,,approved,Calcium-sensing receptors,GPCR;Glutamate,established,"cinacalcet hcl, amg 073,sensipar",P41180,422
423,-,Class A (Rhodopsin),small molecule,cinalukast,cltr1_human,CYSLTR1,NRDD106,Anti-Asthmatic Agents,Lipid ,,in trial,Leukotriene receptors,GPCR;Rhodopsin,established,-,Q9Y271,423
424,-,Class A (Rhodopsin),small molecule,cinnarizine,hrh1_human,HRH1,NRDD107,Anti-Allergic Agents,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,424
425,1993,Class A (Rhodopsin),small molecule,cisapride,5ht4r_human,HTR4,NRDD109,Parasympathomimetics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,Q13639,425
426,-,Class A (Rhodopsin),small molecule,cis-uca eye drops,5ht2a_human,HTR2A,MMAmay2016_0333,for ocular surface inflammation,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,cis-uca eye drops,P28223,426
427,-,Class A (Rhodopsin),small molecule,cis-urocanic acid,5ht2a_human,HTR2A,2488,,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,biocis,P28223,427
428,-,Class A (Rhodopsin),small molecule,clazosentan,ednra_human,EDNRA,495,for treatment and prevention of vasospasm,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"clazosentan, axv-343434,pivlaz",P25101,428
429,1977,Class A (Rhodopsin),small molecule,clemastine,hrh1_human,HRH1,NRDD112,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,429
430,-,Class A (Rhodopsin),small molecule,clenbuterol,adrb2_human,ADRB2,NRDD113,Bronchodilator agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,430
431,-,Class A (Rhodopsin),small molecule,clidinium,acm1_human,CHRM1,NRDD114,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,431
432,-,Class A (Rhodopsin),small molecule,clonidine,ada2a_human,ADRA2A,220,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"arc-4558, 0.1% clonidine hycrochloride gel",P08913,432
433,-,Class A (Rhodopsin),small molecule,clonidine,ada2b_human,ADRA2B,220,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"arc-4558, 0.1% clonidine hycrochloride gel",P18089,433
434,-,Class A (Rhodopsin),small molecule,clonidine,ada2c_human,ADRA2C,220,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"arc-4558, 0.1% clonidine hycrochloride gel",P18825,434
435,-,Class A (Rhodopsin),small molecule,clonidine,ada2a_human,ADRA2A,501,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",P08913,435
436,-,Class A (Rhodopsin),small molecule,clonidine,ada2b_human,ADRA2B,501,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",P18089,436
437,-,Class A (Rhodopsin),small molecule,clonidine,ada2c_human,ADRA2C,501,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",P18825,437
438,-,Class A (Rhodopsin),small molecule,clonidine,ada2a_human,ADRA2A,502,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine lauriad, ba-028",P08913,438
439,-,Class A (Rhodopsin),small molecule,clonidine,ada2b_human,ADRA2B,502,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine lauriad, ba-028",P18089,439
440,-,Class A (Rhodopsin),small molecule,clonidine,ada2c_human,ADRA2C,502,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine lauriad, ba-028",P18825,440
441,-,Class A (Rhodopsin),small molecule,clopidogrel,p2y12_human,P2RY12,478,antiplatelet agent,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,cgt-2168,Q9H244,441
442,-,Class A (Rhodopsin),small molecule,clopidogrel,p2y12_human,P2RY12,1619,antithrombotic,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,plavix,Q9H244,442
443,1989,Class A (Rhodopsin),small molecule,clozapine,drd1_human,DRD1,NRDD120,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,443
444,1989,Class A (Rhodopsin),small molecule,clozapine,drd2_human,DRD2,NRDD120,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,444
445,1989,Class A (Rhodopsin),small molecule,clozapine,drd4_human,DRD4,NRDD120,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21917,445
446,1989,Class A (Rhodopsin),small molecule,clozapine,hrh1_human,HRH1,NRDD120,Antipsychotic agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,446
447,1989,Class A (Rhodopsin),small molecule,clozapine,hrh4_human,HRH4,NRDD120,Antipsychotic agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,Q9H3N8,447
448,1989,Class A (Rhodopsin),small molecule,clozapine,5ht1a_human,HTR1A,NRDD120,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P08908,448
449,1989,Class A (Rhodopsin),small molecule,clozapine,5ht2a_human,HTR2A,NRDD120,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,449
450,1989,Class A (Rhodopsin),small molecule,clozapine,5ht2c_human,HTR2C,NRDD120,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,450
451,-,Class A (Rhodopsin),small molecule,cocaine,drd3_human,DRD3,NRDD123,local anesthetic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P35462,451
452,-,Class A (Rhodopsin),small molecule,cocaine,oprk_human,OPRK1,NRDD123,local anesthetic,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,452
453,-,Class A (Rhodopsin),small molecule,codeine,oprd_human,OPRD1,NRDD124,Analgesics; Opioid; Antitussive Agents,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41143,453
454,-,Class A (Rhodopsin),small molecule,codeine,oprk_human,OPRK1,NRDD124,Analgesics; Opioid; Antitussive Agents,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,454
455,-,Class A (Rhodopsin),small molecule,codeine,oprm_human,OPRM1,NRDD124,Analgesics; Opioid; Antitussive Agents,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,455
456,-,Class A (Rhodopsin),small molecule,conivaptan,v1ar_human,AVPR1A,519,for treatment of hyponatremia,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"conivaptan, ym-087,vaprisol",P37288,456
457,-,Class A (Rhodopsin),small molecule,conivaptan,v2r_human,AVPR2,519,for treatment of hyponatremia,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"conivaptan, ym-087,vaprisol",P30518,457
458,-,Class A (Rhodopsin),protein,corifollitropin alfa,fshr_human,FSHR,526,Fertility Agents,Protein ,,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"corifollitropin alfa,elonva",P23945,458
459,1950,Class A (Rhodopsin),protein,corticotropin,acthr_human,MC2R,NRDD127,Diagnostic Agents,Peptide ,,approved,Melanocortin receptors,GPCR;Rhodopsin,established,-,Q01718,459
460,-,Class B1 (Secretin),peptide,corticotropin-releasing factor,crfr1_human,CRHR1,528,for treatment of peritumoral brain edema,Peptide ,,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"corticotropin-releasing factor,xerecept",P34998,460
461,-,Class B1 (Secretin),peptide,corticotropin-releasing factor,crfr2_human,CRHR2,528,for treatment of peritumoral brain edema,Peptide ,,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"corticotropin-releasing factor,xerecept",Q13324,461
462,1970,Class A (Rhodopsin),peptide,cosyntropin,acthr_human,MC2R,NRDD128,Diagnostic Agents,Peptide ,,approved,Melanocortin receptors,GPCR;Rhodopsin,established,-,Q01718,462
463,-,Class A (Rhodopsin),small molecule,cpb-307,s1pr1_human,S1PR1,MMAmar2016_0127,for treatment of autoimmune diseases,Lipid ,,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,cpb-307,P21453,463
464,-,Class A (Rhodopsin),small molecule,cr665,oprk_human,OPRK1,539,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,cr665,P41145,464
465,-,Class A (Rhodopsin),small molecule,cr845,oprk_human,OPRK1,540,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,cr845,P41145,465
466,-,Class A (Rhodopsin),small molecule,crth2 receptor antagonist,pd2r2_human,GPR44,546,Anti-Allergic Agents,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,crth2 receptor antagonist,Q9Y5Y4,466
467,-,Class A (Rhodopsin),protein,ctce-9908,cxcr4_human,CXCR4,2376,Antineoplastic agent,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,ctce-9908,P61073,467
468,-,Class A (Rhodopsin),small molecule,ctp-499,aa1r_human,ADORA1,2268,for treatment of diabetic nephropathy,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,ctp-499,P30542,468
469,-,Class A (Rhodopsin),small molecule,ctp-499,aa2ar_human,ADORA2A,2268,for treatment of diabetic nephropathy,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,ctp-499,P29274,469
470,-,Class F (Frizzled),small molecule,cur-61414,smo_human,SMO,2823,Antineoplastic agent,Protein ,,in trial,Frizzled,GPCR;Frizzled,established,cur-61414,Q99835,470
471,-,Class A (Rhodopsin),small molecule,cvt-3619,aa1r_human,ADORA1,568,Antihyperlipidemic agent,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cvt-3619,P30542,471
472,-,Class A (Rhodopsin),small molecule,cvt-6883,aa2br_human,ADORA2B,569,Anti-Asthmatic Agents,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cvt-6883,P29275,472
473,-,Class A (Rhodopsin),small molecule,cyclizine,hrh1_human,HRH1,NRDD130,Antiemetics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,473
474,1977,Class A (Rhodopsin),small molecule,cyclobenzaprine,5ht2a_human,HTR2A,NRDD131,Antidepressive Agents; Tricyclic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,474
475,-,Class A (Rhodopsin),small molecule,cyclobenzaprine,5ht2a_human,HTR2A,2489,Muscle Relaxants,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cyclobenzaprine hydrochloride extended-release capsules,amrix",P28223,475
476,-,Class A (Rhodopsin),small molecule,cyclobenzaprine,5ht2a_human,HTR2A,MMAmay2016_0082,for treatment of fibromyalgia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,tnx-102,P28223,476
477,-,Class A (Rhodopsin),small molecule,cyclopentolate,acm1_human,CHRM1,NRDD132,Mydriatics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,477
478,-,Class A (Rhodopsin),small molecule,cycrimine,acm1_human,CHRM1,NRDD134,Antiparkinson agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,478
479,1961,Class A (Rhodopsin),small molecule,cyproheptadine,hrh1_human,HRH1,NRDD135,Anti-Allergic Agents; Appetite Stimulant,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,479
480,1961,Class A (Rhodopsin),small molecule,cyproheptadine,5ht2a_human,HTR2A,NRDD135,Anti-Allergic Agents; Appetite Stimulant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,480
481,-,Class B1 (Secretin),peptide,dac:glp-1,glp1r_human,GLP1R,590,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"dac:glp-1, cjc-1131",P43220,481
482,-,Class B1 (Secretin),peptide,dac:grf,ghrhr_human,GHRHR,591,hormone replacement,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,dac:grf,Q02643,482
483,1976,Class A (Rhodopsin),small molecule,danazol,gnrhr_human,GNRHR,NRDD139,Antiendometriosis Agent; Antineoplastic agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,P30968,483
484,1976,Class A (Rhodopsin),small molecule,danazol,gnrr2_human,GNRHR2,NRDD139,Antiendometriosis Agent; Antineoplastic agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,Q96P88,484
485,-,Class A (Rhodopsin),small molecule,danazol,gnrhr_human,GNRHR,2297,for treatment of diabetic macular edema,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,optina,P30968,485
486,-,Class A (Rhodopsin),small molecule,danazol,gnrr2_human,GNRHR2,2297,for treatment of diabetic macular edema,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,optina,Q96P88,486
487,1990,Class A (Rhodopsin),small molecule,dapiprazole,ada1a_human,ADRA1A,NRDD141,opthalmological agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,487
488,1990,Class A (Rhodopsin),small molecule,dapiprazole,ada1b_human,ADRA1B,NRDD141,opthalmological agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,488
489,1990,Class A (Rhodopsin),small molecule,dapiprazole,ada1d_human,ADRA1D,NRDD141,opthalmological agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,489
490,-,Class A (Rhodopsin),small molecule,darifenacin,acm3_human,CHRM3,598,for treatment of overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"darifenacin,enablex, emselex",P20309,490
491,-,Class A (Rhodopsin),small molecule,darusentan,ednra_human,EDNRA,599,Antihypertensive agent,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,darusentan,P25101,491
492,-,Class A (Rhodopsin),small molecule,debrisoquin,ada1a_human,ADRA1A,NRDD143,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,492
493,-,Class A (Rhodopsin),small molecule,debrisoquin,ada1b_human,ADRA1B,NRDD143,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,493
494,-,Class A (Rhodopsin),small molecule,debrisoquin,ada1d_human,ADRA1D,NRDD143,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,494
495,-,Class A (Rhodopsin),small molecule,debrisoquin,ada2a_human,ADRA2A,NRDD143,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,495
496,-,Class A (Rhodopsin),small molecule,debrisoquin,ada2b_human,ADRA2B,NRDD143,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089,496
497,-,Class A (Rhodopsin),small molecule,debrisoquin,ada2c_human,ADRA2C,NRDD143,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P18825,497
498,-,Class A (Rhodopsin),small molecule,degarelix,gnrhr_human,GNRHR,610,Antineoplastic agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,degarelix,P30968,498
499,-,Class A (Rhodopsin),small molecule,degarelix,gnrr2_human,GNRHR2,610,Antineoplastic agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,degarelix,Q96P88,499
500,-,Class A (Rhodopsin),small molecule,denufosol,p2ry2_human,P2RY2,614,for treatment of cystic fibrosis,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,"denufosol tetrasodium, ins37217 respiratory",P41231,500
501,-,Class A (Rhodopsin),small molecule,desipramine,adrb1_human,ADRB1,NRDD148,Antidepressive Agents; Tricyclic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,501
502,-,Class A (Rhodopsin),small molecule,desipramine,adrb2_human,ADRB2,NRDD148,Antidepressive Agents; Tricyclic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,502
503,-,Class A (Rhodopsin),small molecule,desipramine,acm1_human,CHRM1,NRDD148,Antidepressive Agents; Tricyclic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,503
504,-,Class A (Rhodopsin),small molecule,desipramine,acm2_human,CHRM2,NRDD148,Antidepressive Agents; Tricyclic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,504
505,-,Class A (Rhodopsin),small molecule,desipramine,hrh1_human,HRH1,NRDD148,Antidepressive Agents; Tricyclic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,505
506,-,Class A (Rhodopsin),small molecule,desloratadine,hrh1_human,HRH1,620,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"desloratadine , clarinex",P35367,506
507,-,Class A (Rhodopsin),peptide,desmopressin,v1ar_human,AVPR1A,1537,for treatment of incontinence,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ox 19, sublingual desmopressin",P37288,507
508,-,Class A (Rhodopsin),peptide,desmopressin,v1br_human,AVPR1B,1537,for treatment of incontinence,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ox 19, sublingual desmopressin",P47901,508
509,-,Class A (Rhodopsin),peptide,desmopressin,v2r_human,AVPR2,1537,for treatment of incontinence,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ox 19, sublingual desmopressin",P30518,509
510,-,Class A (Rhodopsin),peptide,desmopressin (vasopressin),v1ar_human,AVPR1A,MMAjun2016_0039,Antidiuretic Agents,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"nocdurna,  desmopressin",P37288,510
511,-,Class A (Rhodopsin),peptide,desmopressin (vasopressin),v1br_human,AVPR1B,MMAjun2016_0040,Antidiuretic Agents,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"nocdurna,  desmopressin",P47901,511
512,-,Class A (Rhodopsin),peptide,desmopressin (vasopressin),v2r_human,AVPR2,MMAjun2016_0041,Antidiuretic Agents,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"nocdurna,  desmopressin",P30518,512
513,-,Class C (Glutamate) ,small molecule,"deuterium containing analog of sodium oxybate, gamma hydroxybutyric acid",gabr2_human,GABBR2,MMAmay2016_0771,for treatment of sleep disorders; narcolepsy,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,jzp-386,O75899,513
514,-,Class C (Glutamate) ,small molecule,"deuterium containing analog of sodium oxybate, gamma hydroxybutyric acid",gabr1_human,GABBR1,MMAmay2016_0773,for treatment of sleep disorders; narcolepsy,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,jzp-386,Q9UBS5,514
515,-,Class A (Rhodopsin),small molecule,dexbrompheniramine,hrh1_human,HRH1,NRDD153,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,515
516,-,Class A (Rhodopsin),small molecule,dexloxiglumide,cckar_human,CCKAR,626,motilitant,Peptide ,,in trial,Cholecystokinin receptors,GPCR;Rhodopsin,established,"dexloxiglumide, cr 2017",P32238,516
517,-,Class A (Rhodopsin),small molecule,dexmedetomidin,ada2a_human,ADRA2A,MMAapril2016_0144,Analgesics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"dex-in, intranasal dexmedetomidin",P08913,517
518,1999,Class A (Rhodopsin),small molecule,dexmedetomidine,ada2a_human,ADRA2A,NRDD155,Analgesics; Hypnotics and Sedatives,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,518
519,-,Class A (Rhodopsin),small molecule,dexpramipexole,drd2_human,DRD2,627,for treatment of amyotrophic lateral sclerosis (ALS),Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"dexpramipexole, kns-760704",P14416,519
520,-,Class A (Rhodopsin),small molecule,dexpramipexole,drd3_human,DRD3,627,for treatment of amyotrophic lateral sclerosis (ALS),Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"dexpramipexole, kns-760704",P35462,520
521,-,Class A (Rhodopsin),small molecule,dexpramipexole,drd4_human,DRD4,627,for treatment of amyotrophic lateral sclerosis (ALS),Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"dexpramipexole, kns-760704",P21917,521
522,1989,Class A (Rhodopsin),small molecule,dezocine,oprk_human,OPRK1,NRDD157,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,522
523,1989,Class A (Rhodopsin),small molecule,dezocine,oprm_human,OPRM1,NRDD157,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,523
524,-,Class A (Rhodopsin),small molecule,dg041,pe2r3_human,PTGER3,629,Platelet Aggregation Inhibitor,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,dg041,P43115,524
525,-,Class A (Rhodopsin),small molecule,dg3173,ssr1_human,SSTR1,632,hormone replacement,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P30872,525
526,-,Class A (Rhodopsin),small molecule,dg3173,ssr2_human,SSTR2,632,hormone replacement,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P30874,526
527,-,Class A (Rhodopsin),small molecule,dg3173,ssr4_human,SSTR4,632,hormone replacement,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,not established,dg3173,P31391,527
528,-,Class A (Rhodopsin),small molecule,dg3173,ssr5_human,SSTR5,632,hormone replacement,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P35346,528
529,1950,Class A (Rhodopsin),small molecule,dicyclomine,acm1_human,CHRM1,NRDD162,Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,529
530,-,Class A (Rhodopsin),small molecule,dihydroergotamine,5ht1b_human,HTR1B,1214,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"map-0004, tempo migraine,levadex",P28222,530
531,-,Class A (Rhodopsin),small molecule,dihydroergotamine,5ht1d_human,HTR1D,1214,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"map-0004, tempo migraine,levadex",P28221,531
532,-,Class A (Rhodopsin),small molecule,dihydroergotamine,5ht1b_human,HTR1B,1356,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,mt 300,P28222,532
533,-,Class A (Rhodopsin),small molecule,dihydroergotamine,5ht1d_human,HTR1D,1356,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,mt 300,P28221,533
534,-,Class A (Rhodopsin),small molecule,dimenhydrinate,hrh1_human,HRH1,NRDD170,Antiemetics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,534
535,-,Class A (Rhodopsin),small molecule,dinoprost tromethamine,pi2r_human,PTGIR,NRDD171,Abortifacient Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P43119,535
536,1977,Class A (Rhodopsin),small molecule,dinoprostone,pe2r1_human,PTGER1,NRDD172,Abortifacient Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P34995,536
537,1977,Class A (Rhodopsin),small molecule,dinoprostone,pe2r2_human,PTGER2,NRDD172,Abortifacient Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P43116,537
538,1977,Class A (Rhodopsin),small molecule,dinoprostone,pe2r3_human,PTGER3,NRDD172,Abortifacient Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P43115,538
539,1977,Class A (Rhodopsin),small molecule,dinoprostone,pe2r4_human,PTGER4,NRDD172,Abortifacient Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P35408,539
540,-,Class A (Rhodopsin),small molecule,diphemanil methylsulfate,acm3_human,CHRM3,NRDD173,Bronchodilator agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,540
541,1946,Class A (Rhodopsin),small molecule,diphenhydramine,hrh1_human,HRH1,NRDD174,Anti-Allergic Agents; Hypnotics and sedatives; Antiemetics; Antipruritics; Antitussives,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,541
542,1967,Class A (Rhodopsin),small molecule,diphenidol,acm1_human,CHRM1,NRDD175,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,542
543,1967,Class A (Rhodopsin),small molecule,diphenidol,acm2_human,CHRM2,NRDD175,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,543
544,1967,Class A (Rhodopsin),small molecule,diphenidol,acm3_human,CHRM3,NRDD175,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,544
545,-,Class A (Rhodopsin),small molecule,diphenoxylate,oprm_human,OPRM1,NRDD176,Antidiuretic Agents,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,545
546,-,Class A (Rhodopsin),small molecule,diphenylpyraline,hrh1_human,HRH1,NRDD177,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,546
547,-,Class A (Rhodopsin),small molecule,dipivefrin,ada2a_human,ADRA2A,NRDD178,opthalmological agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,547
548,-,Class A (Rhodopsin),small molecule,diquafosol,p2ry2_human,P2RY2,644,opthalmological agent,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,"diquafosol tetrasodium, ins365 ophthalmic,prolacria",P41231,548
549,1978,Class A (Rhodopsin),small molecule,dobutamine,adrb1_human,ADRB1,NRDD182,Cardiotonic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,549
550,-,Class A (Rhodopsin),small molecule,domperidone,drd2_human,DRD2,NRDD184,Antiemetics,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,550
551,1991,Class A (Rhodopsin),small molecule,doxacurium,acm2_human,CHRM2,NRDD185,Muscle Relaxants,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,551
552,1991,Class A (Rhodopsin),small molecule,doxacurium chloride,acm2_human,CHRM2,NRDD186,Muscle Relaxants,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,552
553,1990,Class A (Rhodopsin),small molecule,doxazosin,ada1a_human,ADRA1A,NRDD187,Anticholesteremic Agents; Antihypertensive agent; Vasodilator Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,553
554,1990,Class A (Rhodopsin),small molecule,doxazosin,ada1b_human,ADRA1B,NRDD187,Anticholesteremic Agents; Antihypertensive agent; Vasodilator Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,554
555,1990,Class A (Rhodopsin),small molecule,doxazosin,ada1d_human,ADRA1D,NRDD187,Anticholesteremic Agents; Antihypertensive agent; Vasodilator Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,555
556,-,Class A (Rhodopsin),small molecule,doxepin,acm1_human,CHRM1,1851,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P11229,556
557,-,Class A (Rhodopsin),small molecule,doxepin,acm2_human,CHRM2,1851,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P08172,557
558,-,Class A (Rhodopsin),small molecule,doxepin,acm3_human,CHRM3,1851,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P20309,558
559,-,Class A (Rhodopsin),small molecule,doxepin,acm4_human,CHRM4,1851,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P08173,559
560,-,Class A (Rhodopsin),small molecule,doxepin,acm5_human,CHRM5,1851,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P08912,560
561,-,Class A (Rhodopsin),small molecule,doxepin,hrh1_human,HRH1,1851,Hypnotics and Sedatives,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P35367,561
562,-,Class A (Rhodopsin),small molecule,doxepin,hrh2_human,HRH2,1851,Hypnotics and Sedatives,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P25021,562
563,-,Class A (Rhodopsin),small molecule,doxepin,5ht2a_human,HTR2A,1851,Hypnotics and Sedatives,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P28223,563
564,-,Class A (Rhodopsin),small molecule,doxepin,5ht2b_human,HTR2B,1851,Hypnotics and Sedatives,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P41595,564
565,-,Class A (Rhodopsin),small molecule,doxepin,5ht2c_human,HTR2C,1851,Hypnotics and Sedatives,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P28335,565
566,1948,Class A (Rhodopsin),small molecule,doxylamine,hrh1_human,HRH1,NRDD188,Anti-Allergic Agents; Antiemetics; Antitussive Agents; Hypnotics and Sedatives,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,566
567,-,Class A (Rhodopsin),small molecule,doxylamine,hrh1_human,HRH1,MMAmay2016_0669,Antihistamine; for nausea and vomiting of pregnancy,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,diclectin + diclegis; doxylamine succinate + pyridoxine hydrochloride dr tablets,P35367,567
568,-,Class A (Rhodopsin),small molecule,"drm04, anticholinergic",acm3_human,CHRM3,MMAfeb2016_0095,for treatment of hyperhidrosis,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"drm04, anticholinergic",P20309,568
569,-,Class A (Rhodopsin),small molecule,dronabinol,cnr1_human,CNR1,437,Analgesics,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"cat-310 , relivar",P21554,569
570,-,Class A (Rhodopsin),small molecule,dronabinol,cnr2_human,CNR2,438,Analgesics,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"cat-310,relivar",P34972,570
571,-,Class A (Rhodopsin),small molecule,dronabinol,cnr1_human,CNR1,667,Appetite stimulant,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"dronabinol ,marinol",P21554,571
572,-,Class A (Rhodopsin),small molecule,dronabinol,cnr2_human,CNR2,667,Appetite stimulant,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"dronabinol ,marinol",P34972,572
573,2009,Class A (Rhodopsin),small molecule,dronedarone,ada1a_human,ADRA1A,NRDD190,Anti-Arrhythmia Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,573
574,2009,Class A (Rhodopsin),small molecule,dronedarone,adrb1_human,ADRB1,NRDD190,Anti-Arrhythmia Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,574
575,2009,Class A (Rhodopsin),small molecule,dronedarone,ada1a_human,ADRA1A,2270,Anti-Arrhythmia Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dronedarone,P35348,575
576,2009,Class A (Rhodopsin),small molecule,dronedarone,adrb1_human,ADRB1,2270,Anti-Arrhythmia Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dronedarone,P08588,576
577,-,Class A (Rhodopsin),small molecule,droperidol,drd2_human,DRD2,NRDD191,Adjuvants; Anesthesia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,577
578,-,Class A (Rhodopsin),small molecule,droxidopa,ada1a_human,ADRA1A,2272,for treatment of orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P35348,578
579,-,Class A (Rhodopsin),small molecule,droxidopa,ada1b_human,ADRA1B,2272,for treatment of orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P35368,579
580,-,Class A (Rhodopsin),small molecule,droxidopa,ada1d_human,ADRA1D,2272,for treatment of orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P25100,580
581,-,Class A (Rhodopsin),small molecule,droxidopa,ada2a_human,ADRA2A,2272,for treatment of orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P08913,581
582,-,Class A (Rhodopsin),small molecule,droxidopa,ada2b_human,ADRA2B,2272,for treatment of orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P18089,582
583,-,Class A (Rhodopsin),small molecule,droxidopa,ada2c_human,ADRA2C,2272,for treatment of orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P18825,583
584,-,Class A (Rhodopsin),small molecule,droxidopa,adrb1_human,ADRB1,2272,for treatment of orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P08588,584
585,-,Class A (Rhodopsin),small molecule,droxidopa,adrb2_human,ADRB2,2272,for treatment of orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P07550,585
586,-,Class A (Rhodopsin),small molecule,droxidopa,adrb3_human,ADRB3,2272,for treatment of orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P13945,586
587,-,Class A (Rhodopsin),peptide,dsc127,agtr1_human,AGTR1,2280,for treatment of diabetic foot ulcers,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,dsc127,P30556,587
588,2014,Class B1 (Secretin),protein,duglaglutide,glp1r_human,GLP1R,MMAmay2016_0762,Antidiabetic; type II diabetes,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,"dulaglutide, glp-1fc, trulicity, ly2189265",P43220,588
589,-,Class A (Rhodopsin),small molecule,ecopipam,drd1_human,DRD1,686,for treatment of tourettes syndrome; for treatment of pathological gambling,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,ecopipam,P21728,589
590,-,Class B1 (Secretin),peptide,"efpeglenatide, hm11260c",glp1r_human,GLP1R,MMAmar2016_0245,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"efpeglenatide, hm11260c",P43220,590
591,-,Class A (Rhodopsin),small molecule,eletriptan,5ht1d_human,HTR1D,1731,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,relpax,P28221,591
592,-,Class A (Rhodopsin),small molecule,elinogrel,p2y12_human,P2RY12,701,antiplatelet agent,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,established,"elinogrel, prt060128, adp receptor antagonist",Q9H244,592
593,-,Class B1 (Secretin),peptide,elsiglutide,glp2r_human,GLP2R,2464,Antidiuretic Agents,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,zp1846,O95838,593
594,-,Class A (Rhodopsin),small molecule,eltoprazine,5ht1a_human,HTR1A,MMAmar2016_0086,for treatment of adverse effects; dyskinesias,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,eltoprazine,P08908,594
595,-,Class A (Rhodopsin),small molecule,eltoprazine,5ht1b_human,HTR1B,MMAmar2016_0087,for treatment of adverse effects; dyskinesias,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,eltoprazine,P28222,595
596,-,Class A (Rhodopsin),small molecule,ema401,agtr2_human,AGTR2,MMAmay2016_0377,for treatment of peripheral neuropathic pain; post herpetic neuralgia,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,not established,ema401,P50052,596
597,1997,Class A (Rhodopsin),small molecule,emedastine,hrh1_human,HRH1,NRDD199,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,597
598,-,Class A (Rhodopsin),peptide,ep-100,gnrhr_human,GNRHR,715,Antineoplastic agent,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,ep-100,P30968,598
599,-,Class A (Rhodopsin),peptide,ep-100,gnrr2_human,GNRHR2,715,Antineoplastic agent,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,ep-100,Q96P88,599
600,-,Class A (Rhodopsin),small molecule,ephedrine,ada1a_human,ADRA1A,NRDD204,Central Nervous System Stimulants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,600
601,-,Class A (Rhodopsin),small molecule,epinastine,hrh1_human,HRH1,719,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,epinastine,P35367,601
602,-,Class A (Rhodopsin),small molecule,epinastine,hrh2_human,HRH2,719,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,epinastine,P25021,602
603,-,Class A (Rhodopsin),small molecule,epinephrine,ada1a_human,ADRA1A,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P35348,603
604,-,Class A (Rhodopsin),small molecule,epinephrine,ada1b_human,ADRA1B,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P35368,604
605,-,Class A (Rhodopsin),small molecule,epinephrine,ada1d_human,ADRA1D,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P25100,605
606,-,Class A (Rhodopsin),small molecule,epinephrine,ada2a_human,ADRA2A,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P08913,606
607,-,Class A (Rhodopsin),small molecule,epinephrine,ada2b_human,ADRA2B,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P18089,607
608,-,Class A (Rhodopsin),small molecule,epinephrine,adrb1_human,ADRB1,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P08588,608
609,-,Class A (Rhodopsin),small molecule,epinephrine,adrb2_human,ADRB2,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P07550,609
610,-,Class A (Rhodopsin),small molecule,eplivanserine,5ht2a_human,HTR2A,721,for treatment of insomnia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"eplivanserine, sr 46349,ciltyri",P28223,610
611,-,Class A (Rhodopsin),small molecule,eplivanserine,5ht2c_human,HTR2C,721,for treatment of insomnia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"eplivanserine, sr 46349,ciltyri",P28335,611
612,1995,Class A (Rhodopsin),small molecule,epoprostenol,pi2r_human,PTGIR,NRDD206,Antihypertensive agent; Platelet Aggregation Inhibitors,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P43119,612
613,1997,Class A (Rhodopsin),small molecule,eprosartan,agtr1_human,AGTR1,NRDD207,Antihypertensive agent,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556,613
614,-,Class A (Rhodopsin),small molecule,ergoloid mesylate,ada1a_human,ADRA1A,NRDD209,Nootropic Agents; Vasodilator Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,614
615,-,Class A (Rhodopsin),small molecule,ergoloid mesylate,ada2a_human,ADRA2A,NRDD209,Nootropic Agents; Vasodilator Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,615
616,-,Class A (Rhodopsin),small molecule,ergotamine,5ht1b_human,HTR1B,NRDD210,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28222,616
617,-,Class A (Rhodopsin),small molecule,ergotamine,5ht1d_human,HTR1D,NRDD210,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28221,617
618,-,Class A (Rhodopsin),small molecule,esmirtazapine,ada2a_human,ADRA2A,732,for treatment of insomnia; for treatment of menopausal symptoms,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"esmirtazapine, org-4420",P08913,618
619,-,Class A (Rhodopsin),small molecule,esmirtazapine,5ht2a_human,HTR2A,732,for treatment of insomnia; for treatment of menopausal symptoms,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"esmirtazapine, org-4420",P28223,619
620,1986,Class A (Rhodopsin),small molecule,esmolol,adrb1_human,ADRB1,NRDD212,Anti-Arrhythmia Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,620
621,-,Class C (Glutamate) ,peptide,"etelcalcetide, amg 416, velcalcetide, kai-4169, ono-5163",casr_human,CASR,MMAapril2016_0047,for treatment of parathyroid disorders,Ion ,,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,"etelcalcetide, amg 416, velcalcetide, kai-4169, ono-5163",P41180,621
622,-,Class A (Rhodopsin),small molecule,ethopropazine,acm1_human,CHRM1,NRDD217,Antidyskinetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,622
623,-,Class A (Rhodopsin),small molecule,etilevodopa,drd1_human,DRD1,749,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P21728,623
624,-,Class A (Rhodopsin),small molecule,etilevodopa,drd2_human,DRD2,749,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P14416,624
625,-,Class A (Rhodopsin),small molecule,etilevodopa,drd3_human,DRD3,749,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P35462,625
626,-,Class A (Rhodopsin),small molecule,etilevodopa,drd4_human,DRD4,749,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P21917,626
627,-,Class A (Rhodopsin),small molecule,etilevodopa,drd5_human,DRD5,749,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P21918,627
628,1982,Class A (Rhodopsin),small molecule,etomidate,ada2b_human,ADRA2B,NRDD222,Anesthetics; Intravenous,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089,628
629,-,Class B1 (Secretin),peptide,exenatide,glp1r_human,GLP1R,769,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,exenatide,P43220,629
630,-,Class B1 (Secretin),peptide,exenatide,glp1r_human,GLP1R,1046,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,itca 650,P43220,630
631,-,Class B1 (Secretin),peptide,exendin (9-39) ,glp1r_human,GLP1R,MMAjun2016_0019,for treatment of hypoglycemia,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,exendin (9-39) ,P43220,631
632,-,Class B1 (Secretin),peptide,exendin-4,glp1r_human,GLP1R,1572,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,pc-dac:exendin-4,P43220,632
633,-,Class A (Rhodopsin),small molecule,famotidine,hrh2_human,HRH2,929,acid reducer,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"hzt-501,  ibuprofen + famotidine,duexa",P25021,633
634,-,Class A (Rhodopsin),small molecule,famotidine,hrh2_human,HRH2,929,for treatment of gastric ulcer and gastroesophageal reflux,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"hzt-501,  ibuprofen + famotidine,duexa",P25021,634
635,-,Class A (Rhodopsin),small molecule,famotidine,hrh2_human,HRH2,1539,acid reducer,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,ox17,P25021,635
636,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm1_human,GRM1,MMAmar2016_0121,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q13255,636
637,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm5_human,GRM5,MMAmar2016_0122,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,nfc-1,P41594,637
638,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm3_human,GRM3,MMAmar2016_0123,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14832,638
639,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm7_human,GRM7,MMAmar2016_0124,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14831,639
640,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm2_human,GRM2,MMAmar2016_0125,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14416,640
641,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm4_human,GRM4,MMAmar2016_0125,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14833,641
642,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm6_human,GRM6,MMAmar2016_0125,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,O15303,642
643,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm8_human,GRM8,MMAmar2016_0125,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,O00222,643
644,-,Class A (Rhodopsin),peptide,felypressin,v1ar_human,AVPR1A,NRDD226,Hemostatic agents; Vasoconstricting Agents,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P37288,644
645,-,Class A (Rhodopsin),small molecule,fenfluramine,5ht2b_human,HTR2B,MMAmar2016_0273,for treatment of epilepsy; Dravet's syndrome,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zx008, brabafen, low-dose fenfluramine",P41595,645
646,-,Class A (Rhodopsin),small molecule,fenfluramine,5ht2c_human,HTR2C,MMAmar2016_0274,for treatment of epilepsy; Dravet's syndrome,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zx008, brabafen, low-dose fenfluramine",P28335,646
647,-,Class A (Rhodopsin),small molecule,fenoldopam,drd1_human,DRD1,778,Antihypertensive agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"fenoldopam mesylate, skf-82526,corlopam",P21728,647
648,-,Class A (Rhodopsin),small molecule,fenoldopam,drd5_human,DRD5,778,Antihypertensive agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"fenoldopam mesylate, skf-82526,corlopam",P21918,648
649,-,Class A (Rhodopsin),small molecule,fenoterol,adrb2_human,ADRB2,NRDD229,Bronchodilator agent; Tocolytic Agents,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,649
650,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,51,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ad 923,P41143,650
651,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,51,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ad 923,P35372,651
652,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,69,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,aerolef,P41143,652
653,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,69,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,aerolef,P35372,653
654,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,259,Analgesics; opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,at3022,P41143,654
655,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,259,Analgesics; opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,at3022,P35372,655
656,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,303,adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"az-003, staccato fentanyl",P41143,656
657,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,303,adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"az-003, staccato fentanyl",P35372,657
658,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,334,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"bema fentanyl,onsolis, breakyl",P41143,658
659,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,334,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"bema fentanyl,onsolis, breakyl",P35372,659
660,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,394,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,buccal fentanyl,P41143,660
661,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,394,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,buccal fentanyl,P35372,661
662,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,775,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"febt,fentora, effentora",P41143,662
663,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,775,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"febt,fentora, effentora",P35372,663
664,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,780,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl (sublingual), kw-2246,abstral, rapinyl",P41143,664
665,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,780,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl (sublingual), kw-2246,abstral, rapinyl",P35372,665
666,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,781,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl citrate,pecfent, nasalfent",P41143,666
667,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,781,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl citrate,pecfent, nasalfent",P35372,667
668,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,782,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl lauriad, ba-041",P41143,668
669,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,782,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl lauriad, ba-041",P35372,669
670,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,783,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl mdts,P41143,670
671,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,783,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl mdts,P35372,671
672,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,784,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl spray, intranasal,instanyl",P41143,672
673,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,784,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl spray, intranasal,instanyl",P35372,673
674,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,785,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl sublingual spray,P41143,674
675,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,785,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl sublingual spray,P35372,675
676,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,786,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl taifun,P41143,676
677,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,786,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl taifun,P35372,677
678,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,787,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl transdermal system,duragesic, ionsys",P41143,678
679,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,787,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl transdermal system,duragesic, ionsys",P35372,679
680,-,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,2069,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"transmucosal fentanyl,actiq",P41143,680
681,-,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,2069,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"transmucosal fentanyl,actiq",P35372,681
682,-,Class A (Rhodopsin),small molecule,fesoterodine,acm3_human,CHRM3,788,for treatment of overactive bladder syndrome,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"fesoterodine fumarate, spm 907,toviaz",P20309,682
683,-,Class A (Rhodopsin),small molecule,fexofenadine,hrh1_human,HRH1,789,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,fexofenadine + ps/,P35367,683
684,-,Class A (Rhodopsin),small molecule,fingolimod,s1pr1_human,S1PR1,794,For treatment of Multiple Sclerosis,Lipid ,,approved,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,"fingolimod, fty 720,gilenia, gilenya",P21453,684
685,-,Class A (Rhodopsin),small molecule,fipamezole,ada2a_human,ADRA2A,795,Antiparkinson agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"fipamezole , jp-1730",P08913,685
686,-,Class A (Rhodopsin),small molecule,fipamezole,ada2b_human,ADRA2B,796,Antiparkinson agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"fipamezole, jp-1730",P18089,686
687,-,Class A (Rhodopsin),small molecule,fipamezole,ada2c_human,ADRA2C,796,Antiparkinson agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"fipamezole, jp-1730",P18825,687
688,-,Class A (Rhodopsin),small molecule,fk352b,aa1r_human,ADORA1,799,Antihypertensive agent,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,fk352b,P30542,688
689,1970,Class A (Rhodopsin),small molecule,flavoxate,acm1_human,CHRM1,NRDD230,Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,689
690,1970,Class A (Rhodopsin),small molecule,flavoxate,acm2_human,CHRM2,NRDD230,Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,690
691,2015,Class A (Rhodopsin),small molecule,flibanserin,5ht1a_human,HTR1A,801,for treatment of female sexual dysfunction,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,flibanserin,P08908,691
692,2015,Class A (Rhodopsin),small molecule,flibanserin,5ht2a_human,HTR2A,801,for treatment of female sexual dysfunction,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,flibanserin,P28223,692
693,-,Class A (Rhodopsin),small molecule,flunarizine,hrh1_human,HRH1,NRDD236,Anticonvulsants; Vasodilator Agents,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,693
694,-,Class A (Rhodopsin),small molecule,fluoxetine,5ht2a_human,HTR2A,1440,for treatment of autism,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"npl-2008, fluoxetine",P28223,694
695,-,Class A (Rhodopsin),small molecule,flupenthixol,drd1_human,DRD1,NRDD240,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,695
696,-,Class A (Rhodopsin),small molecule,flupenthixol,drd2_human,DRD2,NRDD240,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,696
697,1959,Class A (Rhodopsin),small molecule,fluphenazine,drd1_human,DRD1,NRDD241,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,697
698,1959,Class A (Rhodopsin),small molecule,fluphenazine,drd2_human,DRD2,NRDD241,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,698
699,-,Class A (Rhodopsin),small molecule,fluspirilene,drd2_human,DRD2,NRDD244,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,699
700,-,Class A (Rhodopsin),protein,follitropin alfa,fshr_human,FSHR,MMAmay2016_0738,Fertility Agents,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"bemfola, afolia recombinant follicle stimulating hormone",P23945,700
701,-,Class A (Rhodopsin),protein,follitropin alpha,fshr_human,FSHR,814,Fertility Agents,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"follitropin alpha ,gonal-f",P23945,701
702,1997,Class A (Rhodopsin),protein,follitropin beta,fshr_human,FSHR,NRDD246,Fertility Agents,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945,702
703,-,Class A (Rhodopsin),small molecule,forasartan,agtr1_human,AGTR1,NRDD248,Antihypertensive agent,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556,703
704,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,MMAmay2016_0044,Anti-Asthmatic Agents; COPD,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P07550,704
705,-,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2275,Appetite stimulant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,apd209,P07550,705
706,-,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,397,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"budesonide + formoterol,symbicort",P07550,706
707,-,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,481,Anti-Asthmatic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"chf-1535, beclomethasone dipropionate + formoterol fumarate",P07550,707
708,-,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,815,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"formoterol ,foradil",P07550,708
709,-,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,816,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"formoterol fumarate,perforomist",P07550,709
710,-,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,1215,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,map-0005,P07550,710
711,-,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,1325,Anti-Asthmatic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"mometasone furoate + formoterol fumarate dihydrate,dulera",P07550,711
712,-,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,1681,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"pt003, glycopyrrolate + formoterol inhalation aerosol",P07550,712
713,-,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,1682,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"pt005, formoterol fumarate hydrofluoroalkane metered dose inhaler",P07550,713
714,-,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,1861,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"skyepharma,flutiform",P07550,714
715,-,Class A (Rhodopsin),small molecule,frovatriptan,5ht1b_human,HTR1B,823,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"frovatriptan,frovelan, frova",P28222,715
716,-,Class A (Rhodopsin),small molecule,frovatriptan,5ht1d_human,HTR1D,823,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"frovatriptan,frovelan, frova",P28221,716
717,-,Class A (Rhodopsin),protein,fsh-gex,fshr_human,FSHR,825,Fertility Agents,Protein ,,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,fsh-gex,P23945,717
718,-,Class A (Rhodopsin),small molecule,fx125l,ccr1_human,CCR1,831,Anti-Asthmatic Agents,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,fx125l,P32246,718
719,-,Class A (Rhodopsin),small molecule,fx125l,cxcr1_human,CXCR1,831,Anti-Asthmatic Agents,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,fx125l,P25024,719
720,-,Class A (Rhodopsin),small molecule,fx125l,cxcr2_human,CXCR2,831,Anti-Asthmatic Agents,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,fx125l,P25025,720
721,-,Class A (Rhodopsin),small molecule,fx125l,cxcr4_human,CXCR4,831,Anti-Asthmatic Agents,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,fx125l,P61073,721
722,-,Class C (Glutamate) ,small molecule,gamma hydroxybutyric acid,gabr1_human,GABBR1,1871,Hypnotics and Sedatives,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,sodium oxybate,Q9UBS5,722
723,-,Class C (Glutamate) ,small molecule,gamma hydroxybutyric acid,gabr2_human,GABBR2,1871,Hypnotics and Sedatives,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,sodium oxybate,O75899,723
724,-,Class A (Rhodopsin),small molecule,gc021109,p2ry6_human,P2RY6,MMAfeb2016_0055,for treatment of Alzheimer's disease,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,gc021109,Q15077,724
725,-,Class A (Rhodopsin),small molecule,gepirone,5ht1a_human,HTR1A,848,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,gepirone,P08908,725
726,-,Class B1 (Secretin),peptide,glp,glp1r_human,GLP1R,699,Appetite suppressant,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,eligen pyy-3-36 + glp-1,P43220,726
727,-,Class B1 (Secretin),unknown,glp1 agonist ,glp1r_human,GLP1R,2155,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,viaderm-glp1 agonist,P43220,727
728,-,Class A (Rhodopsin),small molecule,glpg0974,ffar2_human,FFAR2,MMAmay2016_0156,Anti-inflammatory agent; neutrophil driven inflammation; ulcerative colitis,Lipid ,,in trial,Free fatty acid receptors,GPCR;Rhodopsin,not established,glpg0974,O15552,728
729,-,Class A (Rhodopsin),small molecule,glpg1205,gpr84_human,GPR84,MMAapril2016_0323,for ulcerative colitis; IBS,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,glpg1205,Q9NQS5,729
730,-,Class B1 (Secretin),peptide,glucagon,glr_human,GCGR,2458,for prevention of hypoglycemia,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,dio-901,P47871,730
731,-,Class B1 (Secretin),peptide,glucagon,glr_human,GCGR,MMAmar2016_0239,Antidiabetic agent,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,zp-glucagon,P47871,731
732,1960,Class B1 (Secretin),peptide,glucagon recombinant,glr_human,GCGR,NRDD256,Antihypoglycemic Agents,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,-,P47871,732
733,-,Class A (Rhodopsin),small molecule,glycopyrrolate,acm1_human,CHRM1,MMAmay2016_0378,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,ep-101,P11229,733
734,-,Class A (Rhodopsin),small molecule,glycopyrrolate,acm1_human,CHRM1,864,Antineoplastic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"glycopyrrolate, fhpc-02,cuvposa",P11229,734
735,-,Class A (Rhodopsin),small molecule,glycopyrrolate,acm1_human,CHRM1,1680,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,pt001,P11229,735
736,-,Class A (Rhodopsin),small molecule,glycopyrrolate,acm1_human,CHRM1,1681,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"pt003, glycopyrrolate + formoterol inhalation aerosol",P11229,736
737,-,Class A (Rhodopsin),small molecule,glycopyrronium,acm1_human,CHRM1,1457,for treatment of chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"nva237, inhaled glycopyrronium bromide",P11229,737
738,-,Class A (Rhodopsin),small molecule,glycopyrronium bromide,adrb2_human,ADRB2,1702,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"qva149, glycopyrronium bromide + i/",P07550,738
739,1982,Class A (Rhodopsin),small molecule,gonadorelin,gnrhr_human,GNRHR,NRDD259,Fertility Agents,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,P30968,739
740,1982,Class A (Rhodopsin),small molecule,gonadorelin,gnrr2_human,GNRHR2,NRDD259,Fertility Agents,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,Q96P88,740
741,-,Class A (Rhodopsin),protein,gonadotropin,lshr_human,LHCGR,1904,for treatment of stroke,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"stem,ntx-265",P22888,741
742,1989,Class A (Rhodopsin),peptide,goserelin,lshr_human,LHCGR,NRDD260,Antineoplastic agents; Hormonal,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P22888,742
743,-,Class A (Rhodopsin),small molecule,gsk-1004723,hrh1_human,HRH1,878,Anti-Allergic Agents,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,gsk-1004723,P35367,743
744,-,Class A (Rhodopsin),small molecule,gsk-1004723,hrh3_human,HRH3,878,Anti-Allergic Agents,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,gsk-1004723,Q9Y5N1,744
745,-,Class A (Rhodopsin),small molecule,gsk-961081,adrb2_human,ADRB2,881,Bronchodilator agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,gsk-961081,P07550,745
746,-,Class A (Rhodopsin),small molecule,gsk-961081,acm3_human,CHRM3,881,Bronchodilator agent,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,gsk-961081,P20309,746
747,-,Class B1 (Secretin),protein,gtp-010,glp1r_human,GLP1R,885,for treatment of irritable bowel syndrome,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,gtp-010,P43220,747
748,-,Class A (Rhodopsin),peptide,gtp-200,ghsr_human,GHSR,886,Appetite stimulant,Peptide ,,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,gtp-200,Q92847,748
749,-,Class A (Rhodopsin),small molecule,gtx-758,lshr_human,LHCGR,888,Antineoplastic agent,Protein ,,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,gtx-758,P22888,749
750,1982,Class A (Rhodopsin),small molecule,guanabenz,ada2a_human,ADRA2A,NRDD261,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,750
751,-,Class A (Rhodopsin),small molecule,guanfacine,ada2a_human,ADRA2A,889,for treatment of ADHD,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"guanfacine, spd 503,intuniv",P08913,751
752,-,Class A (Rhodopsin),small molecule,gw642444,adrb2_human,ADRB2,892,Bronchodilator agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,gw642444,P07550,752
753,1967,Class A (Rhodopsin),small molecule,haloperidol,drd2_human,DRD2,NRDD266,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,753
754,-,Class A (Rhodopsin),small molecule,histamine,hrh2_human,HRH2,463,cytorprotective agent during cancer treatment ,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,ceplene,P25021,754
755,-,Class A (Rhodopsin),small molecule,histrelin,gnrhr_human,GNRHR,2177,Antineoplastic agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"vp 002, histrelin implant,vantas, supprelin",P30968,755
756,-,Class A (Rhodopsin),small molecule,histrelin,gnrr2_human,GNRHR2,2177,Antineoplastic agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"vp 002, histrelin implant,vantas, supprelin",Q96P88,756
757,-,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm1_human,CHRM1,NRDD271,GI Anti-Ulcer Agents; Antimuscarinics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,757
758,-,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm2_human,CHRM2,NRDD271,GI Anti-Ulcer Agents; Antimuscarinics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,758
759,-,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm3_human,CHRM3,NRDD271,GI Anti-Ulcer Agents; Antimuscarinics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,759
760,-,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm4_human,CHRM4,NRDD271,GI Anti-Ulcer Agents; Antimuscarinics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,760
761,-,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm5_human,CHRM5,NRDD271,GI Anti-Ulcer Agents; Antimuscarinics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,761
762,-,Class A (Rhodopsin),protein,homspera,nk1r_human,TACR1,1907,for treatment of idiopathic pulmonary fibrosis,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"substance p,homspera, radilex, viprovex",P25103,762
763,-,Class B1 (Secretin),peptide,h-pth 1-34,pth1r_human,PTH1R,2153,Anti-osteoporotic agent,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,viaderm hpth 1-34,Q03431,763
764,-,Class B1 (Secretin),peptide,h-pth 1-34,pth2r_human,PTH2R,2153,Anti-osteoporotic agent,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,viaderm hpth 1-34,P49190,764
765,-,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,MMAmay2016_0753,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone bitartrate with acetaminophen,P35372,765
766,-,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,MMAmay2016_0754,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone bitartrate with acetaminophen,P41143,766
767,-,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,1686,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P41143,767
768,-,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,1686,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P35372,768
769,-,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,MMAmar2016_0081,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"s-718632, extended release hydrocodone",P35372,769
770,-,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,MMAmar2016_0082,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"s-718632, extended release hydrocodone",P41143,770
771,-,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,2254,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"zx002, hydrocodone bitartrate",P41143,771
772,-,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,2254,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"zx002, hydrocodone bitartrate",P35372,772
773,2014,Class A (Rhodopsin),small molecule,hydrocodone bitartrate,oprm_human,OPRM1,MMAmar2016_0009,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"hysingla er, hydrocodone bitartrate extended release",P35372,773
774,2014,Class A (Rhodopsin),small molecule,hydrocodone bitartrate,oprd_human,OPRD1,MMAmar2016_0010,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"hysingla er, hydrocodone bitartrate extended release",P41143,774
775,-,Class A (Rhodopsin),small molecule,hydrocodone deterx,oprm_human,OPRM1,MMAapril2016_0192,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone deterx,P35372,775
776,-,Class A (Rhodopsin),small molecule,hydrocodone deterx,oprd_human,OPRD1,MMAapril2016_0193,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone deterx,P41143,776
777,-,Class A (Rhodopsin),small molecule,hydromorphone,oprm_human,OPRM1,MMAapril2016_0260,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ltx-04,  hydromorphone hcl",P35372,777
778,-,Class A (Rhodopsin),small molecule,hydromorphone,oprd_human,OPRD1,MMAapril2016_0261,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ltx-04,  hydromorphone hcl",P41143,778
779,-,Class A (Rhodopsin),small molecule,hydromorphone,oprk_human,OPRK1,MMAapril2016_0262,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ltx-04,  hydromorphone hcl",P41145,779
780,-,Class A (Rhodopsin),small molecule,hydromorphone,oprd_human,OPRD1,1422,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nmed-1077,exalgo, jurnista, dilaudid",P41143,780
781,-,Class A (Rhodopsin),small molecule,hydromorphone,oprk_human,OPRK1,1422,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nmed-1077,exalgo, jurnista, dilaudid",P41145,781
782,-,Class A (Rhodopsin),small molecule,hydromorphone,oprm_human,OPRM1,1422,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nmed-1077,exalgo, jurnista, dilaudid",P35372,782
783,-,Class A (Rhodopsin),small molecule,hydroxyzine,hrh1_human,HRH1,NRDD275,Antipruritics; Anxiolytics sedatives and hypnotics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,783
784,-,Class A (Rhodopsin),small molecule,icatibant,bkrb2_human,BDKRB2,797,for treatment of hereditary angioedema,Peptide ,,approved,Bradykinin receptors,GPCR;Rhodopsin,established,"firazyr, icatibant, je049",P30411,784
785,-,Class A (Rhodopsin),small molecule,iferanserin,5ht2a_human,HTR2A,942,Antihemorrhoidal agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,iferanserin ointment,P28223,785
786,-,Class A (Rhodopsin),small molecule,iferanserin,5ht2a_human,HTR2A,MMAmay2016_0414,Antihemorrhoidal agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iferanserin ointment, ven 309",P28223,786
787,-,Class A (Rhodopsin),small molecule,iloperidone,ada1a_human,ADRA1A,951,Antipsychotic agent; atypical,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P35348,787
788,-,Class A (Rhodopsin),small molecule,iloperidone,ada2c_human,ADRA2C,951,Antipsychotic agent; atypical,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P18825,788
789,-,Class A (Rhodopsin),small molecule,iloperidone,drd1_human,DRD1,951,Antipsychotic agent; atypical,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P21728,789
790,-,Class A (Rhodopsin),small molecule,iloperidone,drd2_human,DRD2,951,Antipsychotic agent; atypical,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P14416,790
791,-,Class A (Rhodopsin),small molecule,iloperidone,drd3_human,DRD3,951,Antipsychotic agent; atypical,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P35462,791
792,-,Class A (Rhodopsin),small molecule,iloperidone,hrh1_human,HRH1,951,Antipsychotic agent; atypical,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P35367,792
793,-,Class A (Rhodopsin),small molecule,iloperidone,5ht1a_human,HTR1A,951,Antipsychotic agent; atypical,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P08908,793
794,-,Class A (Rhodopsin),small molecule,iloperidone,5ht2a_human,HTR2A,951,Antipsychotic agent; atypical,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P28223,794
795,-,Class A (Rhodopsin),small molecule,iloperidone,5ht6r_human,HTR6,951,Antipsychotic agent; atypical,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P50406,795
796,-,Class A (Rhodopsin),small molecule,iloperidone,5ht7r_human,HTR7,951,Antipsychotic agent; atypical,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P34969,796
797,-,Class A (Rhodopsin),small molecule,iloprost,pe2r1_human,PTGER1,952,Antihypertensive agent,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"iloprost,ventavis",P34995,797
798,-,Class A (Rhodopsin),small molecule,iloprost,pi2r_human,PTGIR,952,Antihypertensive agent,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"iloprost,ventavis",P43119,798
799,-,Class A (Rhodopsin),small molecule,incb3284,ccr2_human,CCR2,966,Anti-inflammatory agent; DMARD,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,incb3284,P41597,799
800,-,Class A (Rhodopsin),small molecule,indacaterol,adrb2_human,ADRB2,969,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,indacaterol,P07550,800
801,-,Class A (Rhodopsin),small molecule,indacaterol,acm1_human,CHRM1,1702,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"qva149, glycopyrronium bromide + indacaterol",P11229,801
802,-,Class A (Rhodopsin),small molecule,ino-8875,aa1r_human,ADORA1,985,for treatment of glaucoma,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,ino-8875,P30542,802
803,-,Class A (Rhodopsin),small molecule,ins37217,p2ry2_human,P2RY2,990,for treatment of rhegmatogenous retinal detachment,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,ins37217,P41231,803
804,-,Class A (Rhodopsin),small molecule,ins37217,p2ry2_human,P2RY2,991,for treatment of cystic fibrosis; for treatment of perennial allergic rhinitis,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,ins37217 intranasal,P41231,804
805,-,Class A (Rhodopsin),unknown,ins-50589,p2y12_human,P2RY12,992,antithrombotic,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,established,ins-50589,Q9H244,805
806,-,Class A (Rhodopsin),small molecule,int-767,gpbar_human,GPBAR1,MMAapril2016_0196,Treatment of liver fibrosis,Steroid ,,in trial,Bile acid receptors,GPCR;Rhodopsin,not established,int-767,Q8TDU6,806
807,-,Class A (Rhodopsin),small molecule,"inv102, nadolol",adrb2_human,ADRB2,MMAmay2016_0225,for inflammatory lung disease,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"inv102, nadolol",P07550,807
808,-,Class F (Frizzled),small molecule,ipi-926,smo_human,SMO,2824,Antineoplastic agent,Protein ,,in trial,Frizzled,GPCR;Frizzled,established,ipi-926,Q99835,808
809,-,Class A (Rhodopsin),small molecule,ipratropium,acm1_human,CHRM1,1021,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ipratropium bromide + albuterol sulfate,duoneb",P11229,809
810,-,Class A (Rhodopsin),small molecule,ipratropium,acm2_human,CHRM2,1021,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ipratropium bromide + albuterol sulfate,duoneb",P08172,810
811,-,Class A (Rhodopsin),small molecule,irbesartan,agtr1_human,AGTR1,1023,Antihypertensive agent,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"irbesartan,avapro, irbetan",P30556,811
812,-,Class B1 (Secretin),antisense oligo,isis 325568,glr_human,GCGR,1030,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,isis 325568,P47871,812
813,-,Class A (Rhodopsin),small molecule,isoetharine,adrb1_human,ADRB1,NRDD290,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,813
814,-,Class A (Rhodopsin),small molecule,isometheptene mucate,ada1a_human,ADRA1A,MMAmar2016_0022,Anti-migraine Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tnx-201, single isomer isometheptene, imh",P35348,814
815,-,Class A (Rhodopsin),small molecule,isoproterenol,adrb1_human,ADRB1,NRDD293,Bronchodilator agent; Cardiotonic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,815
816,-,Class A (Rhodopsin),small molecule,isoproterenol,adrb2_human,ADRB2,NRDD293,Bronchodilator agent; Cardiotonic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,816
817,-,Class A (Rhodopsin),small molecule,istradefylline,aa2ar_human,ADORA2A,1043,Antiparkinson agent,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"istradefylline, kw-6002",P29274,817
818,-,Class A (Rhodopsin),small molecule,iti-007,drd2_human,DRD2,1048,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"iti-007, iti-722",P14416,818
819,-,Class A (Rhodopsin),small molecule,iti-007,5ht2a_human,HTR2A,1048,Antipsychotic agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iti-007, iti-722",P28223,819
820,-,Class A (Rhodopsin),small molecule,itopride,drd2_human,DRD2,1049,motilitant,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"itopride,itax",P14416,820
821,-,Class F (Frizzled),small molecule,itraconazole,smo_human,SMO,MMAmar2016_0140,Antineoplastic agent; basal cell carcinoma,Protein ,,approved,Frizzled,GPCR;Frizzled,established,suba-itraconazole,Q99835,821
822,-,Class A (Rhodopsin),small molecule,jnj-37822681,drd2_human,DRD2,1054,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,jnj-37822681,P14416,822
823,-,Class A (Rhodopsin),dna plasmid,jvs-100,cxcr4_human,CXCR4,1056,cardioprotectant,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,jvs-100,P61073,823
824,-,Class C (Glutamate) ,peptide,kai-4169,casr_human,CASR,2328,for treatment of hyperparathyroidism,Ion ,,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,kai-4169,P41180,824
825,-,Class A (Rhodopsin),small molecule,ketotifen,hrh1_human,HRH1,1074,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"ketotifen fumarate,zaditen, zaditor",P35367,825
826,-,Class A (Rhodopsin),small molecule,kn38-7271,cnr1_human,CNR1,1076,neuroprotectant,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,kn38-7271,P21554,826
827,-,Class A (Rhodopsin),small molecule,kn38-7271,cnr2_human,CNR2,1076,neuroprotectant,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,kn38-7271,P34972,827
828,-,Class A (Rhodopsin),small molecule,kos-2187,mtlr_human,MLNR,1078,for treatment of gastrointestinal motility disorders,Peptide ,,in trial,Motilin receptors,GPCR;Rhodopsin,not established,kos-2187,O43193,828
829,-,Class A (Rhodopsin),small molecule,kp201,oprd_human,OPRD1,1079,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,kp201 (prodrug of hydrocodone),P41143,829
830,-,Class A (Rhodopsin),small molecule,kp201,oprk_human,OPRK1,1079,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,kp201 (prodrug of hydrocodone),P41145,830
831,-,Class A (Rhodopsin),small molecule,kp201,oprm_human,OPRM1,1079,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,kp201 (prodrug of hydrocodone),P35372,831
832,-,Class A (Rhodopsin),small molecule,kuc-7483,adrb3_human,ADRB3,1082,for treatment of overactive bladder,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,kuc-7483,P13945,832
833,1984,Class A (Rhodopsin),small molecule,labetalol,ada1a_human,ADRA1A,NRDD296,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,833
834,1984,Class A (Rhodopsin),small molecule,labetalol,ada1b_human,ADRA1B,NRDD296,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,834
835,1984,Class A (Rhodopsin),small molecule,labetalol,adrb1_human,ADRB1,NRDD296,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,835
836,1984,Class A (Rhodopsin),small molecule,labetalol,adrb2_human,ADRB2,NRDD296,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,836
837,-,Class A (Rhodopsin),small molecule,lanreotide,ssr1_human,SSTR1,1088,for treatment of acromegaly,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"lanreotide ,somatuline autogel, somatuline depot",P30872,837
838,-,Class A (Rhodopsin),small molecule,lanreotide,ssr5_human,SSTR5,1089,for treatment of acromegaly,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"lanreotide,somatuline autogel, somatuline depot",P35346,838
839,-,Class A (Rhodopsin),small molecule,laropiprant,pd2r_human,PTGDR,1300,for counteracting niacin-induced flushing,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",Q13258,839
840,-,Class A (Rhodopsin),small molecule,laropiprant,pd2r_human,PTGDR,1301,for counteracting niacin-induced flushing,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,"mk-0542b, extended release niacin + laropiprant +simvastatin",Q13258,840
841,-,Class A (Rhodopsin),small molecule,las-100977,adrb2_human,ADRB2,1092,Bronchodilator agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,las-100977,P07550,841
842,-,Class A (Rhodopsin),small molecule,lasmiditan,5ht1f_human,HTR1F,1093,Anti-migraine Agents,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lasmiditan, col-144, ly-573144",P30939,842
843,-,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,MMAmay2016_0719,for treatment of glaucoma,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"eye-d, controlled-release latanoprost insert",P43088,843
844,-,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1095,for treatment of glaucoma,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"latanoprost + timolol,xalcom, xalacom",P43088,844
845,-,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1096,for treatment of glaucoma,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"latanoprost, (sustained release, punctal plug delivery system)",P43088,845
846,-,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1097,for treatment of glaucoma,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"latanoprost,xalatan fixed flow device",P43088,846
847,-,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1436,for treatment of glaucoma,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"nova21027,catioprost",P43088,847
848,-,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,MMAfeb2016_0059,for treatment of glaucoma,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"roclatan, rhopressa + latanoprost",P43088,848
849,-,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1918,for treatment of glaucoma,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,sustained release latanoprost,P43088,849
850,-,Class C (Glutamate) ,small molecule,lesogaberan,gabr1_human,GABBR1,1108,for treatment of gastrointestinal reflux disease,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,"lesogaberan, azd-3355",Q9UBS5,850
851,-,Class C (Glutamate) ,small molecule,lesogaberan,gabr2_human,GABBR2,1108,for treatment of gastrointestinal reflux disease,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,"lesogaberan, azd-3355",O75899,851
852,-,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,697,Antineoplastic agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,eligard,P30968,852
853,-,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1113,Antineoplastic agent; for treatment of endometriosis,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,leuprolide,P30968,853
854,-,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1114,Antineoplastic agent; for treatment of endometriosis,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"leuprolide acetate, tap-144 sr",P30968,854
855,-,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1115,Antineoplastic agent; for treatment of endometriosis,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,leupromaxx,P30968,855
856,-,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1250,for treatment of Alzheimer's disease,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,memryte,P30968,856
857,-,Class A (Rhodopsin),small molecule,levallorphan,oprm_human,OPRM1,NRDD298,Opiate Antagonists,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,857
858,1985,Class A (Rhodopsin),small molecule,levobunolol,adrb1_human,ADRB1,NRDD299,Antiglaucomic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,858
859,1985,Class A (Rhodopsin),small molecule,levobunolol,adrb2_human,ADRB2,NRDD299,Antiglaucomic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,859
860,1993,Class A (Rhodopsin),small molecule,levocabastine,hrh1_human,HRH1,NRDD301,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,860
861,-,Class A (Rhodopsin),small molecule,levocetirizine,hrh1_human,HRH1,1118,Anti-Allergic Agents,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,"levocetirizine dihydrochloride,xusal, xyzal",P35367,861
862,-,Class A (Rhodopsin),small molecule,levodopa,drd1_human,DRD1,646,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P21728,862
863,-,Class A (Rhodopsin),small molecule,levodopa,drd2_human,DRD2,646,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P14416,863
864,-,Class A (Rhodopsin),small molecule,levodopa,drd3_human,DRD3,646,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P35462,864
865,-,Class A (Rhodopsin),small molecule,levodopa,drd4_human,DRD4,646,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P21917,865
866,-,Class A (Rhodopsin),small molecule,levodopa,drd5_human,DRD5,646,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P21918,866
867,-,Class A (Rhodopsin),small molecule,levodopa,drd1_human,DRD1,712,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P21728,867
868,-,Class A (Rhodopsin),small molecule,levodopa,drd2_human,DRD2,712,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P14416,868
869,-,Class A (Rhodopsin),small molecule,levodopa,drd3_human,DRD3,712,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P35462,869
870,-,Class A (Rhodopsin),small molecule,levodopa,drd4_human,DRD4,712,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P21917,870
871,-,Class A (Rhodopsin),small molecule,levodopa,drd5_human,DRD5,712,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P21918,871
872,-,Class A (Rhodopsin),small molecule,levodopa,drd1_human,DRD1,1119,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P21728,872
873,-,Class A (Rhodopsin),small molecule,levodopa,drd2_human,DRD2,1119,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P14416,873
874,-,Class A (Rhodopsin),small molecule,levodopa,drd3_human,DRD3,1119,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P35462,874
875,-,Class A (Rhodopsin),small molecule,levodopa,drd4_human,DRD4,1119,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P21917,875
876,-,Class A (Rhodopsin),small molecule,levodopa,drd5_human,DRD5,1119,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P21918,876
877,-,Class A (Rhodopsin),small molecule,levodopa,drd2_human,DRD2,MMAmay2016_0101,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P14416,877
878,-,Class A (Rhodopsin),small molecule,levodopa,drd1_human,DRD1,MMAmay2016_0102,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P21728,878
879,-,Class A (Rhodopsin),small molecule,levodopa,drd4_human,DRD4,MMAmay2016_0103,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P21917,879
880,-,Class A (Rhodopsin),small molecule,levodopa,drd5_human,DRD5,MMAmay2016_0104,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P21918,880
881,-,Class A (Rhodopsin),small molecule,levodopa,drd3_human,DRD3,MMAmay2016_0105,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P35462,881
882,1993,Class A (Rhodopsin),small molecule,levomethadyl acetate,oprm_human,OPRM1,NRDD302,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,882
883,1953,Class A (Rhodopsin),small molecule,levorphanol,oprm_human,OPRM1,NRDD303,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,883
884,-,Class B1 (Secretin),small molecule,lgd-6972,glr_human,GCGR,MMAmay2016_0453,Antidiabetic; type II diabetes,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,lgd-6972,P47871,884
885,-,Class B1 (Secretin),protein,liraglutide,glp1r_human,GLP1R,MMAmay2016_0808,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,"ideglira,  insulin degludec + liraglutide,  nn-9068",P43220,885
886,-,Class B1 (Secretin),protein,liraglutide,glp1r_human,GLP1R,1154,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,liraglutide,P43220,886
887,2010,Class B1 (Secretin),peptide,liraglutide recombinant,glp1r_human,GLP1R,NRDD305,Antidiabetic agent,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,-,P43220,887
888,2007,Class A (Rhodopsin),small molecule,lisdexamfetamine,ada1a_human,ADRA1A,NRDD306,Central Nervous System Stimulants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,888
889,2007,Class A (Rhodopsin),small molecule,lisdexamfetamine,ada1b_human,ADRA1B,NRDD306,Central Nervous System Stimulants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,889
890,-,Class A (Rhodopsin),small molecule,lisuride,drd1_human,DRD1,NRDD307,Antiparkinson agents,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,890
891,-,Class A (Rhodopsin),small molecule,lisuride,drd2_human,DRD2,NRDD307,Antiparkinson agents,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,891
892,-,Class A (Rhodopsin),small molecule,lisuride,5ht1a_human,HTR1A,NRDD307,Antiparkinson agents,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P08908,892
893,-,Class B1 (Secretin),small molecule,lixisenatide,glp1r_human,GLP1R,MMAmar2016_0257,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"lixilan, lantus (basal insulin) + lyxumia (lixisenatide)",P43220,893
894,-,Class A (Rhodopsin),small molecule,lixivaptan,v2r_human,AVPR2,1157,for treatment of hyponatremia,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,lixivaptan,P30518,894
895,-,Class A (Rhodopsin),peptide,ljpc-501,agtr1_human,AGTR1,MMA2015_0090,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,athos-3,P30556,895
896,-,Class A (Rhodopsin),peptide,ljpc-501,agtr2_human,AGTR2,MMA2015_0091,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,not established,athos-3,P50052,896
897,-,Class A (Rhodopsin),small molecule,lofexidine,ada2a_human,ADRA2A,1159,for treatment of opiate withdrawal,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lofexidine,britlofex",P08913,897
898,-,Class A (Rhodopsin),small molecule,lofexidine,ada2b_human,ADRA2B,1159,for treatment of opiate withdrawal,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lofexidine,britlofex",P18089,898
899,-,Class A (Rhodopsin),small molecule,lofexidine,ada2c_human,ADRA2C,1159,for treatment of opiate withdrawal,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lofexidine,britlofex",P18825,899
900,-,Class A (Rhodopsin),small molecule,loperamide,oprm_human,OPRM1,NRDD308,Antidiuretic Agents,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,900
901,-,Class A (Rhodopsin),small molecule,loratadine,hrh1_human,HRH1,1163,Anti-Asthmatic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"loratadine + montelukast sodium,claritin + singulair",P35367,901
902,-,Class A (Rhodopsin),small molecule,lorcaserin,5ht2c_human,HTR2C,1164,Anti-obesity agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lorcaserin,P28335,902
903,1995,Class A (Rhodopsin),small molecule,losartan,agtr1_human,AGTR1,NRDD310,Antihypertensive agent,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556,903
904,1995,Class A (Rhodopsin),small molecule,losartan,agtr1_human,AGTR1,MMAmay2016_0431,Antihypertensive agent; for Diabetic neuropathy,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,inv-144,P30556,904
905,-,Class A (Rhodopsin),small molecule,loxapine,drd2_human,DRD2,304,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,az-004,P14416,905
906,-,Class A (Rhodopsin),small molecule,loxapine,5ht2a_human,HTR2A,304,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,az-004,P28223,906
907,-,Class A (Rhodopsin),unknown,lu 02-750,drd1_human,DRD1,1170,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P21728,907
908,-,Class A (Rhodopsin),unknown,lu 02-750,drd2_human,DRD2,1170,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P14416,908
909,-,Class A (Rhodopsin),unknown,lu 02-750,drd3_human,DRD3,1170,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P35462,909
910,-,Class A (Rhodopsin),unknown,lu 02-750,drd4_human,DRD4,1170,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P21917,910
911,-,Class A (Rhodopsin),unknown,lu 02-750,drd5_human,DRD5,1170,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P21918,911
912,-,Class A (Rhodopsin),unknown,lu ae04621,drd1_human,DRD1,1175,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P21728,912
913,-,Class A (Rhodopsin),unknown,lu ae04621,drd2_human,DRD2,1175,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P14416,913
914,-,Class A (Rhodopsin),unknown,lu ae04621,drd3_human,DRD3,1175,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P35462,914
915,-,Class A (Rhodopsin),unknown,lu ae04621,drd4_human,DRD4,1175,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P21917,915
916,-,Class A (Rhodopsin),unknown,lu ae04621,drd5_human,DRD5,1175,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P21918,916
917,-,Class A (Rhodopsin),small molecule,lu-ae58054,5ht6r_human,HTR6,1177,Antipsychotic agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lu-ae58054 , ly-483518, sgs518",P50406,917
918,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht1a_human,HTR1A,MMAapril2016_0233,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P08908,918
919,2010,Class A (Rhodopsin),small molecule,lurasidone,drd2_human,DRD2,MMAapril2016_0234,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P14416,919
920,2010,Class A (Rhodopsin),small molecule,lurasidone,ada2c_human,ADRA2C,MMAapril2016_0235,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P18825,920
921,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht2a_human,HTR2A,MMAapril2016_0236,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P28223,921
922,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht7r_human,HTR7,MMAapril2016_0237,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P34969,922
923,2010,Class A (Rhodopsin),small molecule,lurasidone,ada2c_human,ADRA2C,1184,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P18825,923
924,2010,Class A (Rhodopsin),small molecule,lurasidone,drd2_human,DRD2,1184,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P14416,924
925,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht1a_human,HTR1A,1184,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P08908,925
926,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht2a_human,HTR2A,1184,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P28223,926
927,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht7r_human,HTR7,1184,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P34969,927
928,-,Class A (Rhodopsin),peptide,luteinizing hormone-releasing hormone,gnrhr_human,GNRHR,2097,Antineoplastic agent,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"tztx-001,teverelix la",P30968,928
929,-,Class A (Rhodopsin),peptide,luteinizing hormone-releasing hormone,gnrr2_human,GNRHR2,2097,Antineoplastic agent,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"tztx-001,teverelix la",Q96P88,929
930,2004,Class A (Rhodopsin),peptide,lutropin alfa,lshr_human,LHCGR,NRDD311,Fertility Agents,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P22888,930
931,-,Class C (Glutamate) ,small molecule,ly2140023,grm2_human,GRM2,1190,Antipsychotic agent,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,ly2140023,Q14416,931
932,-,Class C (Glutamate) ,small molecule,ly2140023,grm3_human,GRM3,1190,Antipsychotic agent,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,ly2140023,Q14832,932
933,-,Class B1 (Secretin),peptide,ly-2189265,glp1r_human,GLP1R,1192,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,ly-2189265,P43220,933
934,-,Class A (Rhodopsin),small molecule,m0002,v2r_human,AVPR2,1204,for treatemnt of ascites,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,m0002,P30518,934
935,-,Class A (Rhodopsin),peptide,"macimorelin,  aezs-130",ghsr_human,GHSR,MMAmay2016_0080,for treatment of cancer cachexia,Peptide ,,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,"macimorelin,  aezs-130",Q92847,935
936,2013,Class A (Rhodopsin),small molecule,macitentan,ednra_human,EDNRA,1209,cardiovascular agent,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,"macitentan , act-064992",P25101,936
937,2013,Class A (Rhodopsin),small molecule,macitentan,ednrb_human,EDNRB,1210,cardiovascular agent,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,"macitentan, act-064992",P24530,937
938,-,Class B1 (Secretin),peptide,mar701,gipr_human,GIPR,1217,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,not established,mar701,P48546,938
939,-,Class B1 (Secretin),peptide,mar701,glp1r_human,GLP1R,1217,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,mar701,P43220,939
940,-,Class A (Rhodopsin),small molecule,maraviroc,ccr5_human,CCR5,1834,antiviral agent; HIV,Protein ,,approved,Chemokine receptors,GPCR;Rhodopsin,established,selzentry,P51681,940
941,1985,Class A (Rhodopsin),small molecule,marinol,cnr1_human,CNR1,NRDD314,Antiemetics,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,-,P21554,941
942,-,Class A (Rhodopsin),small molecule,mbx-2982,gp119_human,GPR119,1225,Antidiabetic,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,mbx-2982,Q8TDV5,942
943,-,Class A (Rhodopsin),small molecule,mc-1,lpar4_human,LPAR4,1227,cardioprotectant,Lipid ,,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,mc-4232,Q99677,943
944,-,Class A (Rhodopsin),small molecule,mc-1,lpar6_human,LPAR6,1227,cardioprotectant,Lipid ,,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,mc-4232,P43657,944
945,-,Class A (Rhodopsin),small molecule,mc-1,p2ry1_human,P2RY1,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,P47900,945
946,-,Class A (Rhodopsin),small molecule,mc-1,p2y10_human,P2RY10,1227,cardioprotectant,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,mc-4232,O00398,946
947,-,Class A (Rhodopsin),small molecule,mc-1,p2y11_human,P2RY11,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q96G91,947
948,-,Class A (Rhodopsin),small molecule,mc-1,p2y12_human,P2RY12,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,established,mc-4232,Q9H244,948
949,-,Class A (Rhodopsin),small molecule,mc-1,p2y13_human,P2RY13,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q9BPV8,949
950,-,Class A (Rhodopsin),small molecule,mc-1,p2y14_human,P2RY14,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q15391,950
951,-,Class A (Rhodopsin),small molecule,mc-1,p2ry2_human,P2RY2,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,P41231,951
952,-,Class A (Rhodopsin),small molecule,mc-1,p2ry4_human,P2RY4,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,P51582,952
953,-,Class A (Rhodopsin),small molecule,mc-1,p2ry6_human,P2RY6,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q15077,953
954,-,Class A (Rhodopsin),small molecule,mc-1,p2ry8_human,P2RY8,1227,cardioprotectant,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,mc-4232,Q86VZ1,954
955,-,Class A (Rhodopsin),small molecule,mcd-386,acm1_human,CHRM1,1228,for treatment of Alzheimer's disease,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,mcd-386,P11229,955
956,1957,Class A (Rhodopsin),small molecule,meclizine,hrh1_human,HRH1,NRDD315,Antiemetics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,956
957,-,Class A (Rhodopsin),small molecule,melatonin,mtr1a_human,MTNR1A,NRDD320,Hypnotics and Sedatives,Melatonin ,,in trial,Melatonin,GPCR;Rhodopsin,established,-,P48039,957
958,-,Class A (Rhodopsin),small molecule,melatonin,mtr1b_human,MTNR1B,NRDD320,Hypnotics and Sedatives,Melatonin ,,in trial,Melatonin,GPCR;Rhodopsin,established,-,P49286,958
959,-,Class A (Rhodopsin),small molecule,melevodopa,drd1_human,DRD1,2110,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P21728,959
960,-,Class A (Rhodopsin),small molecule,melevodopa,drd2_human,DRD2,2110,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P14416,960
961,-,Class A (Rhodopsin),small molecule,melevodopa,drd3_human,DRD3,2110,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P35462,961
962,-,Class A (Rhodopsin),small molecule,melevodopa,drd4_human,DRD4,2110,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P21917,962
963,-,Class A (Rhodopsin),small molecule,melevodopa,drd5_human,DRD5,2110,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P21918,963
964,-,Class A (Rhodopsin),protein,menotropins,fshr_human,FSHR,NRDD322,Fertility Agents,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945,964
965,-,Class A (Rhodopsin),protein,menotropins,lshr_human,LHCGR,NRDD322,Fertility Agents,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P22888,965
966,1956,Class A (Rhodopsin),small molecule,mepenzolate,hcar2_human,HCAR2,NRDD324,Antispasmodics,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,-,Q8TDS4,966
967,1956,Class A (Rhodopsin),small molecule,mepenzolate,hcar3_human,HCAR3,NRDD324,Antispasmodics,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,-,P49019,967
968,1942,Class A (Rhodopsin),small molecule,meperidine,oprk_human,OPRK1,NRDD325,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,968
969,-,Class A (Rhodopsin),small molecule,mephentermine,ada1a_human,ADRA1A,NRDD326,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,969
970,-,Class A (Rhodopsin),small molecule,mequitazine,hrh1_human,HRH1,NRDD329,Anti-Allergic Agents,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,970
971,1970,Class A (Rhodopsin),small molecule,mesoridazine,drd2_human,DRD2,NRDD331,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,971
972,1970,Class A (Rhodopsin),small molecule,mesoridazine,5ht2a_human,HTR2A,NRDD331,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,972
973,-,Class A (Rhodopsin),small molecule,metaraminol,ada1a_human,ADRA1A,NRDD333,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,973
974,-,Class A (Rhodopsin),small molecule,methadone,oprm_human,OPRM1,NRDD334,Analgesics; Opioid; Antitussive Agents,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,974
975,1993,Class A (Rhodopsin),small molecule,methadyl acetate,oprm_human,OPRM1,NRDD335,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,975
976,-,Class A (Rhodopsin),small molecule,methamphetamine,ada2a_human,ADRA2A,1167,neuroprotectant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,low dose intravenous methamphetamine,P08913,976
977,-,Class A (Rhodopsin),small molecule,methamphetamine,ada2b_human,ADRA2B,1167,neuroprotectant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,low dose intravenous methamphetamine,P18089,977
978,-,Class A (Rhodopsin),small molecule,methamphetamine,ada2c_human,ADRA2C,1167,neuroprotectant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,low dose intravenous methamphetamine,P18825,978
979,-,Class A (Rhodopsin),small molecule,methamphetamine,taar1_human,TAAR1,1167,neuroprotectant,Aminergic ,,approved,Trace amine receptors,GPCR;Rhodopsin,established,low dose intravenous methamphetamine,Q96RJ0,979
980,1951,Class A (Rhodopsin),small molecule,methantheline,acm1_human,CHRM1,NRDD336,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,980
981,-,Class A (Rhodopsin),small molecule,methdilazine,hrh1_human,HRH1,NRDD339,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,981
982,-,Class A (Rhodopsin),small molecule,methotrimeprazine,ada1a_human,ADRA1A,NRDD342,Antipsychotic agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,982
983,-,Class A (Rhodopsin),small molecule,methotrimeprazine,ada1b_human,ADRA1B,NRDD342,Antipsychotic agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,983
984,-,Class A (Rhodopsin),small molecule,methotrimeprazine,ada1d_human,ADRA1D,NRDD342,Antipsychotic agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,984
985,-,Class A (Rhodopsin),small molecule,methotrimeprazine,acm1_human,CHRM1,NRDD342,Antipsychotic agent,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,985
986,-,Class A (Rhodopsin),small molecule,methotrimeprazine,acm2_human,CHRM2,NRDD342,Antipsychotic agent,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,986
987,-,Class A (Rhodopsin),small molecule,methotrimeprazine,acm3_human,CHRM3,NRDD342,Antipsychotic agent,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,987
988,-,Class A (Rhodopsin),small molecule,methotrimeprazine,acm4_human,CHRM4,NRDD342,Antipsychotic agent,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,988
989,-,Class A (Rhodopsin),small molecule,methotrimeprazine,acm5_human,CHRM5,NRDD342,Antipsychotic agent,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,989
990,-,Class A (Rhodopsin),small molecule,methotrimeprazine,drd3_human,DRD3,NRDD342,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P35462,990
991,-,Class A (Rhodopsin),small molecule,methotrimeprazine,hrh1_human,HRH1,NRDD342,Antipsychotic agent,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,991
992,-,Class A (Rhodopsin),small molecule,methotrimeprazine,5ht2b_human,HTR2B,NRDD342,Antipsychotic agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P41595,992
993,-,Class A (Rhodopsin),small molecule,methoxamine,ada1a_human,ADRA1A,NRDD343,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,993
994,-,Class A (Rhodopsin),small molecule,methoxamine,ada1b_human,ADRA1B,NRDD343,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,994
995,1962,Class A (Rhodopsin),small molecule,methyldopa,ada2a_human,ADRA2A,NRDD346,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,995
996,1946,Class A (Rhodopsin),small molecule,methylergonovine,drd1_human,DRD1,NRDD347,Abortifacient Agents,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,996
997,-,Class A (Rhodopsin),small molecule,methylnaltrexone,oprm_human,OPRM1,1262,for treatment of opioid-induced constipation,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,methylnaltrexone,P35372,997
998,2008,Class A (Rhodopsin),small molecule,methylnaltrexone bromide,oprm_human,OPRM1,NRDD348,OIC treatment,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,998
999,1953,Class A (Rhodopsin),small molecule,methylscopolamine,acm1_human,CHRM1,NRDD351,Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,999
1000,1962,Class A (Rhodopsin),small molecule,methysergide,5ht1a_human,HTR1A,NRDD353,Anti-migraine agents; Vasoconstrictor Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P08908,1000
1001,1962,Class A (Rhodopsin),small molecule,methysergide,5ht2a_human,HTR2A,NRDD353,Anti-migraine agents; Vasoconstrictor Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,1001
1002,1962,Class A (Rhodopsin),small molecule,methysergide,5ht2c_human,HTR2C,NRDD353,Anti-migraine agents; Vasoconstrictor Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,1002
1003,1962,Class A (Rhodopsin),small molecule,methysergide,5ht7r_human,HTR7,NRDD353,Anti-migraine agents; Vasoconstrictor Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P34969,1003
1004,1989,Class A (Rhodopsin),small molecule,metipranolol,adrb1_human,ADRB1,NRDD354,Anti-Arrhythmia Agents; Antihypertensive agent; Anti-glaucoma agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,1004
1005,1989,Class A (Rhodopsin),small molecule,metipranolol,adrb2_human,ADRB2,NRDD354,Anti-Arrhythmia Agents; Antihypertensive agent; Anti-glaucoma agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,1005
1006,-,Class A (Rhodopsin),small molecule,metixene,acm1_human,CHRM1,NRDD355,Antiparkinson agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1006
1007,-,Class A (Rhodopsin),small molecule,metixene,acm2_human,CHRM2,NRDD355,Antiparkinson agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,1007
1008,-,Class A (Rhodopsin),small molecule,metixene,acm3_human,CHRM3,NRDD355,Antiparkinson agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,1008
1009,-,Class A (Rhodopsin),small molecule,metixene,acm4_human,CHRM4,NRDD355,Antiparkinson agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,1009
1010,-,Class A (Rhodopsin),small molecule,metixene,acm5_human,CHRM5,NRDD355,Antiparkinson agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,1010
1011,-,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,758,for treatment of diabetic gastroparesis,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,evk-001,P11229,1011
1012,-,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,758,for treatment of diabetic gastroparesis,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,evk-001,P14416,1012
1013,-,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,MMAmay2016_0859,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"evk-001, metoclopramide nasal spray",P11229,1013
1014,-,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,MMAmay2016_0860,Antiemetics,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"evk-001, metoclopramide nasal spray",P14416,1014
1015,-,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,1268,motilitant; for treatment of gastroesophageal reflux disease ,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"metoclopramide hcl,metzoliv odt",P11229,1015
1016,-,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,1268,motilitant; for treatment of gastroesophageal reflux disease ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"metoclopramide hcl,metzoliv odt",P14416,1016
1017,-,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,1269,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"metoclopramide,emitasol, pramidin",P11229,1017
1018,-,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,1269,Antiemetics,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"metoclopramide,emitasol, pramidin",P14416,1018
1019,-,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,1355,Anti-migraine Agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,mt 100,P11229,1019
1020,-,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,1355,Anti-migraine Agents,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,mt 100,P14416,1020
1021,1978,Class A (Rhodopsin),small molecule,metoprolol,adrb1_human,ADRB1,NRDD359,Anti-Arrhythmia Agents; Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,1021
1022,-,Class A (Rhodopsin),small molecule,metoprolol ,adrb1_human,ADRB1,1270,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"metoprolol succinate,toprol-xl",P08588,1022
1023,-,Class A (Rhodopsin),small molecule,"mg01ci, extended-release metadoxine,",5ht2b_human,HTR2B,MMAmay2016_0480,for treatment of neurologic disorders; ADHD,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mg01ci, extended-release metadoxine,",P41595,1023
1024,-,Class A (Rhodopsin),small molecule,mianserin,ada2a_human,ADRA2A,NRDD363,Antidepressive Agents; Second-Generation,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,1024
1025,-,Class A (Rhodopsin),small molecule,mianserin,hrh1_human,HRH1,NRDD363,Antidepressive Agents; Second-Generation,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,1025
1026,-,Class A (Rhodopsin),small molecule,mianserin,5ht2a_human,HTR2A,NRDD363,Antidepressive Agents; Second-Generation,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,1026
1027,-,Class A (Rhodopsin),small molecule,mianserin,5ht2c_human,HTR2C,NRDD363,Antidepressive Agents; Second-Generation,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,1027
1028,1996,Class A (Rhodopsin),small molecule,midodrine,ada1a_human,ADRA1A,NRDD365,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1028
1029,1996,Class A (Rhodopsin),small molecule,midodrine,ada1b_human,ADRA1B,NRDD365,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,1029
1030,-,Class A (Rhodopsin),small molecule,milveterol,adrb2_human,ADRB2,1290,Bronchodilator agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"milveterol. td-3327, gsk-159797",P07550,1030
1031,-,Class A (Rhodopsin),small molecule,"min-001,  cyr-101",5ht2a_human,HTR2A,MMAapril2016_0202,for treatment of schizophrenia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"min-001,  cyr-101",P28223,1031
1032,-,Class A (Rhodopsin),small molecule,min-117,5ht2a_human,HTR2A,MMAapril2016_0203,for treatment of major depressive disorder,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,min-117,P28223,1032
1033,-,Class A (Rhodopsin),small molecule,min-117,5ht1a_human,HTR1A,MMAapril2016_0204,for treatment of major depressive disorder,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,min-117,P08908,1033
1034,-,Class A (Rhodopsin),small molecule,min-117,ada1a_human,ADRA1A,MMAapril2016_0206,for treatment of major depressive disorder,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,min-117,P35348,1034
1035,-,Class A (Rhodopsin),small molecule,min-117,ada1b_human,ADRA1B,MMAapril2016_0207,for treatment of major depressive disorder,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,min-117,P35368,1035
1036,-,Class A (Rhodopsin),small molecule,"min-202, jnj-42847922",ox2r_human,HCRTR2,MMA2016_0029,Anti-depressant and sleep disorder therapy,Peptide ,,in trial,Orexin receptors,GPCR;Rhodopsin,established,"min-202, jnj-42847922",O43614,1036
1037,-,Class A (Rhodopsin),small molecule,minaprine,drd1_human,DRD1,NRDD368,Antidepressive Agents,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,1037
1038,-,Class A (Rhodopsin),small molecule,minaprine,drd2_human,DRD2,NRDD368,Antidepressive Agents,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1038
1039,-,Class A (Rhodopsin),small molecule,minaprine,5ht2a_human,HTR2A,NRDD368,Antidepressive Agents,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,1039
1040,-,Class A (Rhodopsin),small molecule,minaprine,5ht2b_human,HTR2B,NRDD368,Antidepressive Agents,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P41595,1040
1041,-,Class A (Rhodopsin),small molecule,minaprine,5ht2c_human,HTR2C,NRDD368,Antidepressive Agents,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,1041
1042,-,Class A (Rhodopsin),small molecule,mirtazapine,ada2a_human,ADRA2A,1295,Anti-depressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"mirtazapine,remeron, remeron soltab, reflex",P08913,1042
1043,-,Class A (Rhodopsin),small molecule,mirtazapine,5ht2a_human,HTR2A,1295,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mirtazapine,remeron, remeron soltab, reflex",P28223,1043
1044,-,Class A (Rhodopsin),small molecule,misoprostol,pi2r_human,PTGIR,202,Labor Inducing Agents,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"apl-202,isprelor",P43119,1044
1045,-,Class A (Rhodopsin),small molecule,mitemcinal,mtlr_human,MLNR,1296,for treatment of gastroparesis,Peptide ,,in trial,Motilin receptors,GPCR;Rhodopsin,not established,"mitemcinal, gm-611",O43193,1045
1046,1992,Class A (Rhodopsin),small molecule,mivacurium,acm2_human,CHRM2,NRDD370,Muscle Relaxants,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,1046
1047,-,Class B1 (Secretin),protein,mkc-253,glp1r_human,GLP1R,1308,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,mkc-253,P43220,1047
1048,-,Class A (Rhodopsin),small molecule,"mle4901,  azd4901",nk3r_human,TACR3,MMAapril2016_0263,for Polycystic Ovarian Syndrome,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"mle4901,  azd4901",P29371,1048
1049,-,Class A (Rhodopsin),antibody,mln-1202,ccr2_human,CCR2,1310,Anti-inflammatory agent; DMARD,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,mln-1202,P41597,1049
1050,-,Class A (Rhodopsin),unknown,mn-221,adrb2_human,ADRB2,1317,Anti-Asthmatic Agents,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,mn-221,P07550,1050
1051,-,Class A (Rhodopsin),small molecule,mn-246,adrb3_human,ADRB3,1318,for treatment of overactive bladder,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,mn-246,P13945,1051
1052,-,Class A (Rhodopsin),small molecule,mn-305,5ht1a_human,HTR1A,1319,Anti-depressant; hypnotic,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,mn-305,P08908,1052
1053,-,Class B1 (Secretin),peptide,"mod-6031, long-acting oxyntomodulin",glp1r_human,GLP1R,MMAmay2016_0898,for treatment of metabolic disorders; type II diabetes; obesity,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"mod-6031, long-acting oxyntomodulin",P43220,1053
1054,-,Class B1 (Secretin),peptide,"mod-6031, long-acting oxyntomodulin",glr_human,GCGR,MMAmay2016_0899,for treatment of metabolic disorders; type II diabetes; obesity,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"mod-6031, long-acting oxyntomodulin",P47871,1054
1055,-,Class A (Rhodopsin),antibody,mogamulizumab,ccr4_human,CCR4,MMAjun2016_0001,Antineoplastic agent,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,mogamulizumab,P51679,1055
1056,1974,Class A (Rhodopsin),small molecule,molindone,drd2_human,DRD2,NRDD372,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1056
1057,1974,Class A (Rhodopsin),small molecule,molindone,drd2_human,DRD2,2425,for treatment of ADHD,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"spn810 ,zalvari",P14416,1057
1058,-,Class A (Rhodopsin),small molecule,montelukast,cltr1_human,CYSLTR1,1163,Anti-Asthmatic Agents,Lipid ,,approved,Leukotriene receptors,GPCR;Rhodopsin,established,"loratadine + montelukast sodium,claritin + singulair",Q9Y271,1058
1059,-,Class A (Rhodopsin),small molecule,montelukast,cltr1_human,CYSLTR1,1327,Anti-Asthmatic Agents,Lipid ,,approved,Leukotriene receptors,GPCR;Rhodopsin,established,"montelukast sodium,singulair",Q9Y271,1059
1060,-,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,122,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P41143,1060
1061,-,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,122,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P41145,1061
1062,-,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,122,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P35372,1062
1063,-,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,MMAmar2016_0055,Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"egalet-001, reformulated morphine",P41145,1063
1064,-,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,MMAmar2016_0056,Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"egalet-001, reformulated morphine",P35372,1064
1065,-,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,MMAmar2016_0057,Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"egalet-001, reformulated morphine",P41143,1065
1066,-,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1013,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"intranasal morphine,rylomine",P41143,1066
1067,-,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1013,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"intranasal morphine,rylomine",P41145,1067
1068,-,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1013,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"intranasal morphine,rylomine",P35372,1068
1069,-,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1207,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"m6g, cee 04-410",P41143,1069
1070,-,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1207,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"m6g, cee 04-410",P41145,1070
1071,-,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1207,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"m6g, cee 04-410",P35372,1071
1072,-,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1279,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"mh-200, tak-453 sr, morphine hcl,anpec",P41143,1072
1073,-,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1279,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"mh-200, tak-453 sr, morphine hcl,anpec",P41145,1073
1074,-,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1279,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"mh-200, tak-453 sr, morphine hcl,anpec",P35372,1074
1075,-,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1333,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,avinza",P41143,1075
1076,-,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1333,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,avinza",P41145,1076
1077,-,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1333,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,avinza",P35372,1077
1078,-,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1334,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,depodur, depomorphine",P41143,1078
1079,-,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1334,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,depodur, depomorphine",P41145,1079
1080,-,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1334,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,depodur, depomorphine",P35372,1080
1081,-,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1335,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine/dextromethorphan,morphidex",P41143,1081
1082,-,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1335,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine/dextromethorphan,morphidex",P41145,1082
1083,-,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1335,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine/dextromethorphan,morphidex",P35372,1083
1084,-,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1336,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P41143,1084
1085,-,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1336,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P41145,1085
1086,-,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1336,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P35372,1086
1087,-,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1341,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P41143,1087
1088,-,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1341,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P41145,1088
1089,-,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1341,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P35372,1089
1090,-,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1903,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,statex,P41145,1090
1091,-,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,2051,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,tpm-1/morphine,P41143,1093
1092,-,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,2051,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,tpm-1/morphine,P41145,1094
1093,-,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,2051,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,tpm-1/morphine,P35372,1095
1094,-,Class A (Rhodopsin),small molecule,mosapride,5ht4r_human,HTR4,1337,for treatment of Gastrointestinal reflux disease (GERD),Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mosapride citrate, tak-370,gasmotin",Q13639,1096
1095,-,Class A (Rhodopsin),small molecule,msx-122,cxcr4_human,CXCR4,1354,Antineoplastic agent,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,msx-122,P61073,1097
1096,-,Class A (Rhodopsin),small molecule,mt-1303,s1pr1_human,S1PR1,MMAmar2016_0211,for treatment of autoimmune diseases; Multiple Sclerosis; Crohn's disease ,Lipid ,,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,mt-1303,P21453,1098
1097,2015,Class A (Rhodopsin),small molecule,"mu delta, eluxadoline",oprd_human,OPRD1,1363,for treatment of irritable bowel syndrome,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"mu delta, eluxadoline",P41143,1099
1098,2015,Class A (Rhodopsin),small molecule,"mu delta, eluxadoline",oprm_human,OPRM1,1363,for treatment of irritable bowel syndrome,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"mu delta, eluxadoline",P35372,1100
1099,-,Class A (Rhodopsin),small molecule,nabilone,cnr1_human,CNR1,1373,Antiemetics,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"nabilone,cesamet",P21554,1101
1100,-,Class A (Rhodopsin),small molecule,nabilone,cnr2_human,CNR2,1373,Antiemetics,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"nabilone,cesamet",P34972,1102
1101,-,Class A (Rhodopsin),small molecule,nabilone,cnr1_human,CNR1,1812,Analgesics; neuropathic pain; for treatment of restlegs legs syndrome,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,sativex,P21554,1103
1102,-,Class A (Rhodopsin),small molecule,nabilone,cnr2_human,CNR2,1812,Analgesics; neuropathic pain; for treatment of restlegs legs syndrome,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,sativex,P34972,1104
1103,1979,Class A (Rhodopsin),small molecule,nadolol,adrb1_human,ADRB1,NRDD376,Anti-Arrhythmia Agents; Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,1105
1104,1979,Class A (Rhodopsin),small molecule,nadolol,adrb2_human,ADRB2,NRDD376,Anti-Arrhythmia Agents; Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,1106
1105,1990,Class A (Rhodopsin),small molecule,nafarelin,gnrhr_human,GNRHR,NRDD377,Antiendometriosis Agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,P30968,1107
1106,1990,Class A (Rhodopsin),small molecule,nafarelin,gnrr2_human,GNRHR2,NRDD377,Antiendometriosis Agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,Q96P88,1108
1107,-,Class A (Rhodopsin),small molecule,nalbuphine,oprd_human,OPRD1,1374,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalbuphine hydrochloride,  pw-4142",P41143,1109
1108,-,Class A (Rhodopsin),small molecule,nalbuphine,oprk_human,OPRK1,1374,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalbuphine hydrochloride,  pw-4142",P41145,1110
1109,-,Class A (Rhodopsin),small molecule,nalbuphine,oprm_human,OPRM1,1374,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalbuphine hydrochloride,  pw-4142",P35372,1111
1110,-,Class A (Rhodopsin),small molecule,nalbuphine,oprd_human,OPRD1,1733,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P41143,1112
1111,-,Class A (Rhodopsin),small molecule,nalbuphine,oprk_human,OPRK1,1733,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P41145,1113
1112,-,Class A (Rhodopsin),small molecule,nalbuphine,oprm_human,OPRM1,1733,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P35372,1114
1113,-,Class A (Rhodopsin),small molecule,nalmefene,oprd_human,OPRD1,1375,smoking-cessation agent; for treatment of addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalmefene, cph-101",P41143,1115
1114,-,Class A (Rhodopsin),small molecule,nalmefene,oprk_human,OPRK1,1375,smoking-cessation agent; for treatment of addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalmefene, cph-101",P41145,1116
1115,-,Class A (Rhodopsin),small molecule,nalmefene,oprm_human,OPRM1,1375,smoking-cessation agent; for treatment of addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalmefene, cph-101",P35372,1117
1116,1995,Class A (Rhodopsin),small molecule,nalmefene ,oprd_human,OPRD1,2766,for treatment of pruritus,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,srd174,P41143,1118
1117,1995,Class A (Rhodopsin),small molecule,nalmefene ,oprk_human,OPRK1,2766,for treatment of pruritus,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,srd174,P41145,1119
1118,1995,Class A (Rhodopsin),small molecule,nalmefene ,oprm_human,OPRM1,2766,for treatment of pruritus,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,srd174,P35372,1120
1119,2014,Class A (Rhodopsin),small molecule,"naloxegol, peg-naloxol",oprm_human,OPRM1,1419,for treatment of opioid-induced constipation,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,nktr-118,P35372,1121
1120,-,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,405,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P41143,1122
1121,-,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,405,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P41145,1123
1122,-,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,405,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P35372,1124
1123,-,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,406,Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P41143,1125
1124,-,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,406,Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P41145,1126
1125,-,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,406,Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P35372,1127
1126,-,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,MMAmay2016_0645,Analgesics; overdose/drug toxicity,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, indivior",P35372,1128
1127,-,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,MMAmay2016_0646,Analgesics; overdose/drug toxicity,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, indivior",P41143,1129
1128,-,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,MMAmay2016_0647,Analgesics; overdose/drug toxicity,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, indivior",P41145,1130
1129,-,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,MMAmar2016_0088,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",P35372,1131
1130,-,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,MMAmar2016_0089,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",P41143,1132
1131,-,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,MMAmar2016_0090,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",P41145,1133
1132,-,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,MMAmay2016_0517,Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P35372,1134
1133,-,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,MMAmay2016_0518,Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P41145,1135
1134,-,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,MMAmay2016_0921,Analgesics; for treatment of opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P41143,1136
1135,-,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,1733,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P41143,1137
1136,-,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,1733,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P41145,1138
1137,-,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,1733,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P35372,1139
1138,-,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,MMAmay2016_0709,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P35372,1140
1139,-,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,MMAmay2016_0710,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P41143,1141
1140,-,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,MMAmay2016_0711,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P41145,1142
1141,-,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,122,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P41143,1143
1142,-,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,122,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P41145,1144
1143,-,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,122,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P35372,1145
1144,-,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,522,Appetite suppressant,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,contrave,P41143,1146
1145,-,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,522,Appetite suppressant,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,contrave,P41145,1147
1146,-,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,522,Appetite suppressant,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,contrave,P35372,1148
1147,-,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,MMAfeb2016_0084,Opioid antagonist - addiction therapy,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P35372,1149
1148,-,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,MMAfeb2016_0085,Opioid antagonist - addiction therapy,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P41143,1150
1149,-,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,MMAfeb2016_0086,Opioid antagonist - addiction therapy,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P41145,1151
1150,-,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1336,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P41143,1152
1151,-,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1336,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P41145,1153
1152,-,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1336,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P35372,1154
1153,-,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1685,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P41143,1155
1154,-,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1685,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P41145,1156
1155,-,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1685,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P35372,1157
1156,-,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1686,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P41143,1158
1157,-,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1686,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P41145,1159
1158,-,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1686,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P35372,1160
1159,-,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1687,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P41143,1161
1160,-,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1687,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P41145,1162
1161,-,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1687,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P35372,1163
1162,-,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1688,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-901,P41143,1164
1163,-,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1688,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-901,P41145,1165
1164,-,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1688,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-901,P35372,1166
1165,-,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,MMAmay2016_0073,Analgesics; for type 1A Charcot-Marie-Tooth disease,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pxt3003, baclofen + naltrexone + sorbitol",P35372,1167
1166,-,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,MMAmay2016_0074,Analgesics; for type 1A Charcot-Marie-Tooth disease,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pxt3003, baclofen + naltrexone + sorbitol",P41143,1168
1167,-,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,MMAmay2016_0075,Analgesics; for type 1A Charcot-Marie-Tooth disease,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pxt3003, baclofen + naltrexone + sorbitol",P41145,1169
1168,-,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,2168,for treatment of substance abuse,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,vivitrol,P41143,1170
1169,-,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,2168,for treatment of substance abuse,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,vivitrol,P41145,1171
1170,-,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,2168,for treatment of substance abuse,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,vivitrol,P35372,1172
1171,-,Class A (Rhodopsin),small molecule,naratriptan,5ht1a_human,HTR1A,1381,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"naratriptan,naramig, amerge",P08908,1173
1172,-,Class A (Rhodopsin),small molecule,naratriptan,5ht1b_human,HTR1B,1381,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"naratriptan,naramig, amerge",P28222,1174
1173,-,Class A (Rhodopsin),small molecule,naratriptan,5ht1d_human,HTR1D,1381,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"naratriptan,naramig, amerge",P28221,1175
1174,-,Class A (Rhodopsin),small molecule,naratriptan,5ht1f_human,HTR1F,1381,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"naratriptan,naramig, amerge",P30939,1176
1175,-,Class A (Rhodopsin),small molecule,nbi-42902,gnrhr_human,GNRHR,869,for treatment of postmenopausal symptoms; Antineoplastic agent,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"gnrh receptor antagonist, nbi-42902",P30968,1177
1176,-,Class A (Rhodopsin),small molecule,nbi-42902,gnrr2_human,GNRHR2,869,for treatment of postmenopausal symptoms; Antineoplastic agent,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"gnrh receptor antagonist, nbi-42902",Q96P88,1178
1177,-,Class A (Rhodopsin),small molecule,nbi-56418,gnrhr_human,GNRHR,1388,Antineoplastic agent,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,nbi-56418,P30968,1179
1178,-,Class A (Rhodopsin),small molecule,ncx 1510,hrh1_human,HRH1,1390,Anti-Allergic Agents,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,"ncx 1510, ox-nla",P35367,1180
1179,-,Class A (Rhodopsin),small molecule,ncx116,pf2r_human,PTGFR,378,for treatment of glaucoma,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"bol-303259-x, ncx 116, pf-03187207",P43088,1181
1180,-,Class A (Rhodopsin),small molecule,nebivolol,adrb1_human,ADRB1,1394,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"nebivolol ,bystolic",P08588,1182
1181,1992,Class A (Rhodopsin),small molecule,nedocromil,cltr1_human,CYSLTR1,NRDD379,Anti-Allergic Agents; Anti-Asthmatic Agents,Lipid ,,approved,Leukotriene receptors,GPCR;Rhodopsin,established,-,Q9Y271,1183
1182,1994,Class A (Rhodopsin),small molecule,nefazodone,ada1a_human,ADRA1A,NRDD380,Antidepressive Agents; Second-Generation,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1184
1183,1994,Class A (Rhodopsin),small molecule,nefazodone,ada1b_human,ADRA1B,NRDD380,Antidepressive Agents; Second-Generation,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,1185
1184,1994,Class A (Rhodopsin),small molecule,nefazodone,5ht2a_human,HTR2A,NRDD380,Antidepressive Agents; Second-Generation,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,1186
1185,-,Class A (Rhodopsin),small molecule,"nelotanserin, apd-125",5ht2a_human,HTR2A,MMAmar2016_0233,for treatment of dementia; Parkinson's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"nelotanserin, apd-125",P28223,1187
1186,-,Class A (Rhodopsin),peptide,nemifitide,5ht2a_human,HTR2A,983,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"inn-00835, nemifitide",P28223,1188
1187,2014,Class A (Rhodopsin),small molecule,netupitant,nk1r_human,TACR1,MMAmay2016_0499,Antiemetics; chemotherapy induced nausea and vomiting,Peptide ,,approved,Tachykinin receptors,GPCR;Rhodopsin,established,netupitant + palonosetron,P25103,1189
1188,-,Class A (Rhodopsin),small molecule,ngd-4715,mchr1_human,MCHR1,1408,Appetite suppressant,Peptide ,,in trial,Melanin-concentrating hormone,GPCR;Rhodopsin,not established,ngd-4715,Q99705,1190
1189,-,Class A (Rhodopsin),small molecule,ngx267,acm1_human,CHRM1,1410,for treatment of dry mouth,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,ngx267,P11229,1191
1190,-,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,467,Antidyslipidaemic agent,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,Q8TDS4,1192
1191,-,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,467,Antidyslipidaemic agent,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,P49019,1193
1192,-,Class A (Rhodopsin),small molecule: combination,niacin,hcar3_human,HCAR3,MMA2015_0071,Dyslipidemia with low HDL,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,P49019,1194
1193,-,Class A (Rhodopsin),small molecule: combination,niacin,hcar2_human,HCAR2,MMA2015_0072,Dyslipidemia with low HDL,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,Q8TDS4,1195
1194,-,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,1300,Antidyslipidaemic agent,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",Q8TDS4,1196
1195,-,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,1300,Antidyslipidaemic agent,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",P49019,1197
1196,-,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,1301,Antidyslipidaemic agent,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"mk-0542b, extended release niacin + laropiprant +simvastatin",Q8TDS4,1198
1197,-,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,1301,Antidyslipidaemic agent,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"mk-0542b, extended release niacin + laropiprant +simvastatin",P49019,1199
1198,-,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,2468,Antihyperlipidemic agent,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"niacin extended-release tablets,niaspan",Q8TDS4,1200
1199,-,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,2468,Antihyperlipidemic agent,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"niacin extended-release tablets,niaspan",P49019,1201
1200,-,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,1546,substance abuse deterrant,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",Q8TDS4,1202
1201,-,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,1546,substance abuse deterrant,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",P49019,1203
1202,-,Class A (Rhodopsin),small molecule,niacin receptor agonist,hcar2_human,HCAR2,1412,Anti-atherosclerotic agent,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,niacin receptor agonist,Q8TDS4,1204
1203,-,Class A (Rhodopsin),small molecule,niacin receptor agonist,hcar3_human,HCAR3,1412,Anti-atherosclerotic agent,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,niacin receptor agonist,P49019,1205
1204,-,Class A (Rhodopsin),small molecule,nicergoline,ada1a_human,ADRA1A,NRDD384,Nootropic Agents; Vasodilator Agents,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1206
1205,1988,Class A (Rhodopsin),small molecule,nizatidine,hrh2_human,HRH2,NRDD394,GI Anti-Ulcer Agents; antihistamines,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P25021,1207
1206,-,Class A (Rhodopsin),small molecule polymer conjugate,nktr-181,oprm_human,OPRM1,1420,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,nktr-181,P35372,1208
1207,-,Class B1 (Secretin),protein,nn9924,glp1r_human,GLP1R,1429,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,nn9924,P43220,1209
1208,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada1a_human,ADRA1A,NRDD395,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1210
1209,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada1b_human,ADRA1B,NRDD395,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,1211
1210,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada1d_human,ADRA1D,NRDD395,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,1212
1211,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada2a_human,ADRA2A,NRDD395,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,1213
1212,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada2b_human,ADRA2B,NRDD395,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089,1214
1213,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada2c_human,ADRA2C,NRDD395,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18825,1215
1214,1950,Class A (Rhodopsin),small molecule,norepinephrine,adrb1_human,ADRB1,NRDD395,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,1216
1215,1950,Class A (Rhodopsin),small molecule,norepinephrine,adrb2_human,ADRB2,NRDD395,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,1217
1216,1950,Class A (Rhodopsin),small molecule,norepinephrine,adrb3_human,ADRB3,NRDD395,Antihypotensive Agents; Vasoconstrictor Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P13945,1218
1217,-,Class A (Rhodopsin),small molecule,norepinephrine,ada1a_human,ADRA1A,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P35348,1219
1218,-,Class A (Rhodopsin),small molecule,norepinephrine,ada1b_human,ADRA1B,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P35368,1220
1219,-,Class A (Rhodopsin),small molecule,norepinephrine,ada1d_human,ADRA1D,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P25100,1221
1220,-,Class A (Rhodopsin),small molecule,norepinephrine,ada2a_human,ADRA2A,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P08913,1222
1221,-,Class A (Rhodopsin),small molecule,norepinephrine,ada2b_human,ADRA2B,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P18089,1223
1222,-,Class A (Rhodopsin),small molecule,norepinephrine,ada2c_human,ADRA2C,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P18825,1224
1223,-,Class A (Rhodopsin),small molecule,norepinephrine,adrb1_human,ADRB1,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P08588,1225
1224,-,Class A (Rhodopsin),small molecule,norepinephrine,adrb2_human,ADRB2,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P07550,1226
1225,-,Class A (Rhodopsin),small molecule,norepinephrine,adrb3_human,ADRB3,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P13945,1227
1226,-,Class A (Rhodopsin),unknown,not disclosed,oprd_human,OPRD1,1684,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-202,P41143,1228
1227,-,Class A (Rhodopsin),unknown,not disclosed,oprk_human,OPRK1,1684,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-202,P41145,1229
1228,-,Class A (Rhodopsin),unknown,not disclosed,oprm_human,OPRM1,1684,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-202,P35372,1230
1229,-,Class A (Rhodopsin),viral gene delivery,np2 enkephalin,oprd_human,DOR,2421,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,np2 enkephalin,P41143,1231
1230,-,Class C (Glutamate) ,small molecule,nps-2143,casr_human,CASR,1441,Anti-osteoporotic agent,Ion ,,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,nps-2143,P41180,1232
1231,-,Class C (Glutamate) ,small molecule,npsp795,casr_human,CASR,MMAmar2016_0202,for treatment of hypocalcaemia,Ion ,,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,npsp795,P41180,1233
1232,-,Class A (Rhodopsin),small molecule,nrp104,ada1b_human,ADRA1B,2199,for treatment of ADHD,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,vyvanse,P35368,1234
1233,-,Class A (Rhodopsin),small molecule,nrp290,oprd_human,OPRD1,1444,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,nrp290,P41143,1235
1234,-,Class A (Rhodopsin),small molecule,nrp290,oprk_human,OPRK1,1444,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,nrp290,P41145,1236
1235,-,Class A (Rhodopsin),small molecule,nrp290,oprm_human,OPRM1,1444,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,nrp290,P35372,1237
1236,-,Class A (Rhodopsin),small molecule,ns-304,pi2r_human,PTGIR,1448,Antihypertensive agent,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,ns-304,P43119,1238
1237,-,Class A (Rhodopsin),protein,nu206,lgr4_human,LGR4,2528,for treatment of gastrointestinal disease,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,"nu206, r-spondin1",Q9BXB1,1239
1238,-,Class A (Rhodopsin),protein,nu206,lgr5_human,LGR5,2528,for treatment of gastrointestinal disease,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,"nu206, r-spondin1",O75473,1240
1239,-,Class A (Rhodopsin),small molecule,nxn-188,5ht1b_human,HTR1B,1460,Anti-migraine Agents,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,nxn-188,P28222,1241
1240,-,Class A (Rhodopsin),small molecule,nxn-188,5ht1d_human,HTR1D,1460,Anti-migraine Agents,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,nxn-188,P28221,1242
1241,-,Class A (Rhodopsin),small molecule,obe001,oxyr_human,OXTR,MMAapril2016_0035,for treatment of labor and delivery,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,obe001,P30559,1243
1242,-,Class A (Rhodopsin),small molecule,obinepitide,npy2r_human,NPY2R,2027,Anti-obesity agent,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"tm30338,obinepitide",P49146,1244
1243,-,Class A (Rhodopsin),small molecule,obinepitide,npy4r_human,PPYR1,2027,Anti-obesity agent,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"tm30338,obinepitide",P50391,1245
1244,-,Class A (Rhodopsin),small molecule,oc000459 ,pd2r2_human,PD2R2,1466,Anti-Allergic Agents,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,oc000459,Q9Y5Y4,1246
1245,-,Class A (Rhodopsin),small molecule,oc459,pd2r2_human,GPR44,MMAmay2016_0684,for allergic rhinitis,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,oc459,Q9Y5Y4,1247
1246,-,Class A (Rhodopsin),peptide,octreotide,ssr1_human,SSTR1,421,Antineoplastic agent,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,cam-2029,P30872,1248
1247,-,Class A (Rhodopsin),peptide,octreotide,ssr2_human,SSTR2,421,Antineoplastic agent,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,cam-2029,P30874,1249
1248,-,Class A (Rhodopsin),peptide,octreotide,ssr5_human,SSTR5,421,Antineoplastic agent,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,cam-2029,P35346,1250
1249,-,Class A (Rhodopsin),peptide,octreotide,ssr1_human,SSTR1,981,Antineoplastic agent,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"injectable octreotide acetate,sandostatin lar",P30872,1251
1250,-,Class A (Rhodopsin),peptide,octreotide,ssr2_human,SSTR2,981,Antineoplastic agent,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"injectable octreotide acetate,sandostatin lar",P30874,1252
1251,-,Class A (Rhodopsin),peptide,octreotide,ssr5_human,SSTR5,981,Antineoplastic agent,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"injectable octreotide acetate,sandostatin lar",P35346,1253
1252,-,Class A (Rhodopsin),peptide,octreotide,ssr1_human,SSTR1,1470,Antineoplastic agent,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"octrotide,atrigel",P30872,1254
1253,-,Class A (Rhodopsin),peptide,octreotide,ssr2_human,SSTR2,1470,Antineoplastic agent,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"octrotide,atrigel",P30874,1255
1254,-,Class A (Rhodopsin),peptide,octreotide,ssr5_human,SSTR5,1470,Antineoplastic agent,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"octrotide,atrigel",P35346,1256
1255,-,Class A (Rhodopsin),peptide,octreotide,ssr1_human,SSTR1,1508,Antihypertensive agent,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"oral octreotide actetate ,octreolin",P30872,1257
1256,-,Class A (Rhodopsin),peptide,octreotide,ssr2_human,SSTR2,1509,Antihypertensive agent,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"oral octreotide actetate,octreolin",P30874,1258
1257,-,Class A (Rhodopsin),peptide,octreotide,ssr5_human,SSTR5,1509,Antihypertensive agent,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"oral octreotide actetate,octreolin",P35346,1259
1258,-,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P35348,1260
1259,-,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P35368,1261
1260,-,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P08913,1262
1261,-,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P18089,1263
1262,-,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P18825,1264
1263,-,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P11229,1265
1264,-,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P08172,1266
1265,-,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P20309,1267
1266,-,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P08173,1268
1267,-,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P08912,1269
1268,-,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P21728,1270
1269,-,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P14416,1271
1270,-,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P35462,1272
1271,-,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P21917,1273
1272,-,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P21918,1274
1273,-,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,APR13_0013,Antipsychotic agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,alks 3831,P35367,1275
1274,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,APR13_0013,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P08908,1276
1275,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,APR13_0013,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28222,1277
1276,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,APR13_0013,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28221,1278
1277,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,APR13_0013,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28566,1279
1278,-,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,APR13_0013,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28223,1280
1279,-,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,APR13_0013,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28335,1281
1280,-,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,APR13_0013,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P50406,1282
1281,-,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,APR13_0013,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P34969,1283
1282,-,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,MMAmay2016_0185,Antipsychotic agent; antipsychotic-related metabolic weight gain,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08172,1284
1283,-,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,MMAmay2016_0186,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08173,1285
1284,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,MMAmay2016_0187,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08908,1286
1285,-,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,MMAmay2016_0188,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08912,1287
1286,-,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,MMAmay2016_0189,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08913,1288
1287,-,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,MMAmay2016_0190,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P11229,1289
1288,-,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,MMAmay2016_0191,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P14416,1290
1289,-,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,MMAmay2016_0192,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P18089,1291
1290,-,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,MMAmay2016_0193,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P18825,1292
1291,-,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,MMAmay2016_0194,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P20309,1293
1292,-,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,MMAmay2016_0195,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P21728,1294
1293,-,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,MMAmay2016_0196,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P21917,1295
1294,-,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,MMAmay2016_0197,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P21918,1296
1295,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,MMAmay2016_0198,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28221,1297
1296,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,MMAmay2016_0199,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28222,1298
1297,-,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,MMAmay2016_0200,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28223,1299
1298,-,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,MMAmay2016_0201,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28335,1300
1299,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,MMAmay2016_0202,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28566,1301
1300,-,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,MMAmay2016_0203,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P34969,1302
1301,-,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,MMAmay2016_0204,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35348,1303
1302,-,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,MMAmay2016_0205,Antipsychotic agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35367,1304
1303,-,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,MMAmay2016_0206,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35368,1305
1304,-,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,MMAmay2016_0207,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35462,1306
1305,-,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,MMAmay2016_0209,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P50406,1307
1306,-,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,1475,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P35348,1308
1307,-,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,1475,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P35368,1309
1308,-,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,1475,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08913,1310
1309,-,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,1475,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P18089,1311
1310,-,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,1475,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P18825,1312
1311,-,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,1475,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P11229,1313
1312,-,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,1475,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08172,1314
1313,-,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,1475,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P20309,1315
1314,-,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,1475,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08173,1316
1315,-,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,1475,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08912,1317
1316,-,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,1475,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P21728,1318
1317,-,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,1475,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P14416,1319
1318,-,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,1475,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P35462,1320
1319,-,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,1475,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P21917,1321
1320,-,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,1475,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P21918,1322
1321,-,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,1475,Antipsychotic agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P35367,1323
1322,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,1475,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08908,1324
1323,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,1475,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28222,1325
1324,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,1475,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28221,1326
1325,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,1475,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28566,1327
1326,-,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,1475,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28223,1328
1327,-,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,1475,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28335,1329
1328,-,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,1475,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P50406,1330
1329,-,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,1475,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P34969,1331
1330,-,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P35348,1332
1331,-,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P35368,1333
1332,-,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08913,1334
1333,-,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P18089,1335
1334,-,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P18825,1336
1335,-,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P11229,1337
1336,-,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08172,1338
1337,-,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P20309,1339
1338,-,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08173,1340
1339,-,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08912,1341
1340,-,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P21728,1342
1341,-,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P14416,1343
1342,-,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P35462,1344
1343,-,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P21917,1345
1344,-,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P21918,1346
1345,-,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P35367,1347
1346,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08908,1348
1347,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28222,1349
1348,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28221,1350
1349,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28566,1351
1350,-,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28223,1352
1351,-,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28335,1353
1352,-,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P50406,1354
1353,-,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,1476,Anti-depressant; for treatment of bipolar disorder,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P34969,1355
1354,-,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,1515,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P35348,1356
1355,-,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,1515,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P35368,1357
1356,-,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,1515,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08913,1358
1357,-,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,1515,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P18089,1359
1358,-,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,1515,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P18825,1360
1359,-,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,1515,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P11229,1361
1360,-,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,1515,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08172,1362
1361,-,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,1515,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P20309,1363
1362,-,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,1515,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08173,1364
1363,-,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,1515,Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08912,1365
1364,-,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,1515,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P21728,1366
1365,-,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,1515,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P14416,1367
1366,-,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,1515,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P35462,1368
1367,-,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,1515,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P21917,1369
1368,-,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,1515,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P21918,1370
1369,-,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,1515,Antipsychotic agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P35367,1371
1370,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,1515,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08908,1372
1371,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,1515,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28222,1373
1372,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,1515,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28221,1374
1373,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,1515,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28566,1375
1374,-,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,1515,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28223,1376
1375,-,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,1515,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28335,1377
1376,-,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,1515,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P50406,1378
1377,-,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,1515,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P34969,1379
1378,-,Class A (Rhodopsin),small molecule,olmesartan,agtr1_human,AGTR1,557,Antihypertensive agent,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"cs-8663, amlodipine + olmesartan,azor, sevikar",P30556,1380
1379,-,Class A (Rhodopsin),small molecule,olmesartan,agtr1_human,AGTR1,1478,Antihypertensive agent,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"olmesartan medoxomil (cs-866),benicar",P30556,1381
1380,-,Class A (Rhodopsin),small molecule,olmesartan,agtr1_human,AGTR1,1479,for treatment of glaucoma,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"olmesartan, de-092",P30556,1382
1381,-,Class A (Rhodopsin),small molecule,olmesartan,agtr1_human,AGTR1,2080,Antihypertensive agent,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,tribenzor,P30556,1383
1382,2014,Class A (Rhodopsin),small molecule,olodaterol,adrb2_human,ADRB2,351,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,bi-1744-cl,P07550,1384
1383,2015,Class A (Rhodopsin),small molecule,olodaterol,adrb2_human,ADRB2,MMAmay2016_0592,Bronchodilator agent; COPD,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,tiotropium + olodaterol,P07550,1385
1384,-,Class A (Rhodopsin),small molecule,olopatadine,hrh1_human,HRH1,1480,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"olopatadine hydrochloride,patanase",P35367,1386
1385,-,Class F (Frizzled),antibody,omp-18r5,fzd7_human,FZD7,2457,Antineoplastic agent,Protein ,,in trial,Frizzled,GPCR;Frizzled,not established,omp-18r5,O75084,1387
1386,-,Class A (Rhodopsin),small molecule,opa-6566,aa2ar_human,ADORA2A,MMAmay2016_0512,for treatment of glaucoma,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,opa-6566,P29274,1388
1387,-,Class A (Rhodopsin),small molecule,opc-14523,5ht1a_human,HTR1A,1662,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"prs-013, opc-14523",P08908,1389
1388,-,,small molecule,opc-14523,pgrc1_human,PGRMC1,1662,Anti-depressant,,,in trial,,GPCR;Rhodopsin,not established,"prs-013, opc-14523",O00264,1390
1389,-,Class A (Rhodopsin),small molecule,opc-28326,ada2b_human,ADRA2B,1501,vasodilator,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,opc-28326,P18089,1391
1390,-,Class A (Rhodopsin),small molecule,opc-28326,ada2c_human,ADRA2C,1501,vasodilator,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,opc-28326,P18825,1392
1391,2015,Class A (Rhodopsin),small molecule,"opc-34712, brexpiprazole",drd2_human,DRD2,1502,Anti-depressant,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"opc-34712, brexpiprazole",P14416,1393
1392,2015,Class A (Rhodopsin),small molecule,"opc-34712, brexpiprazole",5ht1a_human,HTR1A,1502,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"opc-34712, brexpiprazole",P08908,1394
1393,2015,Class A (Rhodopsin),small molecule,"opc-34712, brexpiprazole",5ht2a_human,HTR2A,1502,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"opc-34712, brexpiprazole",P28223,1395
1394,2015,Class A (Rhodopsin),small molecule,"opc-34712, brexpiprazole",5ht7r_human,HTR7,1502,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"opc-34712, brexpiprazole",P34969,1396
1395,-,Class A (Rhodopsin),small molecule,opc-51803,v2r_human,AVPR2,1503,for treatment of incontinence,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,opc-51803,P30518,1397
1396,-,Class A (Rhodopsin),small molecule,orciprenaline,adrb2_human,ADRB2,NRDD399,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,1398
1397,-,Class A (Rhodopsin),small molecule,ordopidine,drd2_human,DRD2,2422,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,acr325,P14416,1399
1398,-,Class B1 (Secretin),peptide,ormd-0901,glp1r_human,GLP1R,1519,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"ormd-0901, oral glp-1 analog",P43220,1400
1399,1957,Class A (Rhodopsin),small molecule,orphenadrine,hrh1_human,HRH1,NRDD400,Antiparkinson agents; Muscle Relaxants; Central,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,1401
1400,-,Class B1 (Secretin),peptide,ostabolin-c,pth1r_human,PTH1R,1530,Anti-osteoporotic agent,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"ostabolin-c,  zt-031",Q03431,1402
1401,-,Class B1 (Secretin),peptide,ostabolin-c,pth2r_human,PTH2R,1530,Anti-osteoporotic agent,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"ostabolin-c,  zt-031",P49190,1403
1402,-,Class A (Rhodopsin),small molecule,ot-730,adrb1_human,ADRB1,1533,for treatment of glaucoma,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,ot-730,P08588,1404
1403,-,Class A (Rhodopsin),small molecule,ot-730,adrb2_human,ADRB2,1533,for treatment of glaucoma,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,ot-730,P07550,1405
1404,1983,Class A (Rhodopsin),small molecule,oxprenolol,adrb1_human,ADRB1,NRDD405,Antihypertensive agent; Anti-Arrhythmia Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,1406
1405,1983,Class A (Rhodopsin),small molecule,oxprenolol,adrb2_human,ADRB2,NRDD405,Antihypertensive agent; Anti-Arrhythmia Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,1407
1406,-,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,14,for treatment of incontinence,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aa-2010,P11229,1408
1407,-,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,14,for treatment of incontinence,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aa-2010,P08172,1409
1408,-,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,14,for treatment of incontinence,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aa-2010,P20309,1410
1409,-,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,190,for treatment of overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ap-1034,anturol",P11229,1411
1410,-,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,190,for treatment of overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ap-1034,anturol",P08172,1412
1411,-,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,190,for treatment of overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ap-1034,anturol",P20309,1413
1412,-,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,2351,Anti-incontinence agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dr-3001,P11229,1414
1413,-,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,2351,Anti-incontinence agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dr-3001,P08172,1415
1414,-,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,2351,Anti-incontinence agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dr-3001,P20309,1416
1415,-,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,MMAapril2016_0197,for treatment of overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,jnp-010,P11229,1417
1416,-,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,MMAapril2016_0198,for treatment of overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,jnp-010,P08172,1418
1417,-,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,MMAapril2016_0199,for treatment of overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,jnp-010,P20309,1419
1418,-,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,2067,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",P11229,1420
1419,-,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,2067,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",P08172,1421
1420,-,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,2067,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",P20309,1422
1421,-,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,514,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-003, sustained release oxycodone",P41143,1423
1422,-,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,514,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-003, sustained release oxycodone",P41145,1424
1423,-,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,514,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-003, sustained release oxycodone",P35372,1425
1424,-,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,515,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-172, extended-release oxycodone",P41143,1426
1425,-,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,515,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-172, extended-release oxycodone",P41145,1427
1426,-,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,515,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-172, extended-release oxycodone",P35372,1428
1427,-,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,696,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"eli-154, oxycodone (once daily)",P41143,1429
1428,-,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,696,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"eli-154, oxycodone (once daily)",P41145,1430
1429,-,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,696,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"eli-154, oxycodone (once daily)",P35372,1431
1430,-,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,MMAfeb2016_0087,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P35372,1432
1431,-,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,MMAfeb2016_0088,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P41143,1433
1432,-,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,MMAfeb2016_0089,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P41145,1434
1433,-,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1341,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P41143,1435
1434,-,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1341,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P41145,1436
1435,-,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1341,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P35372,1437
1436,-,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1545,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone art, eli216,oxynal",P41143,1438
1437,-,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1545,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone art, eli216,oxynal",P41145,1439
1438,-,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1545,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone art, eli216,oxynal",P35372,1440
1439,-,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1546,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",P41143,1441
1440,-,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1546,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",P41145,1442
1441,-,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1546,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",P35372,1443
1442,-,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1547,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone, pti-821,remoxy",P41143,1444
1443,-,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1547,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone, pti-821,remoxy",P41145,1445
1444,-,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1547,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone, pti-821,remoxy",P35372,1446
1445,-,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1687,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P41143,1447
1446,-,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1687,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P41145,1448
1447,-,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1687,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P35372,1449
1448,-,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,MMAmay2016_0706,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P35372,1450
1449,-,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,MMAmay2016_0707,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P41143,1451
1450,-,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,MMAmay2016_0708,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P41145,1452
1451,-,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,2068,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,transdermal oxycodone,P41143,1453
1452,-,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,2068,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,transdermal oxycodone,P41145,1454
1453,-,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,2068,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,transdermal oxycodone,P35372,1455
1454,-,Class A (Rhodopsin),small molecule,oxycodone xr,oprm_human,OPRM1,MMAmar2016_0078,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"rexista, oxycodone xr",P35372,1456
1455,-,Class A (Rhodopsin),small molecule,oxycodone xr,oprd_human,OPRD1,MMAmar2016_0079,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"rexista, oxycodone xr",P41143,1457
1456,-,Class A (Rhodopsin),small molecule,oxycodone xr,oprk_human,OPRK1,MMAmar2016_0080,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"rexista, oxycodone xr",P41145,1458
1457,-,Class A (Rhodopsin),small molecule,oxymetazoline,ada1a_human,ADRA1A,1491,Analgesics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,oms-103hp,P35348,1459
1458,-,Class A (Rhodopsin),small molecule,oxymetazoline,ada2a_human,ADRA2A,1491,Analgesics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,oms-103hp,P08913,1460
1459,-,Class A (Rhodopsin),small molecule,oxymorphone,oprd_human,OPRD1,1548,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxymorphone hydrochloride, en3202,opana, opana er",P41143,1461
1460,-,Class A (Rhodopsin),small molecule,oxymorphone,oprm_human,OPRM1,1548,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxymorphone hydrochloride, en3202,opana, opana er",P35372,1462
1461,-,Class A (Rhodopsin),small molecule,oxyphencyclimine,acm1_human,CHRM1,NRDD407,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1463
1462,-,Class A (Rhodopsin),small molecule,oxyphencyclimine,acm2_human,CHRM2,NRDD407,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,1464
1463,-,Class A (Rhodopsin),small molecule,oxyphencyclimine,acm3_human,CHRM3,NRDD407,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,1465
1464,-,Class A (Rhodopsin),small molecule,oxyphenonium,acm1_human,CHRM1,NRDD408,Mydriatics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1466
1465,-,Class A (Rhodopsin),peptide,oxytocin,oxyr_human,OXTR,MMA2016_0022,for treatment of autism,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"opn-300, intranasal oxytocin",P30559,1467
1466,-,Class A (Rhodopsin),peptide,oxytocin,oxyr_human,OXTR,2014,Analgesics,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ti-001, intranasal oxytocin",P30559,1468
1467,-,Class A (Rhodopsin),peptide,ozarelix,gnrhr_human,GNRHR,1891,Antineoplastic agent,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"spi-153, d-63153,ozarelix",P30968,1469
1468,-,Class A (Rhodopsin),peptide,ozarelix,gnrr2_human,GNRHR2,1891,Antineoplastic agent,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"spi-153, d-63153,ozarelix",Q96P88,1470
1469,-,Class A (Rhodopsin),peptide,"p2045, 188re-p2045",ssr2_human,SSTR2,MMAmay2016_0746,Antineoplastic agent; lung cancer,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,"p2045, 188re-p2045",P30874,1471
1470,-,Class A (Rhodopsin),small molecule,pa101b,gpr35_human,GPR35,MMAmar2016_0133,for treatment of autoimmune diseases,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,pa101b,Q9HC97,1472
1471,-,Class A (Rhodopsin),protein,pa-401,cxcr1_human,CXCR1,1553,Anti-inflammatory agent; immunosuppressant,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"pa-401, pa04-001",P25024,1473
1472,-,Class A (Rhodopsin),protein,pa-401,cxcr2_human,CXCR2,1553,Anti-inflammatory agent; immunosuppressant,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"pa-401, pa04-001",P25025,1474
1473,-,Class A (Rhodopsin),small molecule,paliperidone,drd2_human,DRD2,1558,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"paliperidone er, paliperidone palmitate",P14416,1475
1474,-,Class A (Rhodopsin),small molecule,paliperidone,5ht2a_human,HTR2A,1558,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"paliperidone er, paliperidone palmitate",P28223,1476
1475,-,Class B1 (Secretin),protein,parathyroid hormone,pth1r_human,PTH1R,377,Anti-osteoporotic agent,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"bn-003,capthymone",Q03431,1477
1476,-,Class B1 (Secretin),protein,parathyroid hormone,pth1r_human,PTH1R,2012,Anti-osteoporotic agent,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,thpth,Q03431,1478
1477,-,Class B1 (Secretin),protein,parathyroid hormone,pth2r_human,PTH2R,2012,Anti-osteoporotic agent,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,thpth,P49190,1479
1478,2015,Class B1 (Secretin),protein,parathyroid horomone,pth1r_human,PTHR1,MMAmay2016_0745,Control hypocalcemia,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"natpara, npsp558, parathyroid horomone",Q03431,1480
1479,-,Class A (Rhodopsin),small molecule,pardoprunox,ada1a_human,ADRA1A,1563,Antiparkinson agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P35348,1481
1480,-,Class A (Rhodopsin),small molecule,pardoprunox,ada2a_human,ADRA2A,1563,Antiparkinson agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P08913,1482
1481,-,Class A (Rhodopsin),small molecule,pardoprunox,drd2_human,DRD2,1563,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P14416,1483
1482,-,Class A (Rhodopsin),small molecule,pardoprunox,drd3_human,DRD3,1563,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P35462,1484
1483,-,Class A (Rhodopsin),small molecule,pardoprunox,drd4_human,DRD4,1563,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P21917,1485
1484,-,Class A (Rhodopsin),small molecule,pardoprunox,5ht1a_human,HTR1A,1563,Antiparkinson agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P08908,1486
1485,-,Class A (Rhodopsin),small molecule,pardoprunox,5ht7r_human,HTR7,1563,Antiparkinson agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P34969,1487
1486,2012,Class A (Rhodopsin),peptide,pasireotide,ssr1_human,SSTR1,1567,Antineoplastic agent; for treatment of acromegaly,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"pasireotide, som230",P30872,1488
1487,2012,Class A (Rhodopsin),peptide,pasireotide,ssr2_human,SSTR2,1567,Antineoplastic agent; for treatment of acromegaly,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"pasireotide, som230",P30874,1489
1488,2012,Class A (Rhodopsin),peptide,pasireotide,ssr3_human,SSTR3,1567,Antineoplastic agent; for treatment of acromegaly,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"pasireotide, som230",P32745,1490
1489,2012,Class A (Rhodopsin),peptide,pasireotide,ssr5_human,SSTR5,1567,Antineoplastic agent; for treatment of acromegaly,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"pasireotide, som230",P35346,1491
1490,-,Class B1 (Secretin),protein,pb1023,glp1r_human,GLP1R,1569,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"pb1023, glp-1-elp-120,glymera",P43220,1492
1491,-,Class A (Rhodopsin),small molecule,pbf-509,aa2ar_human,ADORA2A,MMAapril2016_0077,Antineoplastic agent; lung cancer,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,pbf-509,P29274,1493
1492,-,Class A (Rhodopsin),small molecule,pbf-680,aa1r_human,ADORA1,MMAmar2016_0115,antiasthmatic,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,pbf-680,P30542,1494
1493,-,Class A (Rhodopsin),small molecule,pbf-999,aa1r_human,ADORA1,MMAapril2016_0022,for treatment of Huntington's disease,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,pbf-999,P30542,1495
1494,-,Class A (Rhodopsin),small molecule,pd-6735,mtr1a_human,MTNR1A,1575,Hypnotics and Sedatives,Melatonin ,,in trial,Melatonin,GPCR;Rhodopsin,established,"pd-6735, ly-156735",P48039,1496
1495,-,Class A (Rhodopsin),small molecule,pd-6735,mtr1b_human,MTNR1B,1575,Hypnotics and Sedatives,Melatonin ,,in trial,Melatonin,GPCR;Rhodopsin,established,"pd-6735, ly-156735",P49286,1497
1496,-,Class A (Rhodopsin),peptide,pdc31,pf2r_human,PTGFR,MMAmay2016_0526,for treatment of pre-term labor; dysmenorrhea ,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,pdc31,P43088,1498
1497,1999,Class A (Rhodopsin),small molecule,pemirolast,hrh1_human,HRH1,NRDD416,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,1499
1498,1987,Class A (Rhodopsin),small molecule,penbutolol,adrb1_human,ADRB1,NRDD417,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,1500
1499,1987,Class A (Rhodopsin),small molecule,penbutolol,adrb2_human,ADRB2,NRDD417,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,1501
1500,1974,Class A (Rhodopsin),small molecule,pentagastrin,gasr_human,CCKBR,NRDD418,Diagnostic Agents,Peptide ,,approved,Cholecystokinin receptors,GPCR;Rhodopsin,established,-,P32239,1502
1501,-,Class A (Rhodopsin),small molecule,pentazocine,oprk_human,OPRK1,NRDD419,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,1503
1502,-,Class A (Rhodopsin),small molecule,pentazocine,oprm_human,OPRM1,NRDD419,Analgesics; Opioid,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,1504
1503,-,Class A (Rhodopsin),small molecule,pentoxifylline,aa1r_human,ADORA1,1586,for treatment of amyotrophic lateral sclerosis (ALS),Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"pentoxifylline, eht0201",P30542,1505
1504,-,Class A (Rhodopsin),small molecule,pentoxifylline,aa2ar_human,ADORA2B,1586,for treatment of amyotrophic lateral sclerosis (ALS),Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"pentoxifylline, eht0201",P29274,1506
1505,-,Class A (Rhodopsin),peptide,peptide yy,npy2r_human,NPY2R,699,Appetite suppressant,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,eligen pyy-3-36 + glp-1,P49146,1507
1506,1988,Class A (Rhodopsin),small molecule,pergolide,drd1_human,DRD1,NRDD422,Antiparkinson agents,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,1508
1507,1988,Class A (Rhodopsin),small molecule,pergolide,drd2_human,DRD2,NRDD422,Antiparkinson agents,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1509
1508,1957,Class A (Rhodopsin),small molecule,perphenazine,drd1_human,DRD1,NRDD425,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,1510
1509,1957,Class A (Rhodopsin),small molecule,perphenazine,drd2_human,DRD2,NRDD425,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1511
1510,-,Class A (Rhodopsin),small molecule,pf-00610355,adrb2_human,ADRB2,1591,Bronchodilator agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,pf-00610355,P07550,1512
1511,-,Class A (Rhodopsin),small molecule,phendimetrazine,ada1a_human,ADRA1A,NRDD427,Appetite Depressants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1513
1512,-,Class A (Rhodopsin),small molecule,phendimetrazine,ada1b_human,ADRA1B,NRDD427,Appetite Depressants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,1514
1513,-,Class A (Rhodopsin),small molecule,pheniramine,hrh1_human,HRH1,NRDD431,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,1515
1514,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada1a_human,ADRA1A,NRDD434,Anticonvulsants; Hypnotics and Sedatives,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1516
1515,1952,Class A (Rhodopsin),small molecule,phentolamine,ada2a_human,ADRA2A,NRDD437,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,1517
1516,-,Class A (Rhodopsin),small molecule,phentolamine ,ada1a_human,ADRA1A,288,for treatment of erectile dysfunction,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"aviptadil,invicorp",P35348,1518
1517,-,Class A (Rhodopsin),small molecule,phentolamine ,ada2a_human,ADRA2A,288,for treatment of erectile dysfunction,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"aviptadil,invicorp",P08913,1519
1518,-,Class A (Rhodopsin),small molecule,phenylephrine,ada1a_human,ADRA1A,1675,for treatment of incontinence,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"psd-503, phenylephrine",P35348,1520
1519,-,Class A (Rhodopsin),small molecule,phenylephrine,ada1b_human,ADRA1B,1675,for treatment of incontinence,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"psd-503, phenylephrine",P35368,1521
1520,-,Class A (Rhodopsin),small molecule,phenylephrine,ada1d_human,ADRA1D,1675,for treatment of incontinence,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"psd-503, phenylephrine",P25100,1522
1521,-,Class A (Rhodopsin),small molecule,phenylpropanolamine,ada1a_human,ADRA1A,NRDD439,Appetite Depressants; Nasal Decongestants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1523
1522,-,Class A (Rhodopsin),small molecule,phenylpropanolamine,ada2a_human,ADRA2A,NRDD439,Appetite Depressants; Nasal Decongestants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,1524
1523,-,Class A (Rhodopsin),small molecule,pilocarpine,acm1_human,CHRM1,2013,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P11229,1525
1524,-,Class A (Rhodopsin),small molecule,pilocarpine,acm2_human,CHRM2,2013,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P08172,1526
1525,-,Class A (Rhodopsin),small molecule,pilocarpine,acm3_human,CHRM3,2013,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P20309,1527
1526,2016,Class A (Rhodopsin),small molecule,pimavanserin,5ht2a_human,HTR2A,1610,Antiparkinson agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pimavanserin,P28223,1528
1527,1984,Class A (Rhodopsin),small molecule,pimozide,drd2_human,DRD2,NRDD443,Antidyskinetics; Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1529
1528,1982,Class A (Rhodopsin),small molecule,pindolol,adrb1_human,ADRB1,NRDD444,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,1530
1529,1982,Class A (Rhodopsin),small molecule,pindolol,adrb2_human,ADRB2,NRDD444,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,1531
1530,-,Class A (Rhodopsin),small molecule,pirenzepine,acm1_human,CHRM1,NRDD446,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1532
1531,-,Class A (Rhodopsin),small molecule,plerixafor,cxcr4_human,CXCR4,1342,Antineoplastic agent,Protein ,,approved,Chemokine receptors,GPCR;Rhodopsin,established,mozobil,P61073,1533
1532,-,Class A (Rhodopsin),small molecule,ponesimod,s1pr1_human,S1PR1,1630,Anti-inflammatory agent; for treatment of multiple sclerosis,Lipid ,,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,ponesimod,P21453,1534
1533,-,Class A (Rhodopsin),small molecule,practolol,adrb1_human,ADRB1,NRDD449,Anti-Arrhythmia Agents,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588,1535
1534,-,Class A (Rhodopsin),small molecule,pramipexole,drd2_human,DRD2,1293,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,mirapex,P14416,1536
1535,-,Class A (Rhodopsin),small molecule,pramipexole,drd3_human,DRD3,1293,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,mirapex,P35462,1537
1536,-,Class A (Rhodopsin),small molecule,pramipexole,drd4_human,DRD4,1293,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,mirapex,P21917,1538
1537,-,Class A (Rhodopsin),small molecule,pramipexole,drd2_human,DRD2,MMAmar2016_0004,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,p2b001,P14416,1539
1538,-,Class A (Rhodopsin),small molecule,pramipexole,drd4_human,DRD4,MMAmar2016_0005,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,p2b001,P21917,1540
1539,-,Class A (Rhodopsin),small molecule,pramipexole,drd3_human,DRD3,MMAmar2016_0006,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,p2b001,P35462,1541
1540,-,Class B1 (Secretin),peptide,pramlintide,calcr_human,CALCR,1924,Antidiabetic; Anti-obesity agent,Peptide ,,approved,Calcitonin receptors,GPCR;Secretin,established,symlin,P30988,1542
1541,-,Class A (Rhodopsin),small molecule,pranlukast,cltr1_human,CYSLTR1,NRDD451,Anti-Asthmatic Agents,Lipid ,,in trial,Leukotriene receptors,GPCR;Rhodopsin,established,-,Q9Y271,1543
1542,-,Class A (Rhodopsin),small molecule,prasugrel,p2y12_human,P2RY12,1640,antithrombotic,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,"prasugrel, cs-747,efient",Q9H244,1544
1543,1976,Class A (Rhodopsin),small molecule,prazosin,ada1a_human,ADRA1A,NRDD453,Antihypertensive agent; antispasmodics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1545
1544,1976,Class A (Rhodopsin),small molecule,prazosin,ada1b_human,ADRA1B,NRDD453,Antihypertensive agent; antispasmodics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,1546
1545,1976,Class A (Rhodopsin),small molecule,prazosin,ada1d_human,ADRA1D,NRDD453,Antihypertensive agent; antispasmodics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,1547
1546,-,Class A (Rhodopsin),small molecule,preladenant,aa2ar_human,ADORA2A,1645,Antiparkinson agent,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"preladenant, sch-420814",P29274,1548
1547,-,Class A (Rhodopsin),small molecule,pridopidine,drd2_human,DRD2,1647,for treatment of Huntington's disease,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"pridopidine, acr-16,huntexil",P14416,1549
1548,-,Class A (Rhodopsin),antibody,pro 140,ccr5_human,CCR5,1649,antiviral agent; HIV,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,pro 140,P51681,1550
1549,-,Class A (Rhodopsin),small molecule,procaterol,adrb2_human,ADRB2,NRDD459,Bronchodilator agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,1551
1550,-,Class A (Rhodopsin),small molecule,prochlorperazine,drd2_human,DRD2,301,Anti-migraine Agents,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"az-001, staccato prochlorperazine",P14416,1552
1551,-,Class A (Rhodopsin),small molecule,prochlorperazine ,drd2_human,DRD2,395,Antiemetics,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"buccal prochlorperazine maleate,emezine",P14416,1553
1552,1955,Class A (Rhodopsin),small molecule,procyclidine,acm1_human,CHRM1,NRDD460,Antidyskinetics; Antiparkinson agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1554
1553,1955,Class A (Rhodopsin),small molecule,procyclidine,acm2_human,CHRM2,NRDD460,Antidyskinetics; Antiparkinson agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,1555
1554,1955,Class A (Rhodopsin),small molecule,procyclidine,acm4_human,CHRM4,NRDD460,Antidyskinetics; Antiparkinson agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,1556
1555,-,Class C (Glutamate) ,small molecule,progabide,gabr1_human,GABBR1,NRDD461,Anticonvulsants,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,-,Q9UBS5,1557
1556,-,Class A (Rhodopsin),small molecule,promazine,ada1a_human,ADRA1A,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1558
1557,-,Class A (Rhodopsin),small molecule,promazine,ada1b_human,ADRA1B,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,1559
1558,-,Class A (Rhodopsin),small molecule,promazine,ada1d_human,ADRA1D,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,1560
1559,-,Class A (Rhodopsin),small molecule,promazine,acm1_human,CHRM1,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1561
1560,-,Class A (Rhodopsin),small molecule,promazine,acm2_human,CHRM2,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,1562
1561,-,Class A (Rhodopsin),small molecule,promazine,acm3_human,CHRM3,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,1563
1562,-,Class A (Rhodopsin),small molecule,promazine,acm4_human,CHRM4,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,1564
1563,-,Class A (Rhodopsin),small molecule,promazine,acm5_human,CHRM5,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,1565
1564,-,Class A (Rhodopsin),small molecule,promazine,drd1_human,DRD1,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,1566
1565,-,Class A (Rhodopsin),small molecule,promazine,drd2_human,DRD2,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1567
1566,-,Class A (Rhodopsin),small molecule,promazine,drd4_human,DRD4,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21917,1568
1567,-,Class A (Rhodopsin),small molecule,promazine,hrh1_human,HRH1,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,1569
1568,-,Class A (Rhodopsin),small molecule,promazine,5ht2a_human,HTR2A,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,1570
1569,-,Class A (Rhodopsin),small molecule,promazine,5ht2c_human,HTR2C,NRDD462,Antiemetics; Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,1571
1570,-,Class A (Rhodopsin),small molecule,promethazine,acm1_human,CHRM1,NRDD463,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1572
1571,-,Class A (Rhodopsin),small molecule,promethazine,acm2_human,CHRM2,NRDD463,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,1573
1572,-,Class A (Rhodopsin),small molecule,promethazine,acm3_human,CHRM3,NRDD463,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,1574
1573,-,Class A (Rhodopsin),small molecule,promethazine,acm4_human,CHRM4,NRDD463,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,1575
1574,-,Class A (Rhodopsin),small molecule,promethazine,acm5_human,CHRM5,NRDD463,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,1576
1575,-,Class A (Rhodopsin),small molecule,promethazine,hrh1_human,HRH1,NRDD463,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,1577
1576,-,Class A (Rhodopsin),small molecule,promethazine,acm2_human,CHRM2,MMAapril2016_0100,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents; Treat migraines and cluster headaches,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P08172,1578
1577,-,Class A (Rhodopsin),small molecule,promethazine,acm4_human,CHRM4,MMAapril2016_0101,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents; Treat migraines and cluster headaches,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P08173,1579
1578,-,Class A (Rhodopsin),small molecule,promethazine,acm5_human,CHRM5,MMAapril2016_0102,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents; Treat migraines and cluster headaches,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P08912,1580
1579,-,Class A (Rhodopsin),small molecule,promethazine,acm1_human,CHRM1,MMAapril2016_0103,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents; Treat migraines and cluster headaches,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P11229,1581
1580,-,Class A (Rhodopsin),small molecule,promethazine,acm3_human,CHRM3,MMAapril2016_0104,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents; Treat migraines and cluster headaches,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P20309,1582
1581,-,Class A (Rhodopsin),small molecule,promethazine,hrh1_human,HRH1,MMAapril2016_0105,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents; Treat migraines and cluster headaches,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P35367,1583
1582,1953,Class A (Rhodopsin),small molecule,propantheline,acm1_human,CHRM1,NRDD464,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1584
1583,-,Class A (Rhodopsin),small molecule,propericiazine,ada1a_human,ADRA1A,NRDD466,Antipsychotic agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1585
1584,-,Class A (Rhodopsin),small molecule,propericiazine,ada1b_human,ADRA1B,NRDD466,Antipsychotic agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,1586
1585,-,Class A (Rhodopsin),small molecule,propericiazine,ada1d_human,ADRA1D,NRDD466,Antipsychotic agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,1587
1586,1960,Class A (Rhodopsin),small molecule,propiomazine,ada1a_human,ADRA1A,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1588
1587,1960,Class A (Rhodopsin),small molecule,propiomazine,ada1b_human,ADRA1B,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,1589
1588,1960,Class A (Rhodopsin),small molecule,propiomazine,ada1d_human,ADRA1D,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,1590
1589,1960,Class A (Rhodopsin),small molecule,propiomazine,acm1_human,CHRM1,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1591
1590,1960,Class A (Rhodopsin),small molecule,propiomazine,acm2_human,CHRM2,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,1592
1591,1960,Class A (Rhodopsin),small molecule,propiomazine,acm3_human,CHRM3,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,1593
1592,1960,Class A (Rhodopsin),small molecule,propiomazine,acm4_human,CHRM4,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,1594
1593,1960,Class A (Rhodopsin),small molecule,propiomazine,acm5_human,CHRM5,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,1595
1594,1960,Class A (Rhodopsin),small molecule,propiomazine,drd1_human,DRD1,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,1596
1595,1960,Class A (Rhodopsin),small molecule,propiomazine,drd2_human,DRD2,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1597
1596,1960,Class A (Rhodopsin),small molecule,propiomazine,drd4_human,DRD4,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21917,1598
1597,1960,Class A (Rhodopsin),small molecule,propiomazine,hrh1_human,HRH1,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,1599
1598,1960,Class A (Rhodopsin),small molecule,propiomazine,5ht2a_human,HTR2A,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,1600
1599,1960,Class A (Rhodopsin),small molecule,propiomazine,5ht2c_human,HTR2C,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,1601
1600,-,Class A (Rhodopsin),small molecule,propoxyphene,oprd_human,OPRD1,NRDD468,Analgesics; Opioid; Antitussive Agents,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41143,1602
1601,-,Class A (Rhodopsin),small molecule,propoxyphene,oprk_human,OPRK1,NRDD468,Analgesics; Opioid; Antitussive Agents,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145,1603
1602,-,Class A (Rhodopsin),small molecule,propoxyphene,oprm_human,OPRM1,NRDD468,Analgesics; Opioid; Antitussive Agents,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372,1604
1603,-,Class A (Rhodopsin),small molecule,propranolol,adrb1_human,ADRB1,2183,for treatment of cancer cachexia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,vt-122,P08588,1605
1604,-,Class A (Rhodopsin),small molecule,prs-211375,cnr2_human,CNR2,429,Analgesics,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,cannabinor,P34972,1606
1605,-,Class A (Rhodopsin),small molecule,prucalopride,5ht4r_human,HTR4,1665,motilitant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"prucalopride ,resolor",Q13639,1607
1606,-,Class A (Rhodopsin),small molecule,prx-00023,5ht1a_human,HTR1A,1666,Anti-depressant; anxiolytic,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,prx-00023,P08908,1608
1607,-,Class A (Rhodopsin),small molecule,prx-07034,5ht6r_human,HTR6,1667,Anti-obesity agent; nootropic,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,prx-07034,P50406,1609
1608,-,Class A (Rhodopsin),small molecule,prx-08066,5ht2b_human,HTR2B,1668,Antihypertensive agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,prx-08066,P41595,1610
1609,-,Class A (Rhodopsin),small molecule,prx-3140,5ht4r_human,HTR4,1671,for treatment of Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,prx-3140,Q13639,1611
1610,-,Class A (Rhodopsin),small molecule,ps433540,agtr1_human,AGTR1,1673,Antihypertensive agent,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,ps433540,P30556,1612
1611,-,Class A (Rhodopsin),small molecule,ps433540,agtr2_human,AGTR2,1673,Antihypertensive agent,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,not established,ps433540,P50052,1613
1612,-,Class A (Rhodopsin),small molecule,ps433540,ednra_human,EDNRA,1673,Antihypertensive agent,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,ps433540,P25101,1614
1613,-,Class A (Rhodopsin),small molecule,psd-506,acm2_human,CHRM2,1676,for treatment of overactive bladder,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,psd-506,P08172,1615
1614,-,Class A (Rhodopsin),small molecule,psd-506,acm3_human,CHRM3,1676,for treatment of overactive bladder,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,psd-506,P20309,1616
1615,-,Class A (Rhodopsin),small molecule,pseudoephedrine,ada1a_human,ADRA1A,789,Anti-Allergic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,fexofenadine + ps/,P35348,1617
1616,-,Class A (Rhodopsin),small molecule,pseudoephedrine,ada2a_human,ADRA2A,789,Anti-Allergic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,fexofenadine + ps/,P08913,1618
1617,-,Class A (Rhodopsin),small molecule,psn602,5ht1a_human,HTR1A,1678,Anti-obesity agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,psn602,P08908,1619
1618,-,Class A (Rhodopsin),small molecule,psn821,gp119_human,GPR119,1679,Antidiabetic,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,psn821,Q8TDV5,1620
1619,-,Class A (Rhodopsin),small molecule,pw2101,adrb2_human,ADRB2,1690,Antihypertensive agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,pw2101,P07550,1621
1620,-,Class C (Glutamate) ,small molecule,pxt002331,grm4_human,GRM4,MMAmay2016_0906,Antiparkinson agents,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,pxt002331,Q14833,1622
1621,-,Class A (Rhodopsin),peptide,pyy3-36,npy2r_human,NPY2R,1698,Anti-obesity agent,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,pyy3-36,P49146,1623
1622,-,Class A (Rhodopsin),small molecule,q-122,cxcr4_human,CXCR4,MMAmar2016_0157,Anti-inflammatory agent; hot flashes,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,q-122,P61073,1624
1623,-,Class A (Rhodopsin),small molecule,quetiapine,drd2_human,DRD2,1840,Antipsychotic agent; Anti-depressant,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,seroquel,P14416,1625
1624,-,Class A (Rhodopsin),small molecule,quetiapine,5ht2a_human,HTR2A,1840,Antipsychotic agent; Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,seroquel,P28223,1626
1625,-,Class A (Rhodopsin),small molecule,quetiapine,5ht2b_human,HTR2B,1840,Antipsychotic agent; Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,seroquel,P41595,1627
1626,-,Class A (Rhodopsin),small molecule,quetiapine,5ht2c_human,HTR2C,1840,Antipsychotic agent; Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,seroquel,P28335,1628
1627,2005,Class A (Rhodopsin),small molecule,ramelteon,mtr1a_human,MTNR1A,1713,for treatment of insomnia,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,"ramelteon, tak-375,rozerem",P48039,1630
1628,2005,Class A (Rhodopsin),small molecule,ramelteon,mtr1b_human,MTNR1B,1713,for treatment of insomnia,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,"ramelteon, tak-375,rozerem",P49286,1631
1629,-,Class A (Rhodopsin),small molecule,ranitidine,hrh2_human,HRH2,1716,antiulcer agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"ranitidine bismuth citrate,tritec",P25021,1632
1630,-,Class A (Rhodopsin),small molecule,ranitidine,hrh2_human,HRH2,2238,antiulcer agent,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"zantac,ranitidine hydrochloride",P25021,1633
1631,-,Class C (Glutamate) ,small molecule,r-baclofen,gabr1_human,GABBR1,2222,for treatment of gastrointestinal reflux disease,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,xp19986,Q9UBS5,1634
1632,-,Class C (Glutamate) ,small molecule,r-baclofen,gabr2_human,GABBR2,2222,for treatment of gastrointestinal reflux disease,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,xp19986,O75899,1635
1633,-,Class A (Rhodopsin),small molecule,"re-021, sparsentan",agtr1_human,AGTR1,MMAapril2016_0044,for treatment of kidney disease; nephropathy,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,"re-021, sparsentan",P30556,1636
1634,-,Class A (Rhodopsin),small molecule,"re-021, sparsentan",ednra_human,EDNRA,MMAapril2016_0045,for treatment of kidney disease; nephropathy,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"re-021, sparsentan",P25101,1637
1635,-,Class A (Rhodopsin),small molecule,"re-034, cosyntropin, tetracosactid",acthr_human,MC2R,MMAmar2016_0275,for treatment of epilepsy,Peptide ,,approved,Melanocortin receptors,GPCR;Rhodopsin,established,"re-034, cosyntropin, tetracosactid",Q01718,1638
1636,-,Class A (Rhodopsin),protein,recombinant human chorionic gonadotropin,lshr_human,LHCGR,1756,Antineoplastic agent,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"r-hcg,ovidrel",P22888,1639
1637,-,Class B1 (Secretin),protein,recombinant parathyroid hormone,pth1r_human,PTH1R,2799,,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"air parathyroid hormone, air pth",Q03431,1640
1638,-,Class A (Rhodopsin),small molecule,regadenoson,aa2ar_human,ADORA2A,1726,Diagnostic Agents,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"regadenoson,lexiscan",P29274,1641
1639,-,Class B1 (Secretin),antibody,remd-477,glr_human,GCGR,MMAapril2016_0214,Antidiabetic agent,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,remd-477,P47871,1642
1640,-,Class A (Rhodopsin),small molecule,remifentanil,oprm_human,OPRM1,1732,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"remifentanil,ultiva",P35372,1643
1641,-,Class A (Rhodopsin),small molecule,remoxipride,drd2_human,DRD2,NRDD479,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1644
1642,-,Class A (Rhodopsin),small molecule,renzapride,5ht2a_human,HTR2A,1734,for treatment of irritable bowel syndrome,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,renzapride,P28223,1645
1643,-,Class A (Rhodopsin),small molecule,renzapride,5ht2b_human,HTR2B,1734,for treatment of irritable bowel syndrome,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,renzapride,P41595,1646
1644,-,Class A (Rhodopsin),small molecule,renzapride,5ht2c_human,HTR2C,1734,for treatment of irritable bowel syndrome,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,renzapride,P28335,1647
1645,-,Class A (Rhodopsin),small molecule,renzapride,5ht4r_human,HTR4,1734,for treatment of irritable bowel syndrome,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,renzapride,Q13639,1648
1646,-,Class A (Rhodopsin),small molecule,reparixin,cxcr1_human,CXCR1,MMAmay2016_0551,Antidiabetic; type I diabetes,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,reparixin,P25024,1649
1647,-,Class A (Rhodopsin),small molecule,reparixin,cxcr2_human,CXCR2,MMAmay2016_0552,Antidiabetic; type I diabetes,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,reparixin,P25025,1650
1648,-,Class A (Rhodopsin),small molecule,rev131,hrh4_human,HRH4,1745,Anti-Allergic Agents,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,rev131,Q9H3N8,1651
1649,-,Class B1 (Secretin),peptide,rg1068,sctr_human,SCTR,1749,for treatment of autism,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"rg1068, synthetic secretin,secreflo",P47872,1652
1650,-,Class A (Rhodopsin),small molecule,ridogrelum,ta2r_human,TBXA2R,MMAjun2016_0002,for the prevention of systemic thrombo-embolism; adjunctive agent to thrombolytic therapy,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,ridogrel,P21731,1653
1651,-,Class A (Rhodopsin),small molecule,rimonabant,cnr1_human,CNR1,1766,Anti-obesity agent,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,rimonabant,P21554,1654
1652,-,Class A (Rhodopsin),small molecule,risperdal,drd2_human,DRD2,1770,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,risperdal,P14416,1655
1653,-,Class A (Rhodopsin),small molecule,risperdal,5ht2a_human,HTR2A,1770,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,risperdal,P28223,1656
1654,1993,Class A (Rhodopsin),small molecule,risperidone,drd2_human,DRD2,NRDD484,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1657
1655,1993,Class A (Rhodopsin),small molecule,risperidone,5ht2a_human,HTR2A,NRDD484,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,1658
1656,-,Class A (Rhodopsin),small molecule,ritodrine,adrb2_human,ADRB2,NRDD485,Tocolytic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,1659
1657,1998,Class A (Rhodopsin),small molecule,rizatriptan,5ht1b_human,HTR1B,NRDD486,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28222,1660
1658,1998,Class A (Rhodopsin),small molecule,rizatriptan,5ht1d_human,HTR1D,NRDD486,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28221,1661
1659,-,Class A (Rhodopsin),peptide,"rm-493, setmelanotide",mc4r_human,MC4R,MMAmay2016_0229,Anti-obesity agent,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,"rm-493, setmelanotide",P32245,1662
1660,-,Class C (Glutamate) ,small molecule,ro4917523,grm5_human,GRM5,MMAmay2016_0177,for Fragile X syndrome and Major Depressive Disorder,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,ro4917523,P41594,1663
1661,-,Class A (Rhodopsin),small molecule,rocuronium,acm2_human,CHRM2,1776,Muscle Relaxants,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"rocuronium bromide,esmeron, zemuron, eslax",P08172,1664
1662,2015,Class A (Rhodopsin),small molecule,rolapitant,nk1r_human,TACR1,MMAmay2016_0753,Anti-emetic,Peptide ,,approved,Tachykinin receptors,GPCR;Rhodopsin,established,"sch 619734, rolapitant",P25103,1665
1663,-,Class A (Rhodopsin),small molecule,rolofylline,aa1r_human,ADORA1,1780,for treatment of congestive heart failure,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"rolofylline, mk-7418, kw-3902",P30542,1666
1664,-,Class C (Glutamate) ,small molecule,ronacaleret,casr_human,CASR,1782,Anti-osteoporotic agent,Ion ,,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,"ronacaleret, 751689",P41180,1667
1665,-,Class A (Rhodopsin),small molecule,ropinirole,drd2_human,DRD2,1057,for treatment of restlegs legs syndrome,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,jzp-7,P14416,1668
1666,-,Class A (Rhodopsin),small molecule,ropinirole,drd3_human,DRD3,1057,for treatment of restlegs legs syndrome,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,jzp-7,P35462,1669
1667,-,Class A (Rhodopsin),small molecule,ropinirole,drd2_human,DRD2,1737,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,requip,P14416,1670
1668,-,Class A (Rhodopsin),small molecule,ropinirole,drd3_human,DRD3,1737,Antiparkinson agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,requip,P35462,1671
1669,-,Class A (Rhodopsin),small molecule,rotigotine,drd2_human,DRD2,1404,Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,neupro,P14416,1672
1670,-,Class A (Rhodopsin),small molecule,rotigotine,drd3_human,DRD3,1404,Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,neupro,P35462,1673
1671,-,Class A (Rhodopsin),small molecule,rotigotine,drd4_human,DRD4,1404,Antiparkinson agent ,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,neupro,P21917,1674
1672,-,Class A (Rhodopsin),small molecule,rpc1063,s1pr1_human,S1PR1,1790,For treatment of Multiple Sclerosis,Lipid ,,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,rpc1063,P21453,1675
1673,-,Class A (Rhodopsin),peptide,rusalatide,par1_human,F2R,2048,for treatment of diabetic foot ulcers,Peptide ,,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",P25116,1676
1674,-,Class A (Rhodopsin),peptide,rusalatide,par3_human,F2RL2,2048,for treatment of diabetic foot ulcers,Peptide ,,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",O00254,1677
1675,-,Class A (Rhodopsin),peptide,rusalatide,par4_human,F2RL3,2048,for treatment of diabetic foot ulcers,Peptide ,,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",Q96RI0,1678
1676,-,Class A (Rhodopsin),small molecule,"rvt-101, sb-742457, gsk 742457",5ht6r_human,HTR6,MMAmar2016_0106,for treatment of Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"rvt-101, sb-742457, gsk 742457",P50406,1679
1677,-,Class A (Rhodopsin),small molecule,rx-10045,lt4r1_human,BLT1,2317,for treatment of dry eye,Lipid ,,in trial,Leukotriene receptors,GPCR;Rhodopsin,not established,rx-10045,Q15722,1680
1678,-,Class A (Rhodopsin),small molecule,rx-10045,cml1_human,CMKLR1,2317,for treatment of dry eye,Protein ,,in trial,Chemerin receptor,GPCR;Rhodopsin,not established,rx-10045,Q99788,1681
1679,-,Class A (Rhodopsin),antibody,ryi-018,cnr1_human,CNR1,MMAapril2016_0280,for treatment of liver disease; nonalcoholic steatohepatitis,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,ryi-018,P21554,1682
1680,-,Class A (Rhodopsin),small molecule,salbutamol,adrb2_human,ADRB2,102,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"albuterol,ventolin",P07550,1683
1681,-,Class A (Rhodopsin),small molecule,salbutamol,adrb2_human,ADRB2,1021,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"ipratropium bromide + albuterol sulfate,duoneb",P07550,1684
1682,-,Class A (Rhodopsin),small molecule,salbutamol,adrb2_human,ADRB2,1116,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,levalbuterol,P07550,1685
1683,-,Class A (Rhodopsin),small molecule,salbutamol,adrb2_human,ADRB2,1146,for treatment of symptomatic exophthalmos associated with thyroid-related eye disease,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lipo-102, salmeterol xinafoate + fluticasone propionate",P07550,1686
1684,-,Class A (Rhodopsin),small molecule,salmeterol,adrb2_human,ADRB2,61,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,advair/seretide/adoair,P07550,1687
1685,-,Class A (Rhodopsin),small molecule,salmeterol,adrb2_human,ADRB2,1839,Bronchodilator agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,serevent,P07550,1688
1686,-,Class B1 (Secretin),peptide,salmon calcitonin,calcr_human,CALCR,817,Anti-osteoporotic agent,Peptide ,,approved,Calcitonin receptors,GPCR;Secretin,established,fortical,P30988,1689
1687,-,Class A (Rhodopsin),small molecule,samidoprhan,oprm_human,MOR,APR13_0013,for treatment of addiction,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 3831,P35372,1690
1688,-,Class A (Rhodopsin),small molecule,saprisartan,agtr1_human,AGTR1,NRDD489,Antihypertensive agent,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556,1691
1689,-,Class A (Rhodopsin),small molecule,saredutant,nk2r_human,TACR2,1810,Anti-depressant; anxiolytic,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"saredutant, sr 48968",P21452,1692
1690,-,Class A (Rhodopsin),small molecule,sch-527123,cxcr1_human,CXCR1,1822,for treatment of chronic obstructive pulmonary disorder (COPD),Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"sch-527123, ps-291822, ps-938285",P25024,1693
1691,-,Class A (Rhodopsin),small molecule,sch-527123,cxcr2_human,CXCR2,1822,for treatment of chronic obstructive pulmonary disorder (COPD),Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"sch-527123, ps-291822, ps-938285",P25025,1694
1692,-,Class A (Rhodopsin),small molecule,scopolamine,acm1_human,CHRM1,NRDD491,Adjuvants; Anesthesia; Antispasmodics; Mydriatics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1695
1693,-,Class B1 (Secretin),peptide,secretin,sctr_human,SCTR,NRDD493,Diagnostic Agents,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,-,P47872,1696
1694,-,Class A (Rhodopsin),small molecule,selexipag,pi2r_human,PTGIR,1831,Antihypertensive agent,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"selexipag, act-293987",P43119,1697
1695,-,Class B1 (Secretin),peptide,"semaglutide, nn9535 ",glp1r_human,GLP1R,MMAmay2016_0563,Antidiabetic; type II diabetes,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"semaglutide, nn9535 ",P43220,1698
1696,-,Class A (Rhodopsin),small molecule,sens-111,hrh4_human,HRH4,MMAapril2016_0282,for vertigo and tinnitus,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,sens-111,Q9H3N8,1699
1697,-,Class A (Rhodopsin),small molecule,ser100,oprx_human,OPRL1,MMAmay2016_0735, for hypertension,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,not established,ser100,P41146,1700
1698,1990,Class B1 (Secretin),peptide,sermorelin,ghrhr_human,GHRHR,NRDD494,Hormone Replacement Agents,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,-,Q02643,1701
1699,-,Class A (Rhodopsin),small molecule,sertindole,ada1a_human,ADRA1A,1838,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,serdolect,P35348,1702
1700,-,Class A (Rhodopsin),small molecule,sertindole,ada1b_human,ADRA1B,1838,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,serdolect,P35368,1703
1701,-,Class A (Rhodopsin),small molecule,sertindole,ada1d_human,ADRA1D,1838,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,serdolect,P25100,1704
1702,-,Class A (Rhodopsin),small molecule,sertindole,drd2_human,DRD2,1838,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,serdolect,P14416,1705
1703,-,Class A (Rhodopsin),small molecule,sertindole,5ht2a_human,HTR2A,1838,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,serdolect,P28223,1706
1704,-,Class A (Rhodopsin),small molecule,sertindole,5ht2c_human,HTR2C,1838,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,serdolect,P28335,1707
1705,-,Class A (Rhodopsin),small molecule,sertindole,5ht6r_human,HTR6,1838,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,serdolect,P50406,1708
1706,-,Class A (Rhodopsin),small molecule,silodosin,ada1a_human,ADRA1A,1852,for treatment of BPH-related urinary symptoms,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,silodosin,P35348,1709
1707,-,Class A (Rhodopsin),small molecule,sitaxsentan,ednra_human,EDNRA,2010,for treatment of pulmonary arterial hypertension,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,thelin,P25101,1710
1708,-,Class A (Rhodopsin),small molecule,sofpironium bromide,acm3_human,CHRM3,MMAmay2016_0805,Anticholinergics; for the topical treatment of primary axillary hyperhidrosis,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,bbi-4000,P20309,1711
1709,-,Class A (Rhodopsin),small molecule,solabegron,adrb3_human,ADRB3,1874,Antidiabetic; for treatment of irritable bowel syndrome; antiincontinence agent,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"solabegron, gw 427353",P13945,1712
1710,-,Class A (Rhodopsin),small molecule,solifenacin,acm1_human,CHRM1,1876,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P11229,1713
1711,-,Class A (Rhodopsin),small molecule,solifenacin,acm2_human,CHRM2,1876,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P08172,1714
1712,-,Class A (Rhodopsin),small molecule,solifenacin,acm3_human,CHRM3,1876,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P20309,1715
1713,-,Class A (Rhodopsin),small molecule,solifenacin,acm4_human,CHRM4,1876,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P08173,1716
1714,-,Class A (Rhodopsin),small molecule,solifenacin,acm5_human,CHRM5,1876,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P08912,1717
1715,2015,Class F (Frizzled),small molecule,sonidegib,smo_human,SMO,1101,Antineoplastic agent,Protein ,,approved,Frizzled,GPCR;Frizzled,established,lde225,Q99835,1718
1716,-,Class A (Rhodopsin),small molecule,sou-001,ada1a_human,ADRA1A,1881,for treatment of incontinence,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"sou-001, drp-001",P35348,1719
1717,-,Class A (Rhodopsin),small molecule,sou-001,ada1b_human,ADRA1B,1881,for treatment of incontinence,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"sou-001, drp-001",P35368,1720
1718,-,Class A (Rhodopsin),small molecule,sou-001,ada1d_human,ADRA1D,1881,for treatment of incontinence,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"sou-001, drp-001",P25100,1721
1719,-,Class A (Rhodopsin),small molecule,sou-003,v2r_human,AVPR2,1882,for treatment of incontinence,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"sou-003, opc-51803",P30518,1722
1720,-,Class A (Rhodopsin),peptide,spi-1620,ednra_human,EDNRA,1892,adjuvant to chemotherapy,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,spi-1620,P25101,1723
1721,-,Class A (Rhodopsin),peptide,spi-1620,ednrb_human,EDNRB,1892,adjuvant to chemotherapy,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,spi-1620,P24530,1724
1722,-,Class A (Rhodopsin),peptide,srx-1177,mshr_human,MC1R,MMAapril2016_0099,Antineoplastic agent; melanoma,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,srx-1177,Q01726,1725
1723,-,Class C (Glutamate) ,small molecule,strontium ranelate,casr_human,CASR,1905,Anti-osteoporotic agent,Ion ,,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,"strontium ranelate, s12911",P41180,1726
1724,-,Class C (Glutamate) ,small molecule,stx107,grm5_human,GRM5,1906,for treatment of Fragile X symptoms,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,stx107,P41594,1727
1725,1952,Class A (Rhodopsin),small molecule,succinylcholine,acm1_human,CHRM1,NRDD501,Muscle Relaxants; Skeletal,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1728
1726,-,Class A (Rhodopsin),small molecule,sufentanil,oprd_human,OPRD1,242,Analgesics; adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-01, sufentanil nanotab",P41143,1729
1727,-,Class A (Rhodopsin),small molecule,sufentanil,oprk_human,OPRK1,242,Analgesics; adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-01, sufentanil nanotab",P41145,1730
1728,-,Class A (Rhodopsin),small molecule,sufentanil,oprm_human,OPRM1,242,Analgesics; adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-01, sufentanil nanotab",P35372,1731
1729,-,Class A (Rhodopsin),small molecule,sufentanil,oprd_human,OPRD1,243,Analgesics; adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-03, sufentanil + triazolam nanotab",P41143,1732
1730,-,Class A (Rhodopsin),small molecule,sufentanil,oprk_human,OPRK1,243,Analgesics; adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-03, sufentanil + triazolam nanotab",P41145,1733
1731,-,Class A (Rhodopsin),small molecule,sufentanil,oprm_human,OPRM1,243,Analgesics; adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-03, sufentanil + triazolam nanotab",P35372,1734
1732,-,Class A (Rhodopsin),small molecule,sufentanil,oprd_human,OPRD1,1909,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil transdermal patch,transdur-sufentanil",P41143,1735
1733,-,Class A (Rhodopsin),small molecule,sufentanil,oprk_human,OPRK1,1909,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil transdermal patch,transdur-sufentanil",P41145,1736
1734,-,Class A (Rhodopsin),small molecule,sufentanil,oprm_human,OPRM1,1909,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil transdermal patch,transdur-sufentanil",P35372,1737
1735,-,Class A (Rhodopsin),small molecule,sufentanil,oprd_human,OPRD1,1910,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil,chronogesic",P41143,1738
1736,-,Class A (Rhodopsin),small molecule,sufentanil,oprk_human,OPRK1,1910,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil,chronogesic",P41145,1739
1737,-,Class A (Rhodopsin),small molecule,sufentanil,oprm_human,OPRM1,1910,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil,chronogesic",P35372,1740
1738,-,Class A (Rhodopsin),small molecule,sulpiride,drd2_human,DRD2,NRDD504,Antidepressive Agents; Second-Generation; Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1741
1739,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,MMAapril2016_0106,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P08908,1742
1740,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,MMAapril2016_0107,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P28221,1743
1741,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,MMAapril2016_0108,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P28222,1744
1742,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,MMAapril2016_0109,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P30939,1745
1743,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1357,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mt 400,treximet",P08908,1746
1744,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1357,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mt 400,treximet",P28222,1747
1745,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1357,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mt 400,treximet",P28221,1748
1746,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1357,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mt 400,treximet",P30939,1749
1747,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1438,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"np101,zelrix",P08908,1750
1748,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1438,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"np101,zelrix",P28222,1751
1749,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1438,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"np101,zelrix",P28221,1752
1750,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1438,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"np101,zelrix",P30939,1753
1751,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1914,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,sumatriptan,P08908,1754
1752,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1914,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,sumatriptan,P28222,1755
1753,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1914,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,sumatriptan,P28221,1756
1754,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1914,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,sumatriptan,P30939,1757
1755,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1915,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan, triptan",P08908,1758
1756,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1915,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan, triptan",P28222,1759
1757,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1915,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan, triptan",P28221,1760
1758,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1915,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan, triptan",P30939,1761
1759,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1916,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan,imitrex",P08908,1762
1760,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1916,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan,imitrex",P28222,1763
1761,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1916,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan,imitrex",P28221,1764
1762,-,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1916,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan,imitrex",P30939,1765
1763,-,Class A (Rhodopsin),small molecule,surinabant,cnr1_human,CNR1,1917,smoking-cessation agent,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"surinabant, sr 147778",P21554,1766
1764,-,Class A (Rhodopsin),small molecule,suvn-502,5ht6r_human,HTR6,1920,for treatment of Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,suvn-502,P50406,1767
1765,-,Class A (Rhodopsin),small molecule,suvn-d4010,5ht4r_human,HTR4,MMAmar2016_0094,for treatment of Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,suvn-d4010,Q13639,1768
1766,-,Class A (Rhodopsin),small molecule,suvn-g3031,hrh3_human,HRH3,MMAmar2016_0093,for treatment of Alzheimer's disease,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,suvn-g3031,Q9Y5N1,1769
1767,2014,Class A (Rhodopsin),small molecule,suvorexant,ox1r_human,HCRTR1,1304,Hypnotics and Sedatives,Peptide ,,approved,Orexin receptors,GPCR;Rhodopsin,established,mk-4305,O43613,1770
1768,2014,Class A (Rhodopsin),small molecule,suvorexant,ox2r_human,HCRTR2,1304,Hypnotics and Sedatives,Peptide ,,approved,Orexin receptors,GPCR;Rhodopsin,established,mk-4305,O43614,1771
1769,-,Class A (Rhodopsin),small molecule,svt-40776,acm3_human,CHRM3,1921,for treatment of incontinence,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,svt-40776,P20309,1772
1770,-,Class A (Rhodopsin),sirna,syl040012,adrb2_human,ADRB2,1922,for treatment of glaucoma,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,syl040012,P07550,1773
1771,-,Class A (Rhodopsin),small molecule,syn120,5ht6r_human,HTR6,MMAapril2016_0309,for treatment of cognitive disorders,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,syn120,P50406,1774
1772,-,Class A (Rhodopsin),small molecule,syn120,5ht2a_human,HTR2A,MMAapril2016_0310,for treatment of cognitive disorders,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,syn120,P28223,1775
1773,-,Class A (Rhodopsin),small molecule,t111,aa2ar_human,ADORA2A,MMAmay2016_0579,for treatment of pruritus,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,t111,P29274,1776
1774,-,Class A (Rhodopsin),small molecule,t-62,aa1r_human,ADORA1,1930,Analgesics,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,t-62,P30542,1777
1775,2012,Class A (Rhodopsin),small molecule,tafluprost,pf2r_human,PTGFR,MMAmay2016_0794,Reduce intraocular pressure,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"taflotan, tapros, zioptan, tafluprost, saflutan, de-085, mk-2452",P43088,1778
1776,-,Class A (Rhodopsin),small molecule,"tak-875, fasiglifam",ffar1_human,FFAR1,MMAmay2016_0580,Antidiabetic; type II diabetes,Lipid ,,in trial,Free fatty acid receptors,GPCR;Rhodopsin,not established,"tak-875, fasiglifam",O14842,1779
1777,-,Class F (Frizzled),small molecule,"taladegib, ly2940680",smo_human,SMO,MMAmar2016_0177,Antineoplastic agent,Protein ,,in trial,Frizzled,GPCR;Frizzled,established,"taladegib, ly2940680",Q99835,1780
1778,-,Class A (Rhodopsin),small molecule,talnetant,nk3r_human,TACR3,1943,Antipsychotic agent,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"talnetant, sb 223412",P29371,1781
1779,-,Class A (Rhodopsin),small molecule,tamsulosin,ada1a_human,ADRA1A,675,for treatment of benign prostatic hyperplasia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"dutasteride + tamsulosin,jalyn",P35348,1782
1780,-,Class A (Rhodopsin),small molecule,tamsulosin,ada1a_human,ADRA1A,1946,for treatment of urinary symptoms associated with BPH,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tamsulosin, ym-617,harnal, flomax",P35348,1783
1781,-,Class A (Rhodopsin),small molecule,tamsulosin,ada1b_human,ADRA1B,1946,for treatment of urinary symptoms associated with BPH,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tamsulosin, ym-617,harnal, flomax",P35368,1784
1782,-,Class A (Rhodopsin),small molecule,tamsulosin,ada1d_human,ADRA1D,1946,for treatment of urinary symptoms associated with BPH,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tamsulosin, ym-617,harnal, flomax",P25100,1785
1783,-,Class A (Rhodopsin),small molecule,tapentadol,oprm_human,OPRM1,1950,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,tapentadol,P35372,1786
1784,-,Class A (Rhodopsin),small molecule,tapentadol,oprm_human,MOR,1951,Analgesics; opioid,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,"tapentadol hydrochloride, cg-5503, r331333",P35372,1787
1785,-,Class A (Rhodopsin),small molecule,taranabant,cnr1_human,CNR1,1952,Anti-obesity agent; smoking-cessation agent,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"taranabant, mk-0364",P21554,1788
1786,-,Class A (Rhodopsin),small molecule,tasimelteon,mtr1a_human,MTNR1A,1956,Hypnotics and Sedatives,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,"tasimelteon, vec-162",P48039,1789
1787,-,Class A (Rhodopsin),small molecule,tasimelteon,mtr1b_human,MTNR1B,1956,Hypnotics and Sedatives,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,"tasimelteon, vec-162",P49286,1790
1788,-,Class A (Rhodopsin),small molecule,tasosartan,agtr1_human,AGTR1,NRDD509,Antihypertensive agent,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556,1791
1789,-,Class B1 (Secretin),protein,taspoglutide,glp1r_human,GLP1R,1958,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"taspoglutide, itm-077, r1583, bim-51077",P43220,1792
1790,-,Class A (Rhodopsin),small molecule,tbr-652,ccr5_human,CCR5,1962,antiviral agent; HIV,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"tbr-652, tak-652",P51681,1793
1791,-,Class A (Rhodopsin),small molecule,td-1211,oprm_human,OPRM1,1971,for treatment of opioid-induced gastrointestinal side-effects,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,td-1211,P35372,1794
1792,-,Class A (Rhodopsin),unknown,td-2749,5ht4r_human,HTR4,1972,motilitant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,td-2749,Q13639,1795
1793,-,Class A (Rhodopsin),small molecule,td-4208,acm3_human,CHRM3,MMAmay2016_0081,for treatment of chronic obstructive pulmonary disease (COPD),Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,td-4208,P20309,1796
1794,-,Class A (Rhodopsin),small molecule,tecadenoson,aa1r_human,ADORA1,1973,Anti-Arrhythmia Agents,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,tecadenoson,P30542,1797
1795,-,Class A (Rhodopsin),small molecule,tedatioxetine,ada1a_human,ADRA1A,1173,Anti-depressant,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,lu aa24530,P35348,1798
1796,-,Class A (Rhodopsin),small molecule,tedatioxetine,5ht2c_human,HTR2C,1173,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lu aa24530,P28335,1799
1797,2012,Class B1 (Secretin),peptide,teduglutide,glp2r_human,GLP2R,2463,for treatment of short bowel syndrome,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,teduglutide,O95838,1800
1798,-,Class A (Rhodopsin),small molecule,tegaserod,5ht4r_human,HTR4,1975,motilitant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"tegaserod,zelnorm, zelmac",Q13639,1801
1799,-,Class A (Rhodopsin),small molecule,telmisartan,agtr1_human,AGTR1,1977,Antihypertensive agent,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,"telmisartan,micardis, micardis hct",P30556,1802
1800,1987,Class A (Rhodopsin),small molecule,terazosin,ada1a_human,ADRA1A,NRDD514,Antineoplastic agents; Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1803
1801,1987,Class A (Rhodopsin),small molecule,terazosin,ada1b_human,ADRA1B,NRDD514,Antineoplastic agents; Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368,1804
1802,1987,Class A (Rhodopsin),small molecule,terazosin,ada1d_human,ADRA1D,NRDD514,Antineoplastic agents; Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100,1805
1803,-,Class A (Rhodopsin),small molecule,terbutaline,adrb2_human,ADRB2,NRDD515,Bronchodilator agent; Tocolytic Agents,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550,1806
1804,1985,Class A (Rhodopsin),small molecule,terfenadine,hrh1_human,HRH1,NRDD516,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,1807
1805,-,Class A (Rhodopsin),small molecule,terguride,5ht2a_human,HTR2A,1981,for treatment of pulmonary arterial hypertension,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,terguride,P28223,1808
1806,-,Class A (Rhodopsin),small molecule,terguride,5ht2b_human,HTR2B,1981,for treatment of pulmonary arterial hypertension,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,terguride,P41595,1809
1807,-,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,MMAmay2016_0763,Anti-osteoporotic agent,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"cp046, intranasal teriparatide",Q03431,1810
1808,-,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,1983,Anti-osteoporotic agent,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"teriparatide, inhaled air",Q03431,1811
1809,-,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,1984,Anti-osteoporotic agent,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"teriparatide, pth1-34 nasal spray",Q03431,1812
1810,-,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,1985,Anti-osteoporotic agent,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"teriparatide,forteo, forsteo",Q03431,1813
1811,-,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTH1R,2252,Anti-osteoporotic agent,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"zt-034, teriparatide nasal spray",Q03431,1814
1812,-,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,2252,Anti-osteoporotic agent,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"zt-034, teriparatide nasal spray",Q03431,1815
1813,-,Class A (Rhodopsin),small molecule,terlipressin,v1ar_human,AVPR1A,1986,for treatment of hepatorenal syndrome,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"terlipressin,lucassin",P37288,1816
1814,-,Class A (Rhodopsin),small molecule,terlipressin,v1br_human,AVPR1B,1986,for treatment of hepatorenal syndrome,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"terlipressin,lucassin",P47901,1817
1815,-,Class A (Rhodopsin),small molecule,terlipressin,v2r_human,AVPR2,1986,for treatment of hepatorenal syndrome,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"terlipressin,lucassin",P30518,1818
1816,-,Class B1 (Secretin),peptide,tesamorelin,ghrhr_human,GHRHR,1987,for treatment of HIV-associated lipodystrophy,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,tesamorelin,Q02643,1819
1817,-,Class A (Rhodopsin),plant extract,tetrahydrocannabinol,cnr1_human,CNR1,1812,Analgesics; neuropathic pain; for treatment of restlegs legs syndrome,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,sativex,P21554,1820
1818,-,Class A (Rhodopsin),plant extract,tetrahydrocannabinol,cnr2_human,CNR2,1812,Analgesics; neuropathic pain; for treatment of restlegs legs syndrome,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,sativex,P34972,1821
1819,-,Class A (Rhodopsin),small molecule,tetrahydrocannabivarin (thcv),cnr1_human,CNR1,MMAapril2016_0329,Antidiabetic agent; Type 2,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,gwp42004,P21554,1822
1820,-,Class A (Rhodopsin),small molecule,tg-0054,cxcr4_human,CXCR4,2002,adjuvant to stem cell transplantation,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,tg-0054,P61073,1823
1821,-,Class B1 (Secretin),peptide,th0318,glp1r_human,GLP1R,2008,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,th0318,P43220,1824
1822,-,Class A (Rhodopsin),small molecule,thc:cbd oral formulation,cnr1_human,CNR1,MMAapril2016_0119,For treatment of Multiple Sclerosis,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,thc:cbd oral formulation,P21554,1825
1823,-,Class A (Rhodopsin),small molecule,thc:cbd oral formulation,cnr2_human,CNR2,MMAapril2016_0120,For treatment of Multiple Sclerosis,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,thc:cbd oral formulation,P34972,1826
1824,-,Class A (Rhodopsin),small molecule,theophylline,aa1r_human,ADORA1,53,Bronchodilator agent,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adc4022, low-dose inhaled theophylline",P30542,1827
1825,-,Class A (Rhodopsin),small molecule,theophylline,aa2ar_human,ADORA2A,53,Bronchodilator agent,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adc4022, low-dose inhaled theophylline",P29274,1828
1826,-,Class A (Rhodopsin),small molecule,theophylline,aa2br_human,ADORA2B,53,Bronchodilator agent,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adc4022, low-dose inhaled theophylline",P29275,1829
1827,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm1_human,CHRM1,NRDD519,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1830
1828,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm2_human,CHRM2,NRDD519,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,1831
1829,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm3_human,CHRM3,NRDD519,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,1832
1830,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm4_human,CHRM4,NRDD519,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,1833
1831,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm5_human,CHRM5,NRDD519,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912,1834
1832,1961,Class A (Rhodopsin),small molecule,thiethylperazine,drd1_human,DRD1,NRDD519,Antiemetics,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,1835
1833,1961,Class A (Rhodopsin),small molecule,thiethylperazine,drd2_human,DRD2,NRDD519,Antiemetics,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1836
1834,1961,Class A (Rhodopsin),small molecule,thiethylperazine,drd4_human,DRD4,NRDD519,Antiemetics,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21917,1837
1835,1961,Class A (Rhodopsin),small molecule,thiethylperazine,hrh1_human,HRH1,NRDD519,Antiemetics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,1838
1836,1961,Class A (Rhodopsin),small molecule,thiethylperazine,5ht2a_human,HTR2A,NRDD519,Antiemetics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,1839
1837,1961,Class A (Rhodopsin),small molecule,thiethylperazine,5ht2c_human,HTR2C,NRDD519,Antiemetics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335,1840
1838,1962,Class A (Rhodopsin),small molecule,thioridazine,ada1a_human,ADRA1A,NRDD521,Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1841
1839,1962,Class A (Rhodopsin),small molecule,thioridazine,drd1_human,DRD1,NRDD521,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,1842
1840,1962,Class A (Rhodopsin),small molecule,thioridazine,drd2_human,DRD2,NRDD521,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1843
1841,1962,Class A (Rhodopsin),small molecule,thioridazine,5ht2a_human,HTR2A,NRDD521,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223,1844
1842,1998,Class A (Rhodopsin),protein,thyrotropin alfa,tshr_human,TSHR,NRDD522,Diagnostic Agents,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P16473,1845
1843,-,Class A (Rhodopsin),small molecule,ticagrelor,p2y12_human,P2RY12,2015,antithrombotic,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,ticagrelor,Q9H244,1846
1844,1991,Class A (Rhodopsin),small molecule,ticlopidine,p2y12_human,P2RY12,NRDD525,Platelet Aggregation Inhibitors,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,-,Q9H244,1847
1845,-,Class A (Rhodopsin),small molecule,timolol,adrb1_human,ADRB1,386,for treatment of glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P08588,1848
1846,-,Class A (Rhodopsin),small molecule,timolol,adrb2_human,ADRB2,386,for treatment of glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P07550,1849
1847,-,Class A (Rhodopsin),small molecule,timolol,adrb1_human,ADRB1,1095,for treatment of glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"latanoprost + timolol,xalcom, xalacom",P08588,1850
1848,-,Class A (Rhodopsin),small molecule,timolol,adrb2_human,ADRB2,1095,for treatment of glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"latanoprost + timolol,xalcom, xalacom",P07550,1851
1849,-,Class A (Rhodopsin),small molecule,timolol,adrb1_human,ADRB1,2071,for treatment of glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"travoprost + timolol,extravan, duotrav",P08588,1852
1850,-,Class A (Rhodopsin),small molecule,timolol,adrb2_human,ADRB2,2071,for treatment of glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"travoprost + timolol,extravan, duotrav",P07550,1853
1851,-,Class A (Rhodopsin),small molecule,tiotropium,acm2_human,CHRM2,MMAmay2016_0589,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,tiotropium + olodaterol,P08172,1854
1852,-,Class A (Rhodopsin),small molecule,tiotropium,acm1_human,CHRM1,MMAmay2016_0590,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,tiotropium + olodaterol,P11229,1855
1853,-,Class A (Rhodopsin),small molecule,tiotropium,acm3_human,CHRM3,MMAmay2016_0591,for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,tiotropium + olodaterol,P20309,1856
1854,-,Class A (Rhodopsin),small molecule,tiotropium,acm1_human,CHRM1,2019,for treatment of cystic fibrosis; for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tiotropium bromide,spiriva",P11229,1857
1855,-,Class A (Rhodopsin),small molecule,tiotropium,acm2_human,CHRM2,2019,for treatment of cystic fibrosis; for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tiotropium bromide,spiriva",P08172,1858
1856,-,Class A (Rhodopsin),small molecule,tiotropium,acm3_human,CHRM3,2019,for treatment of cystic fibrosis; for treatment of chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tiotropium bromide,spiriva",P20309,1859
1857,-,Class A (Rhodopsin),small molecule,tizanidine,ada2a_human,ADRA2A,1458,for treatment of skeletal muscular spasticity,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"nvd-422, tizanidine oral spray",P08913,1860
1858,-,Class A (Rhodopsin),small molecule,tizanidine,ada2b_human,ADRA2B,1458,for treatment of skeletal muscular spasticity,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"nvd-422, tizanidine oral spray",P18089,1861
1859,-,Class A (Rhodopsin),small molecule,tizanidine,ada2c_human,ADRA2C,1458,for treatment of skeletal muscular spasticity,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"nvd-422, tizanidine oral spray",P18825,1862
1860,-,Class A (Rhodopsin),small molecule,tizanidine,ada2a_human,ADRA2A,2021,Muscle Relaxants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tizanidine hydrochloride,zanaflex",P08913,1863
1861,-,Class A (Rhodopsin),small molecule,tizanidine,ada2b_human,ADRA2B,2021,Muscle Relaxants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tizanidine hydrochloride,zanaflex",P18089,1864
1862,-,Class A (Rhodopsin),small molecule,tizanidine,ada2c_human,ADRA2C,2021,Muscle Relaxants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tizanidine hydrochloride,zanaflex",P18825,1865
1863,-,Class A (Rhodopsin),small molecule,tm30339,npy4r_human,PPYR1,2028,Anti-obesity agent,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,tm30339,P50391,1866
1864,-,Class A (Rhodopsin),small molecule,tm38837,cnr1_human,CNR1,2029,Anti-obesity agent,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,tm38837,P21554,1867
1865,1948,Class A (Rhodopsin),small molecule,tolazoline,ada1a_human,ADRA1A,NRDD530,Antihypertensive agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1868
1866,-,Class A (Rhodopsin),small molecule,tolterodine,acm1_human,CHRM1,2013,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P11229,1869
1867,-,Class A (Rhodopsin),small molecule,tolterodine,acm2_human,CHRM2,2013,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P08172,1870
1868,-,Class A (Rhodopsin),small molecule,tolterodine,acm3_human,CHRM3,2013,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P20309,1871
1869,-,Class A (Rhodopsin),small molecule,tolterodine,acm4_human,CHRM4,2013,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P08173,1872
1870,-,Class A (Rhodopsin),small molecule,tolterodine,acm5_human,CHRM5,2013,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P08912,1873
1871,-,Class A (Rhodopsin),small molecule,tolterodine ,acm1_human,CHRM1,2036,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P11229,1874
1872,-,Class A (Rhodopsin),small molecule,tolterodine ,acm2_human,CHRM2,2036,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P08172,1875
1873,-,Class A (Rhodopsin),small molecule,tolterodine ,acm3_human,CHRM3,2036,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P20309,1876
1874,-,Class A (Rhodopsin),small molecule,tolterodine ,acm4_human,CHRM4,2036,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P08173,1877
1875,-,Class A (Rhodopsin),small molecule,tolterodine ,acm5_human,CHRM5,2036,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P08912,1878
1876,-,Class A (Rhodopsin),small molecule,tolvaptan,v2r_human,AVPR2,2037,Antihypertensive agent,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"tolvaptan, opc-41061,samsca",P30518,1879
1877,-,Class A (Rhodopsin),small molecule,tonabersat,5ht1d_human,HTR1D,2038,Anti-migraine Agents,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,tonabersat,P28221,1880
1878,-,Class A (Rhodopsin),small molecule,tozadenant,aa2ar_human,ADORA2A,1926,Antiparkinson agent,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,syn-115,P29274,1881
1879,-,Class A (Rhodopsin),antisense oligo,tpi-asm8,ccr3_human,CCR3,2049,Anti-Asthmatic Agents,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,tpi-asm8,P51677,1882
1880,-,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,MMAmay2016_0676,Analgesics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,e-58425,P28335,1883
1881,-,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,MMAmay2016_0678,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,e-58425,P35372,1884
1882,-,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,MMAmay2016_0679,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,e-58425,P41145,1885
1883,-,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,1685,Analgesics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pti-601,P28335,1886
1884,-,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,1685,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P41145,1887
1885,-,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,1685,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P35372,1888
1886,-,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,2055,Analgesics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"tramadol extended-release,raliva er",P28335,1889
1887,-,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,2055,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol extended-release,raliva er",P41145,1890
1888,-,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,2055,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol extended-release,raliva er",P35372,1891
1889,-,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,2056,Analgesics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"tramadol hydrochloride,ultram",P28335,1892
1890,-,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,2056,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol hydrochloride,ultram",P41145,1893
1891,-,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,2056,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol hydrochloride,ultram",P35372,1894
1892,-,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,2057,Analgesics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"tramadol,tridural, ryzolt",P28335,1895
1893,-,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,2057,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol,tridural, ryzolt",P41145,1896
1894,-,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,2057,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol,tridural, ryzolt",P35372,1897
1895,-,Class A (Rhodopsin),small molecule,travoprost,pf2r_human,PTGFR,2071,for treatment of glaucoma,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"travoprost + timolol,extravan, duotrav",P43088,1898
1896,-,Class A (Rhodopsin),small molecule,trazodone,5ht1a_human,HTR1A,MMAmay2016_0460,Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lorexys, sip-104, bupropion/trazodone",P08908,1899
1897,-,Class A (Rhodopsin),small molecule,trazodone,5ht2a_human,HTR2A,MMAmay2016_0461,Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lorexys, sip-104, bupropion/trazodone",P28223,1900
1898,-,Class A (Rhodopsin),small molecule,trazodone,5ht2c_human,HTR2C,MMAmay2016_0462,Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lorexys, sip-104, bupropion/trazodone",P28335,1901
1899,-,Class A (Rhodopsin),small molecule,trazodone,5ht1a_human,HTR1A,2072,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trazodone extended release, dds-04a,oleptro",P08908,1902
1900,-,Class A (Rhodopsin),small molecule,trazodone,5ht2a_human,HTR2A,2072,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trazodone extended release, dds-04a,oleptro",P28223,1903
1901,-,Class A (Rhodopsin),small molecule,trazodone,5ht2c_human,HTR2C,2072,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trazodone extended release, dds-04a,oleptro",P28335,1904
1902,-,Class A (Rhodopsin),small molecule,trelanserin,5ht1b_human,HTR1B,2074,for treatment of intermittent claudication,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trelanserin, sl 65.0472",P28222,1905
1903,-,Class A (Rhodopsin),small molecule,trelanserin,5ht2a_human,HTR2A,2074,for treatment of intermittent claudication,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trelanserin, sl 65.0472",P28223,1906
1904,2002,Class A (Rhodopsin),small molecule,treprostinil,p2y12_human,P2RY12,NRDD537,Antihypertensive agent; Antithrombotic Agents,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,-,Q9H244,1907
1905,2002,Class A (Rhodopsin),small molecule,treprostinil,pi2r_human,PTGIR,MMA2016_0038,for treatment of pulmonary arterial hypertension,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"transcon treprostinil, subcutaneous injection",P43119,1908
1906,2002,Class A (Rhodopsin),small molecule,treprostinil,p2y12_human,P2RY12,MMA2016_0040,for treatment of pulmonary arterial hypertension,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,"transcon treprostinil, subcutaneous injection",Q9H244,1909
1907,2002,Class A (Rhodopsin),small molecule,treprostinil,p2y12_human,P2RY12,2767,for treatment of pulmonary arterial hypertension,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,"treprostinil inhaled/oral,tyvaso, viveta",Q9H244,1910
1908,2002,Class A (Rhodopsin),small molecule,treprostinil,pi2r_human,PTGIR,2767,for treatment of pulmonary arterial hypertension,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"treprostinil inhaled/oral,tyvaso, viveta",P43119,1911
1909,2002,Class A (Rhodopsin),small molecule,treprostinil,p2y12_human,P2RY12,2768,for treatment of pulmonary arterial hypertension,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,"treprostinil subcutaneous/intravenous,remodulin",Q9H244,1912
1910,2002,Class A (Rhodopsin),small molecule,treprostinil,pi2r_human,PTGIR,2768,for treatment of pulmonary arterial hypertension,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"treprostinil subcutaneous/intravenous,remodulin",P43119,1913
1911,1954,Class A (Rhodopsin),small molecule,tridihexethyl,acm1_human,CHRM1,NRDD540,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1914
1912,1954,Class A (Rhodopsin),small molecule,tridihexethyl,acm2_human,CHRM2,NRDD540,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,1915
1913,1954,Class A (Rhodopsin),small molecule,tridihexethyl,acm3_human,CHRM3,NRDD540,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309,1916
1914,1959,Class A (Rhodopsin),small molecule,trifluoperazine,ada1a_human,ADRA1A,NRDD541,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348,1917
1915,1959,Class A (Rhodopsin),small molecule,trifluoperazine,drd2_human,DRD2,NRDD541,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1918
1916,1957,Class A (Rhodopsin),small molecule,triflupromazine,acm1_human,CHRM1,NRDD542,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1919
1917,1957,Class A (Rhodopsin),small molecule,triflupromazine,acm2_human,CHRM2,NRDD542,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172,1920
1918,1957,Class A (Rhodopsin),small molecule,triflupromazine,drd1_human,DRD1,NRDD542,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,1921
1919,1957,Class A (Rhodopsin),small molecule,triflupromazine,drd2_human,DRD2,NRDD542,Antiemetics; Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,1922
1920,1957,Class A (Rhodopsin),small molecule,triflupromazine,5ht2b_human,HTR2B,NRDD542,Antiemetics; Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P41595,1923
1921,-,Class A (Rhodopsin),small molecule,trihexyphenidyl,acm1_human,CHRM1,NRDD543,Antiparkinson agents,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229,1924
1922,-,Class A (Rhodopsin),small molecule,trimeprazine,hrh1_human,HRH1,NRDD545,Antipruritics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,1925
1923,1948,Class A (Rhodopsin),small molecule,tripelennamine,hrh1_human,HRH1,NRDD550,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,1926
1924,-,Class A (Rhodopsin),small molecule,triprolidine,hrh1_human,HRH1,NRDD551,Anti-Allergic Agents,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367,1927
1925,-,Class A (Rhodopsin),peptide,triptorelin pamoate,gnrhr_human,GNRHR,2084,Antineoplastic agent; chemical castration agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",P30968,1928
1926,-,Class A (Rhodopsin),peptide,triptorelin pamoate,gnrr2_human,GNRHR2,2084,Antineoplastic agent; chemical castration agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",Q96P88,1929
1927,1960,Class A (Rhodopsin),small molecule,tropicamide,acm4_human,CHRM4,NRDD552,Diagnostic Agents; Mydriatics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173,1930
1928,-,Class A (Rhodopsin),small molecule,trospium,acm1_human,CHRM1,2086,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P11229,1931
1929,-,Class A (Rhodopsin),small molecule,trospium,acm2_human,CHRM2,2086,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P08172,1932
1930,-,Class A (Rhodopsin),small molecule,trospium,acm3_human,CHRM3,2086,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P20309,1933
1931,-,Class A (Rhodopsin),small molecule,trospium,acm4_human,CHRM4,2086,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P08173,1934
1932,-,Class A (Rhodopsin),small molecule,trospium,acm5_human,CHRM5,2086,for treatment of incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P08912,1935
1933,2004,Class A (Rhodopsin),small molecule,trospium chloride,acm1_human,CHRM1,2350,for treatment of chronic pulmonary obstructive disorder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks,P11229,1936
1934,-,Class A (Rhodopsin),protein,trv120027,agtr1_human,AGTR1,2279,Antihypertensive agent,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,trv120027,P30556,1937
1935,-,Class A (Rhodopsin),small molecule,trv130,oprm_human,OPRM1,MMAmay2016_0607,Analgesics; post-operative pain,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,trv130,P35372,1938
1936,-,Class A (Rhodopsin),small molecule,trv734,oprk_human,OPRK1,MMAapril2016_0140,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,trv734,P41145,1939
1937,-,Class C (Glutamate) ,unknown,"ts-032, pf-4802540",grm2_human,GRM2,2090,Antipsychotic agent,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,"ts-032, pf-4802540",Q14416,1940
1938,-,Class C (Glutamate) ,unknown,"ts-032, pf-4802540",grm3_human,GRM3,2090,Antipsychotic agent,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,"ts-032, pf-4802540",Q14832,1941
1939,-,Class A (Rhodopsin),injectible islet neogenesis therapy,tt-223,gasr_human,CCKBR,2092,Antidiabetic; injectable islet neogenesis therapy for diabetes,Peptide ,,in trial,Cholecystokinin receptors,GPCR;Rhodopsin,established,tt-223,P32239,1942
1940,-,Class B1 (Secretin),injectible islet neogenesis therapy,tt-223,glp1r_human,GLP1R,2092,Antidiabetic; injectable islet neogenesis therapy for diabetes,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,tt-223,P43220,1943
1941,-,Class B1 (Secretin),peptide,tt-401,glr_human,GCGR,MMAmay2016_0612,Antidiabetic; anti-obesity,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,tt-401,P47871,1944
1942,-,Class B1 (Secretin),peptide,tt-401,glp1r_human,GLP1R,MMAmay2016_0613,Antidiabetic; anti-obesity,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,tt-401,P43220,1945
1943,-,Class B1 (Secretin),small molecule,ttp054,glp1r_human,GLP1R,MMAmay2016_0113,Antidiabetic agent; Type 2,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,ttp054,P43220,1946
1944,-,Class B1 (Secretin),small molecule,ttp273,glp1r_human,GLP1R,MMAmar2016_0255,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,ttp273,P43220,1947
1945,-,Class A (Rhodopsin),peptide,"txa127, angiotensin (1-7)",mas_human,MAS1,MMAmay2016_0617,for stem cell engraftment and thrombocytopenia,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,"txa127, angiotensin (1-7)",P04201,1948
1946,-,Class A (Rhodopsin),small molecule,tzp-101,ghsr_human,GHSR,2095,for treatment of gastroparesis,Peptide ,,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,tzp-101,Q92847,1949
1947,-,Class A (Rhodopsin),small molecule,tzp-102,ghsr_human,GHSR,2096,for treatment of gastroparesis,Peptide ,,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,tzp-102,Q92847,1950
1948,-,Class A (Rhodopsin),small molecule,umeclidinium,acm2_human,CHRM2,MMAmar2016_0193,Anticholinergic; treatment of COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",P08172,1951
1949,-,Class A (Rhodopsin),small molecule,umeclidinium,acm3_human,CHRM3,MMAmar2016_0194,Anticholinergic; treatment of COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",P20309,1952
1950,-,Class A (Rhodopsin),small molecule,umeclidinium,acm2_human,CHRM2,MMAmay2016_0713,Anticholinergic; treatment of COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"incruse ellipta,  umeclidinium bromide",P08172,1953
1951,-,Class A (Rhodopsin),small molecule,umeclidinium,acm3_human,CHRM3,MMAmay2016_0714,Anticholinergic; treatment of COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"incruse ellipta,  umeclidinium bromide",P20309,1954
1952,2013,Class A (Rhodopsin),small molecule,umeclidinium bromide (gsk573719),acm2_human,CHRM2,MMAmay2016_0618,Bronchodilator agent; COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,umeclidinium bromide (gsk573719) + vilanterol (gw642444),P08172,1955
1953,2013,Class A (Rhodopsin),small molecule,umeclidinium bromide (gsk573719),acm3_human,CHRM3,MMAmay2016_0618,Bronchodilator agent; COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,umeclidinium bromide (gsk573719) + vilanterol (gw642444),P20309,1956
1954,-,Class B1 (Secretin),peptide,urocortin 2,crfr2_human,CRHR2,2105,for treatment of congestive heart failure,Peptide ,,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"urocortin 2, 358-086-15",Q13324,1957
1955,1986,Class A (Rhodopsin),protein,urofollitropin,fshr_human,FSHR,NRDD554,Fertility Agents,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945,1958
1956,-,Class A (Rhodopsin),small molecule,v24343,cnr1_human,CNR1,2112,Anti-obesity agent,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,v24343,P21554,1959
1957,-,Class A (Rhodopsin),small molecule,v81444,aa2ar_human,ADORA2A,MMAmay2016_0766,Antiparkinson agent,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,v81444,P29274,1960
1958,-,Class A (Rhodopsin),small molecule,va106483,v2r_human,AVPR2,2115,for treatment of BPH-related urinary symptoms,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,va106483,P30518,1961
1959,-,Class A (Rhodopsin),small molecule,va111913,v1ar_human,AVPR1A,2116,for treatment of dysmenorrhea,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,va111913,P37288,1962
1960,-,Class A (Rhodopsin),small molecule,va111913,v1br_human,AVPR1B,2116,for treatment of dysmenorrhea,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,va111913,P47901,1963
1961,-,Class A (Rhodopsin),small molecule,va111913,v2r_human,AVPR2,2116,for treatment of dysmenorrhea,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,va111913,P30518,1964
1962,-,Class A (Rhodopsin),small molecule,valsartan,agtr1_human,AGTR1,MMAmay2016_0742,Antihypertensive agent,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,sacubitril + valsartan,P30556,1965
1963,-,Class A (Rhodopsin),small molecule,valsartan,agtr1_human,AGTR1,2122,Antihypertensive agent,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"valsartan,diovan",P30556,1966
1964,-,Class A (Rhodopsin),small molecule,vapitadine,hrh1_human,HRH1,2123,Anti-Allergic Agents,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,"vapitadine dihydrochloride,hivenyl",P35367,1967
1965,-,Class A (Rhodopsin),small molecule,vapreotide,ssr2_human,SSTR2,2124,for treatment of liver cirrhosis-related variceal bleeding,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"vapreotide, debio 8609,sanvar, docrised",P30874,1968
1966,-,Class A (Rhodopsin),small molecule,vapreotide,ssr5_human,SSTR5,2124,for treatment of liver cirrhosis-related variceal bleeding,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"vapreotide, debio 8609,sanvar, docrised",P35346,1969
1967,-,Class B1 (Secretin),peptide,vasoactive intestinal peptide,vipr1_human,VIPR1,288,for treatment of erectile dysfunction,Peptide ,,in trial,VIP and PACAP receptors,GPCR;Secretin,not established,"aviptadil,invicorp",P32241,1970
1968,-,Class B1 (Secretin),peptide,vasoactive intestinal peptide,vipr2_human,VIPR2,288,for treatment of erectile dysfunction,Peptide ,,in trial,VIP and PACAP receptors,GPCR;Rhodopsin,not established,"aviptadil,invicorp",P41587,1971
1969,-,Class B1 (Secretin),peptide,"vasomera, pb1046",vipr2_human,VIPR2,MMAmay2016_0630,Antihypertensive agent,Peptide ,,in trial,VIP and PACAP receptors,GPCR;Rhodopsin,not established,"vasomera, pb1046",P41587,1972
1970,-,Class A (Rhodopsin),peptide,vasopressin,v1ar_human,AVPR1A,NRDD560,Antidiuretic Agents,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P37288,1973
1971,-,Class A (Rhodopsin),peptide,vasopressin,v1br_human,AVPR1B,NRDD560,Antidiuretic Agents,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P47901,1974
1972,-,Class A (Rhodopsin),peptide,vasopressin,v2r_human,AVPR2,NRDD560,Antidiuretic Agents,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P30518,1975
1973,-,Class A (Rhodopsin),small molecule,velneperit,npy5r_human,NPY5R,2144,Anti-obesity agent,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"velneperit, s-2367",Q15761,1976
1974,-,Class A (Rhodopsin),small molecule,velusetrag,5ht4r_human,HTR4,2145,motilitant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"velusetrag, td-5108",Q13639,1977
1975,-,Class B1 (Secretin),small molecule,"verucerfont, nbi-77860",crfr1_human,CRHR1,MMA2016_0047,For treatment of Congenital Adrenal Hyperplasia,Peptide ,,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"verucerfont, nbi-77860",P34998,1978
1976,-,Class A (Rhodopsin),small molecule,vestipitant,nk1r_human,TACR1,2148,for treatment of tinnitus; hypnotic,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"vestipitant, gw 597599",P25103,1979
1977,-,Class B1 (Secretin),small molecule,viaderm-glp1 agonist,glp1r_human,GLP1R,MMAmay2016_0133,Antidiabetic agent; Type 2,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,viaderm-glp1 agonist,P43220,1980
1978,-,Class A (Rhodopsin),small molecule,vicriviroc,ccr5_human,CCR5,2157,antiviral agent; HIV,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,vicriviroc,P51681,1981
1979,-,Class C (Glutamate) ,small molecule,vigabatrin,gabr1_human,GABBR1,2159,for treatment of addiction,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,"vigabatrin is a selective, irreversible enzyme-activated gaba transaminase inhibitor. gaba (gamma-aminobutyric acid) is a n/",Q9UBS5,1982
1980,-,Class A (Rhodopsin),small molecule,vilanterol,adrb2_human,ADRB2,MMAmar2016_0195,for treatment of chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",P07550,1983
1981,2013,Class A (Rhodopsin),small molecule,vilanterol,adrb2_human,ADRB2,MMAmay2016_0779,for treatment of chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,fluticasone furoate and vilanterol inhalation powder,P07550,1984
1982,2013,Class A (Rhodopsin),small molecule,vilanterol (gw642444),adrb2_human,ADRB2,MMAmay2016_0619,for treatment of chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,umeclidinium bromide (gsk573719) + vilanterol (gw642444),P07550,1985
1983,-,Class A (Rhodopsin),small molecule,vilazodone ,5ht1a_human,HTR1A,2160,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"vilazodone hydrochloride, sb 659746a",P08908,1986
1984,2012,Class F (Frizzled),small molecule,vismodegib,smo_human,SMO,2822,Antineoplastic agent,Protein ,,approved,Frizzled,GPCR;Frizzled,established,"gdc-0449, hedgehog pathway inhibitor",Q99835,1987
1985,-,Class A (Rhodopsin),small molecule,vofopitant,nk1r_human,TACR1,2170,for treatment of post-traumatic stress disorder; hypnotic,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"vofopitant, gr-205171",P25103,1988
1986,-,Class A (Rhodopsin),small molecule,volinanserin,5ht2a_human,HTR2A,2172,Hypnotics and Sedatives,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,volinanserin,P28223,1989
1987,-,Class A (Rhodopsin),small molecule,vorapaxar,par1_human,F2R,2175,cardiovascular agent,Peptide ,,approved,Proteinase-activated receptors,GPCR;Rhodopsin,established,"vorapaxar , sch-530348",P25116,1990
1988,-,Class A (Rhodopsin),small molecule,vorapaxar,par3_human,F2RL2,2175,cardiovascular agent,Peptide ,,approved,Proteinase-activated receptors,GPCR;Rhodopsin,established,"vorapaxar , sch-530348",O00254,1991
1989,-,Class A (Rhodopsin),small molecule,vorapaxar,par4_human,F2RL3,2175,cardiovascular agent,Peptide ,,approved,Proteinase-activated receptors,GPCR;Rhodopsin,established,"vorapaxar , sch-530348",Q96RI0,1992
1990,2013,Class A (Rhodopsin),small molecule,vortioxetine,5ht1a_human,HTR1A,1171,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lu aa21004,P08908,1993
1991,2013,Class A (Rhodopsin),small molecule,vortioxetine,5ht1b_human,HTR1B,1171,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lu aa21004,P28222,1994
1992,2013,Class A (Rhodopsin),small molecule,vortioxetine,5ht7r_human,HTR7,1171,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lu aa21004,P34969,1995
1993,-,Class A (Rhodopsin),small molecule,"vpd-737, serlopitant",nk1r_human,TACR1,MMAmay2016_0635,for treatment of pruritus,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"vpd-737, serlopitant",P25103,1996
1994,-,Class A (Rhodopsin),small molecule,vr-147,5ht1b_human,HTR1B,2179,Anti-migraine Agents,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vr-147,P28222,1997
1995,-,Class A (Rhodopsin),small molecule,vr-147,5ht1d_human,HTR1D,2179,Anti-migraine Agents,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vr-147,P28221,1998
1996,-,Class B1 (Secretin),peptide,vrs-859,glp1r_human,GLP1R,2182,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,vrs-859,P43220,1999
1997,-,Class A (Rhodopsin),small molecule,vsn16r,gpr55_human,GPR55,MMAmay2016_0803,Antispasmodics;  for spatisity related to multiple sclerosis,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,vsn16r,Q9Y2T6,2000
1998,-,Class A (Rhodopsin),small molecule,x4p-001,cxcr4_human,CXCR4,MMAapril2016_0220,Antineoplastic agent; renal cell carcinoma,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,x4p-001,P61073,2001
1999,-,Class A (Rhodopsin),small molecule,xaliproden,5ht1a_human,HTR1A,2200,neuroprotectant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"xaliproden, sr 57746a",P08908,2002
2000,-,Class A (Rhodopsin),small molecule,xp21279,drd1_human,DRD1,2223,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P21728,2003
2001,-,Class A (Rhodopsin),small molecule,xp21279,drd2_human,DRD2,2223,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P14416,2004
2002,-,Class A (Rhodopsin),small molecule,xp21279,drd3_human,DRD3,2223,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P35462,2005
2003,-,Class A (Rhodopsin),small molecule,xp21279,drd4_human,DRD4,2223,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P21917,2006
2004,-,Class A (Rhodopsin),small molecule,xp21279,drd5_human,DRD5,2223,Antiparkinson agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P21918,2007
2005,-,Class A (Rhodopsin),small molecule,ykp10811,5ht4r_human,HTR4,MMAmay2016_0641,for chronic or functional constipation,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ykp10811,Q13639,2008
2006,-,Class A (Rhodopsin),unknown,ykp-1358,drd2_human,DRD2,2226,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,ykp-1358,P14416,2009
2007,-,Class A (Rhodopsin),unknown,ykp-1358,5ht2a_human,HTR2A,2226,Antipsychotic agent,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ykp-1358,P28223,2010
2008,-,Class A (Rhodopsin),small molecule,ym-178,adrb3_human,ADRB3,2229,for treatment of overactive bladder,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,ym-178,P13945,2011
2009,2012,Class A (Rhodopsin),small molecule,"ym178, mirabegron",adrb3_human,ADRB3,MMAmay2016_0790,for treatment of incontinence,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"ym178, mirabegron",P13945,2012
2010,-,Class A (Rhodopsin),small molecule,ym-598,ednra_human,EDNRA,2230,Antineoplastic agent,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,ym-598,P25101,2013
2011,-,Class A (Rhodopsin),small molecule,yohimbine,ada2a_human,ADRA2A,NRDD564,Mydriatics; Anti-impotence Agents,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913,2014
2012,-,Class A (Rhodopsin),small molecule,yohimbine,ada2b_human,ADRA2B,NRDD564,Mydriatics; Anti-impotence Agents,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089,2015
2013,-,Class A (Rhodopsin),small molecule,yohimbine,ada2c_human,ADRA2C,NRDD564,Mydriatics; Anti-impotence Agents,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P18825,2016
2014,-,Class A (Rhodopsin),peptide,yttrium-90 edotreotide,ssr1_human,SSTR1,2232,Antineoplastic agent,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,"yttrium-90 edotreotide,onalta",P30872,2017
2015,-,Class A (Rhodopsin),peptide,yttrium-90 edotreotide,ssr2_human,SSTR2,2232,Antineoplastic agent,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,"yttrium-90 edotreotide,onalta",P30874,2018
2016,-,Class A (Rhodopsin),peptide,yttrium-90 edotreotide,ssr5_human,SSTR5,2232,Antineoplastic agent,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,"yttrium-90 edotreotide,onalta",P35346,2019
2017,-,Class A (Rhodopsin),small molecule,zafirlukast,cltr1_human,CYSLTR1,2235,Anti-Asthmatic Agents,Lipid ,,approved,Leukotriene receptors,GPCR;Rhodopsin,established,"zafirlukast,accolate",Q9Y271,2020
2018,-,Class A (Rhodopsin),small molecule,zibotentan,ednra_human,EDNRA,2241,Antineoplastic agent,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"zibotentan, zd-4054, azd-4054",P25101,2021
2019,-,Class A (Rhodopsin),small molecule,zicronapine,drd4_human,DRD4,1176,Antipsychotic agent,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu-31130,P21917,2022
2020,-,Class A (Rhodopsin),small molecule,ziprasidone ,drd2_human,DRD2,2243,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",P14416,2023
2021,-,Class A (Rhodopsin),small molecule,ziprasidone ,5ht2a_human,HTR2A,2243,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",P28223,2024
2022,-,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1a_human,HTR1A,2246,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zolmitriptan,zomig",P08908,2025
2023,-,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1b_human,HTR1B,2246,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zolmitriptan,zomig",P28222,2026
2024,-,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1d_human,HTR1D,2246,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zolmitriptan,zomig",P28221,2027
2025,-,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1f_human,HTR1F,2246,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zolmitriptan,zomig",P30939,2028
2026,-,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1a_human,HTR1A,MMAapril2016_0110,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,zp-triptan,P08908,2029
2027,-,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1d_human,HTR1D,MMAapril2016_0111,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,zp-triptan,P28221,2030
2028,-,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1b_human,HTR1B,MMAapril2016_0112,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,zp-triptan,P28222,2031
2029,-,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1f_human,HTR1F,MMAapril2016_0113,Anti-migraine Agents,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,zp-triptan,P30939,2032
2030,-,Class B1 (Secretin),peptide,zp1848,glp2r_human,GLP2R,2251,for treatment of Crohn's disease,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,zp1848,O95838,2033
2031,-,Class A (Rhodopsin),small molecule,"zpl-389, zpl-3893787",hrh4_human,HRH4,MMAmar2016_0120,Anti-inflammatory agent; atopic dermatitis,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,"zpl-389, zpl-3893787",Q9H3N8,2034
2032,1962,Class A (Rhodopsin),small molecule,zuclopenthixol,drd1_human,DRD1,NRDD567,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728,2035
2033,1962,Class A (Rhodopsin),small molecule,zuclopenthixol,drd2_human,DRD2,NRDD567,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416,2036
2034,1962,Class A (Rhodopsin),small molecule,zuclopenthixol,drd5_human,DRD5,NRDD567,Antipsychotic agent,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21918,2037
2035,-,Class B1 (Secretin),peptide,zyd1,glp1r_human,GLP1R,2256,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,zyd1,P43220,2038
2036,-,Class A (Rhodopsin),small molecule,zyn002,cnr1_human,CNR1,MMAapril2016_0296,Anticonvulsants; Antiepileptics,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,zyn002,P21554,2039
2037,-,Class A (Rhodopsin),small molecule,zyn002,cnr2_human,CNR2,MMAapril2016_0297,Anticonvulsants; Antiepileptics,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,zyn002,P34972,2040
2038,-,Class A (Rhodopsin),small molecule,ergoloid,5ht1a_human,HTR1A,ASH_Sep2016_0,cardiovascular disease,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ergoloid,P08908,173
2039,-,Class A (Rhodopsin),unknown,aripiprazole lauroxil,5ht1a_human,HTR1A,ASH_Sep2016_1,psychosis,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,aripiprazole lauroxil,P08908,173
2040,-,Class A (Rhodopsin),small molecule,lecozotan,5ht1a_human,HTR1A,ASH_Sep2016_2,alzheimers disease,Aminergic ,3.0,Phase III,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lecozotan,P08908,173
2041,-,Class A (Rhodopsin),small molecule,piclozotan,5ht1a_human,HTR1A,ASH_Sep2016_3,stroke,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,piclozotan,P08908,173
2042,-,Class A (Rhodopsin),small molecule,naluzotan,5ht1a_human,HTR1A,ASH_Sep2016_4,temporal lobe epilepsy,Aminergic ,3.0,Phase III,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,naluzotan,P08908,173
2043,-,Class A (Rhodopsin),small molecule,gsk163090,5ht1a_human,HTR1A,ASH_Sep2016_5,unipolar depression,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,gsk163090,P08908,173
2044,-,Class A (Rhodopsin),small molecule,eletriptan,5ht1b_human,HTR1B,ASH_Sep2016_6,migraine disorder,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,eletriptan,P28222,83
2045,-,Class A (Rhodopsin),small molecule,ergoloid,5ht1b_human,HTR1B,ASH_Sep2016_7,cardiovascular disease,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ergoloid,P28222,83
2046,-,Class A (Rhodopsin),small molecule,gsk163090,5ht1b_human,HTR1B,ASH_Sep2016_8,unipolar depression,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,gsk163090,P28222,83
2047,-,Class A (Rhodopsin),small molecule,gsk163090,5ht1d_human,HTR1D,ASH_Sep2016_9,unipolar depression,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,gsk163090,P28221,84
2048,-,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,APR13_0013,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28566,1279
2049,-,Class A (Rhodopsin),small molecule,eletriptan,5ht1f_human,HTR1F,ASH_Sep2016_10,migraine disorder,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,eletriptan,P30939,842
2050,-,Class A (Rhodopsin),small molecule,almotriptan,5ht1f_human,HTR1F,ASH_Sep2016_11,migraine disorder,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,almotriptan,P30939,842
2051,-,Class A (Rhodopsin),small molecule,molindone,5ht2a_human,HTR2A,ASH_Sep2016_12,schizophrenia,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,molindone,P28223,25
2052,-,Class A (Rhodopsin),small molecule,haloperidol,5ht2a_human,HTR2A,ASH_Sep2016_13,conduct disorder,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,haloperidol,P28223,25
2053,-,Class A (Rhodopsin),unknown,aripiprazole lauroxil,5ht2a_human,HTR2A,ASH_Sep2016_14,psychosis,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,aripiprazole lauroxil,P28223,25
2054,-,Class A (Rhodopsin),small molecule,trimipramine,5ht2a_human,HTR2A,ASH_Sep2016_15,unipolar depression,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,trimipramine,P28223,25
2055,-,Class A (Rhodopsin),small molecule,chlorpromazine,5ht2a_human,HTR2A,ASH_Sep2016_16,psychosis,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,chlorpromazine,P28223,25
2056,-,Class A (Rhodopsin),small molecule,droperidol,5ht2a_human,HTR2A,ASH_Sep2016_17,psychosis,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,droperidol,P28223,25
2057,-,Class A (Rhodopsin),small molecule,trifluoperazine,5ht2a_human,HTR2A,ASH_Sep2016_18,psychosis,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,trifluoperazine,P28223,25
2058,-,Class A (Rhodopsin),small molecule,thiothixene,5ht2a_human,HTR2A,ASH_Sep2016_19,psychosis,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,thiothixene,P28223,25
2059,-,Class A (Rhodopsin),small molecule,pimozide,5ht2a_human,HTR2A,ASH_Sep2016_20,psychosis,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pimozide,P28223,25
2060,-,Class A (Rhodopsin),small molecule,haloperidol decanoate,5ht2a_human,HTR2A,ASH_Sep2016_21,psychosis,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,haloperidol decanoate,P28223,25
2061,-,Class A (Rhodopsin),small molecule,vabicaserin,5ht2a_human,HTR2A,ASH_Sep2016_22,schizophrenia,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vabicaserin,P28223,25
2062,-,Class A (Rhodopsin),small molecule,tedatioxetine,5ht2a_human,HTR2A,ASH_Sep2016_23,unipolar depression,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,tedatioxetine,P28223,25
2063,-,Class A (Rhodopsin),small molecule,temanogrel,5ht2a_human,HTR2A,ASH_Sep2016_24,acute coronary syndrome,Aminergic ,1.0,Phase I,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,temanogrel,P28223,25
2064,-,Class A (Rhodopsin),small molecule,methysergide,5ht2b_human,HTR2B,ASH_Sep2016_25,migraine disorder,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,methysergide,P41595,49
2065,-,Class A (Rhodopsin),small molecule,methylergonovine,5ht2b_human,HTR2B,ASH_Sep2016_26,hemorrhage,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,methylergonovine,P41595,49
2066,-,Class A (Rhodopsin),small molecule,vabicaserin,5ht2b_human,HTR2B,ASH_Sep2016_27,schizophrenia,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vabicaserin,P41595,49
2067,-,Class A (Rhodopsin),small molecule,risperidone,5ht2c_human,HTR2C,ASH_Sep2016_28,schizophrenia,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,risperidone,P28335,50
2068,-,Class A (Rhodopsin),small molecule,mirtazapine,5ht2c_human,HTR2C,ASH_Sep2016_29,unipolar depression,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,mirtazapine,P28335,50
2069,-,Class A (Rhodopsin),small molecule,ziprasidone,5ht2c_human,HTR2C,ASH_Sep2016_30,schizophrenia,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ziprasidone,P28335,50
2070,-,Class A (Rhodopsin),small molecule,loxapine,5ht2c_human,HTR2C,ASH_Sep2016_31,psychosis,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,loxapine,P28335,50
2071,-,Class A (Rhodopsin),small molecule,cyclobenzaprine,5ht2c_human,HTR2C,ASH_Sep2016_32,spasticity,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,cyclobenzaprine,P28335,50
2072,-,Class A (Rhodopsin),small molecule,nefazodone,5ht2c_human,HTR2C,ASH_Sep2016_33,unipolar depression,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,nefazodone,P28335,50
2073,-,Class A (Rhodopsin),small molecule,thioridazine,5ht2c_human,HTR2C,ASH_Sep2016_34,psychosis,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,thioridazine,P28335,50
2074,-,Class A (Rhodopsin),small molecule,methixene,5ht2c_human,HTR2C,ASH_Sep2016_35,parkinson's disease,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,methixene,P28335,50
2075,-,Class A (Rhodopsin),small molecule,trifluoperazine,5ht2c_human,HTR2C,ASH_Sep2016_36,psychosis,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,trifluoperazine,P28335,50
2076,-,Class A (Rhodopsin),small molecule,trimipramine,5ht2c_human,HTR2C,ASH_Sep2016_37,unipolar depression,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,trimipramine,P28335,50
2077,-,Class A (Rhodopsin),small molecule,esmirtazapine,5ht2c_human,HTR2C,ASH_Sep2016_38,insomnia,Aminergic ,3.0,Phase III,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,esmirtazapine,P28335,50
2078,-,Class A (Rhodopsin),small molecule,vabicaserin,5ht2c_human,HTR2C,ASH_Sep2016_39,schizophrenia,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vabicaserin,P28335,50
2079,-,Class A (Rhodopsin),small molecule,metoclopramide,5ht4r_human,HTR4,ASH_Sep2016_40,pregnancy,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,metoclopramide,Q13639,202
2080,-,Class A (Rhodopsin),small molecule,naronapride,5ht4r_human,HTR4,ASH_Sep2016_41,constipation,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,naronapride,Q13639,202
2081,-,Class A (Rhodopsin),small molecule,asenapine,5ht5a_human,HTR5A,250,Antipsychotic agent,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P47898,194
2082,-,Class A (Rhodopsin),small molecule,idalopirdine,5ht6r_human,HTR6,ASH_Sep2016_42,alzheimers disease,Aminergic ,3.0,Phase III,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,idalopirdine,P50406,195
2083,-,Class A (Rhodopsin),small molecule,cerlapirdine,5ht6r_human,HTR6,ASH_Sep2016_43,alzheimers disease,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,cerlapirdine,P50406,195
2084,-,Class A (Rhodopsin),small molecule,intepirdine,5ht6r_human,HTR6,ASH_Sep2016_44,alzheimers disease,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,intepirdine,P50406,195
2085,-,Class A (Rhodopsin),small molecule,pf-05212377,5ht6r_human,HTR6,ASH_Sep2016_45,alzheimers disease,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pf-05212377,P50406,195
2086,-,Class A (Rhodopsin),small molecule,ly2590443,5ht7r_human,HTR7,ASH_Sep2016_46,migraine disorder,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ly2590443,P34969,196
2087,-,Class A (Rhodopsin),small molecule,mepenzolate,acm1_human,CHRM1,ASH_Sep2016_47,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,mepenzolate,P11229,12
2088,-,Class A (Rhodopsin),small molecule,diphemanil,acm1_human,CHRM1,ASH_Sep2016_48,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,diphemanil,P11229,12
2089,-,Class A (Rhodopsin),small molecule,methixene,acm1_human,CHRM1,ASH_Sep2016_49,parkinson's disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,methixene,P11229,12
2090,-,Class A (Rhodopsin),small molecule,methscopolamine,acm1_human,CHRM1,ASH_Sep2016_50,cycloplegia,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,methscopolamine,P11229,12
2091,-,Class A (Rhodopsin),small molecule,isopropamide,acm1_human,CHRM1,ASH_Sep2016_51,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,isopropamide,P11229,12
2092,-,Class A (Rhodopsin),small molecule,hexocyclium,acm1_human,CHRM1,ASH_Sep2016_52,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,hexocyclium,P11229,12
2093,-,Class A (Rhodopsin),small molecule,fesoterodine,acm2_human,CHRM2,ASH_Sep2016_53,prostate adenocarcinoma,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,fesoterodine,P08172,13
2094,-,Class A (Rhodopsin),small molecule,darifenacin,acm2_human,CHRM2,ASH_Sep2016_54,overactive bladder,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,darifenacin,P08172,13
2095,-,Class A (Rhodopsin),small molecule,propantheline,acm2_human,CHRM2,ASH_Sep2016_55,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,propantheline,P08172,13
2096,-,Class A (Rhodopsin),small molecule,batefenterol,acm2_human,CHRM2,ASH_Sep2016_56,chronic obstructive pulmonary disease,Aminergic ,2.0,Phase II,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,batefenterol,P08172,13
2097,-,Class A (Rhodopsin),small molecule,bethanechol,acm2_human,CHRM2,ASH_Sep2016_57,eosinophilic esophagitis,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,bethanechol,P08172,13
2098,-,Class A (Rhodopsin),unknown,aripiprazole lauroxil,drd2_human,DRD2,ASH_Sep2016_58,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,aripiprazole lauroxil,P14416,11
2099,-,Class A (Rhodopsin),small molecule,chlorpromazine,drd2_human,DRD2,ASH_Sep2016_59,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,chlorpromazine,P14416,11
2100,-,Class A (Rhodopsin),small molecule,ergoloid,drd2_human,DRD2,ASH_Sep2016_60,cardiovascular disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P14416,11
2101,-,Class A (Rhodopsin),small molecule,fluphenazine decanoate,drd2_human,DRD2,ASH_Sep2016_61,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,fluphenazine decanoate,P14416,11
2102,-,Class A (Rhodopsin),small molecule,trimipramine,drd2_human,DRD2,ASH_Sep2016_62,unipolar depression,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,trimipramine,P14416,11
2103,-,Class A (Rhodopsin),small molecule,levomepromazine,drd2_human,DRD2,ASH_Sep2016_63,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,levomepromazine,P14416,11
2104,-,Class A (Rhodopsin),small molecule,amoxapine,drd2_human,DRD2,ASH_Sep2016_64,unipolar depression,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P14416,11
2105,-,Class A (Rhodopsin),small molecule,haloperidol decanoate,drd2_human,DRD2,ASH_Sep2016_65,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol decanoate,P14416,11
2106,-,Class A (Rhodopsin),small molecule,fluphenazine enanthate,drd2_human,DRD2,ASH_Sep2016_66,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,fluphenazine enanthate,P14416,11
2107,-,Class A (Rhodopsin),small molecule,thiothixene,drd2_human,DRD2,ASH_Sep2016_67,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,thiothixene,P14416,11
2108,-,Class A (Rhodopsin),small molecule,acetylcholine,acm3_human,CHRM3,ASH_Sep2016_68,glaucoma,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,acetylcholine,P20309,14
2109,-,Class A (Rhodopsin),small molecule,propantheline,acm3_human,CHRM3,ASH_Sep2016_69,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,propantheline,P20309,14
2110,-,Class A (Rhodopsin),small molecule,tropicamide,acm3_human,CHRM3,ASH_Sep2016_70,myopia,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,tropicamide,P20309,14
2111,-,Class A (Rhodopsin),small molecule,glycopyrrolate,acm3_human,CHRM3,ASH_Sep2016_71,obstructive lung disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,glycopyrrolate,P20309,14
2112,-,Class A (Rhodopsin),small molecule,ipratropium,acm3_human,CHRM3,ASH_Sep2016_72,chronic obstructive pulmonary disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,ipratropium,P20309,14
2113,-,Class A (Rhodopsin),small molecule,cyclopentolate,acm3_human,CHRM3,ASH_Sep2016_73,cycloplegia,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,cyclopentolate,P20309,14
2114,-,Class A (Rhodopsin),small molecule,isopropamide,acm3_human,CHRM3,ASH_Sep2016_74,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,isopropamide,P20309,14
2115,-,Class A (Rhodopsin),small molecule,methscopolamine,acm3_human,CHRM3,ASH_Sep2016_75,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,methscopolamine,P20309,14
2116,-,Class A (Rhodopsin),small molecule,oxyphenonium,acm3_human,CHRM3,ASH_Sep2016_76,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,oxyphenonium,P20309,14
2117,-,Class A (Rhodopsin),small molecule,dicyclomine,acm3_human,CHRM3,ASH_Sep2016_77,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dicyclomine,P20309,14
2118,-,Class A (Rhodopsin),small molecule,hexocyclium,acm3_human,CHRM3,ASH_Sep2016_78,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,hexocyclium,P20309,14
2119,-,Class A (Rhodopsin),small molecule,mepenzolate,acm3_human,CHRM3,ASH_Sep2016_79,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,mepenzolate,P20309,14
2120,-,Class A (Rhodopsin),small molecule,carbachol,acm3_human,CHRM3,ASH_Sep2016_80,glaucoma,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,carbachol,P20309,14
2121,-,Class A (Rhodopsin),small molecule,methacholine,acm3_human,CHRM3,ASH_Sep2016_81,asthma,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,methacholine,P20309,14
2122,-,Class A (Rhodopsin),small molecule,batefenterol,acm3_human,CHRM3,ASH_Sep2016_82,chronic obstructive pulmonary disease,Aminergic ,2.0,Phase II,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,batefenterol,P20309,14
2123,-,Class A (Rhodopsin),small molecule,bethanechol,acm3_human,CHRM3,ASH_Sep2016_83,eosinophilic esophagitis,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,bethanechol,P20309,14
2124,2012,Class A (Rhodopsin),small molecule,aclidinium,acm4_human,CHRM4,44,Bronchodilator agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08173,15
2125,2012,Class A (Rhodopsin),small molecule,aclidinium,acm5_human,CHRM5,44,Bronchodilator agent,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08912,16
2126,-,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada1a_human,ADRA1A,ASH_Sep2016_84,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P35348,42
2127,-,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada1a_human,ADRA1A,ASH_Sep2016_85,eye allergy,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P35348,42
2128,-,Class A (Rhodopsin),small molecule,naphazoline,ada1a_human,ADRA1A,ASH_Sep2016_86,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P35348,42
2129,-,Class A (Rhodopsin),small molecule,ergotamine,ada1a_human,ADRA1A,ASH_Sep2016_87,migraine disorder,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P35348,42
2130,-,Class A (Rhodopsin),small molecule,dipivefrin,ada1a_human,ADRA1A,ASH_Sep2016_88,glaucoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P35348,42
2131,-,Class A (Rhodopsin),small molecule,trimipramine,ada1a_human,ADRA1A,ASH_Sep2016_89,unipolar depression,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,trimipramine,P35348,42
2132,-,Class A (Rhodopsin),small molecule,mephentermine,ada1b_human,ADRA1B,ASH_Sep2016_90,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P35368,43
2133,-,Class A (Rhodopsin),small molecule,carvedilol,ada1b_human,ADRA1B,ASH_Sep2016_91,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,carvedilol,P35368,43
2134,-,Class A (Rhodopsin),small molecule,metaraminol,ada1b_human,ADRA1B,ASH_Sep2016_92,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,metaraminol,P35368,43
2135,-,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada1b_human,ADRA1B,ASH_Sep2016_93,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P35368,43
2136,-,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada1b_human,ADRA1B,ASH_Sep2016_94,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P35368,43
2137,-,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada1b_human,ADRA1B,ASH_Sep2016_95,adrenal gland pheochromocytoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P35368,43
2138,-,Class A (Rhodopsin),small molecule,naphazoline,ada1b_human,ADRA1B,ASH_Sep2016_96,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P35368,43
2139,-,Class A (Rhodopsin),small molecule,tolazoline,ada1b_human,ADRA1B,ASH_Sep2016_97,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P35368,43
2140,-,Class A (Rhodopsin),small molecule,oxymetazoline,ada1b_human,ADRA1B,ASH_Sep2016_98,glaucoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,oxymetazoline,P35368,43
2141,-,Class A (Rhodopsin),small molecule,ergotamine,ada1b_human,ADRA1B,ASH_Sep2016_99,migraine disorder,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P35368,43
2142,-,Class A (Rhodopsin),small molecule,ergoloid,ada1b_human,ADRA1B,ASH_Sep2016_100,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergoloid,P35368,43
2143,-,Class A (Rhodopsin),small molecule,trimipramine,ada1b_human,ADRA1B,ASH_Sep2016_101,unipolar depression,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,trimipramine,P35368,43
2144,-,Class A (Rhodopsin),small molecule,phentolamine,ada1b_human,ADRA1B,ASH_Sep2016_102,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,phentolamine,P35368,43
2145,-,Class A (Rhodopsin),small molecule,dipivefrin,ada1b_human,ADRA1B,ASH_Sep2016_103,glaucoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P35368,43
2146,-,Class A (Rhodopsin),small molecule,midodrine,ada1d_human,ADRA1D,ASH_Sep2016_104,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,midodrine,P25100,44
2147,-,Class A (Rhodopsin),small molecule,mephentermine,ada1d_human,ADRA1D,ASH_Sep2016_105,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P25100,44
2148,-,Class A (Rhodopsin),small molecule,dipivefrin,ada1d_human,ADRA1D,ASH_Sep2016_106,glaucoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P25100,44
2149,-,Class A (Rhodopsin),small molecule,carvedilol,ada1d_human,ADRA1D,ASH_Sep2016_107,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,carvedilol,P25100,44
2150,-,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada1d_human,ADRA1D,ASH_Sep2016_108,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P25100,44
2151,-,Class A (Rhodopsin),small molecule,ergoloid,ada1d_human,ADRA1D,ASH_Sep2016_109,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergoloid,P25100,44
2152,-,Class A (Rhodopsin),small molecule,metaraminol,ada1d_human,ADRA1D,ASH_Sep2016_110,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,metaraminol,P25100,44
2153,-,Class A (Rhodopsin),small molecule,naphazoline,ada1d_human,ADRA1D,ASH_Sep2016_111,eye allergy,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P25100,44
2154,-,Class A (Rhodopsin),small molecule,ergotamine,ada1d_human,ADRA1D,ASH_Sep2016_112,migraine disorder,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P25100,44
2155,-,Class A (Rhodopsin),small molecule,tolazoline,ada1d_human,ADRA1D,ASH_Sep2016_113,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P25100,44
2156,-,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada1d_human,ADRA1D,ASH_Sep2016_114,adrenal gland pheochromocytoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P25100,44
2157,-,Class A (Rhodopsin),small molecule,oxymetazoline,ada1d_human,ADRA1D,ASH_Sep2016_115,allergic conjunctivitis,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,oxymetazoline,P25100,44
2158,-,Class A (Rhodopsin),small molecule,labetalol,ada1d_human,ADRA1D,ASH_Sep2016_116,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P25100,44
2159,-,Class A (Rhodopsin),small molecule,phentolamine,ada1d_human,ADRA1D,ASH_Sep2016_117,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,phentolamine,P25100,44
2160,-,Class A (Rhodopsin),small molecule,trimipramine,ada1d_human,ADRA1D,ASH_Sep2016_118,unipolar depression,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,trimipramine,P25100,44
2161,-,Class A (Rhodopsin),small molecule,methoxamine,ada1d_human,ADRA1D,ASH_Sep2016_119,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,methoxamine,P25100,44
2162,-,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada1d_human,ADRA1D,ASH_Sep2016_120,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P25100,44
2163,-,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada2a_human,ADRA2A,ASH_Sep2016_121,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P08913,36
2164,-,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada2a_human,ADRA2A,ASH_Sep2016_122,eye allergy,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P08913,36
2165,-,Class A (Rhodopsin),small molecule,mephentermine,ada2a_human,ADRA2A,ASH_Sep2016_123,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P08913,36
2166,-,Class A (Rhodopsin),small molecule,ergotamine,ada2a_human,ADRA2A,ASH_Sep2016_124,migraine disorder,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P08913,36
2167,-,Class A (Rhodopsin),small molecule,tolazoline,ada2a_human,ADRA2A,ASH_Sep2016_125,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P08913,36
2168,-,Class A (Rhodopsin),small molecule,naphazoline,ada2a_human,ADRA2A,ASH_Sep2016_126,eye allergy,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P08913,36
2169,-,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada2a_human,ADRA2A,ASH_Sep2016_127,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P08913,36
2170,-,Class A (Rhodopsin),small molecule,labetalol,ada2a_human,ADRA2A,ASH_Sep2016_128,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P08913,36
2171,-,Class A (Rhodopsin),small molecule,naphazoline,ada2b_human,ADRA2B,ASH_Sep2016_129,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P18089,46
2172,-,Class A (Rhodopsin),small molecule,dexmedetomidine,ada2b_human,ADRA2B,ASH_Sep2016_130,pain,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dexmedetomidine,P18089,46
2173,-,Class A (Rhodopsin),small molecule,mirtazapine,ada2b_human,ADRA2B,ASH_Sep2016_131,unipolar depression,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mirtazapine,P18089,46
2174,-,Class A (Rhodopsin),small molecule,oxymetazoline,ada2b_human,ADRA2B,ASH_Sep2016_132,dry eye syndrome,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,oxymetazoline,P18089,46
2175,-,Class A (Rhodopsin),small molecule,guanfacine,ada2b_human,ADRA2B,ASH_Sep2016_133,attention deficit hyperactivity disorder,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,guanfacine,P18089,46
2176,-,Class A (Rhodopsin),small molecule,tolazoline,ada2b_human,ADRA2B,ASH_Sep2016_134,arthralgia,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P18089,46
2177,-,Class A (Rhodopsin),small molecule,apraclonidine,ada2b_human,ADRA2B,ASH_Sep2016_135,glaucoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,apraclonidine,P18089,46
2178,-,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada2b_human,ADRA2B,ASH_Sep2016_136,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P18089,46
2179,-,Class A (Rhodopsin),small molecule,phentolamine,ada2b_human,ADRA2B,ASH_Sep2016_137,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,phentolamine,P18089,46
2180,-,Class A (Rhodopsin),small molecule,labetalol,ada2b_human,ADRA2B,ASH_Sep2016_138,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P18089,46
2181,-,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada2b_human,ADRA2B,ASH_Sep2016_139,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P18089,46
2182,-,Class A (Rhodopsin),small molecule,ergotamine,ada2b_human,ADRA2B,ASH_Sep2016_140,migraine disorder,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P18089,46
2183,-,Class A (Rhodopsin),small molecule,ergoloid,ada2b_human,ADRA2B,ASH_Sep2016_141,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergoloid,P18089,46
2184,-,Class A (Rhodopsin),small molecule,methyldopa,ada2b_human,ADRA2B,ASH_Sep2016_142,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,methyldopa,P18089,46
2185,-,Class A (Rhodopsin),small molecule,dipivefrin,ada2b_human,ADRA2B,ASH_Sep2016_143,glaucoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P18089,46
2186,-,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada2b_human,ADRA2B,ASH_Sep2016_144,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P18089,46
2187,-,Class A (Rhodopsin),small molecule,mephentermine,ada2b_human,ADRA2B,ASH_Sep2016_145,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P18089,46
2188,-,Class A (Rhodopsin),small molecule,esmirtazapine,ada2b_human,ADRA2B,ASH_Sep2016_146,menopause,Aminergic ,3.0,Phase III,Adrenoceptors,GPCR;Rhodopsin,established,esmirtazapine,P18089,46
2189,-,Class A (Rhodopsin),small molecule,guanabenz,ada2b_human,ADRA2B,ASH_Sep2016_147,relapsing-remitting multiple sclerosis,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,guanabenz,P18089,46
2190,-,Class A (Rhodopsin),small molecule,mirtazapine,ada2c_human,ADRA2C,ASH_Sep2016_148,unipolar depression,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mirtazapine,P18825,47
2191,-,Class A (Rhodopsin),small molecule,dexmedetomidine,ada2c_human,ADRA2C,ASH_Sep2016_149,cancer,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dexmedetomidine,P18825,47
2192,-,Class A (Rhodopsin),small molecule,naphazoline,ada2c_human,ADRA2C,ASH_Sep2016_150,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P18825,47
2193,-,Class A (Rhodopsin),small molecule,oxymetazoline,ada2c_human,ADRA2C,ASH_Sep2016_151,dry eye syndrome,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,oxymetazoline,P18825,47
2194,-,Class A (Rhodopsin),small molecule,guanfacine,ada2c_human,ADRA2C,ASH_Sep2016_152,obstructive sleep apnea,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,guanfacine,P18825,47
2195,-,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada2c_human,ADRA2C,ASH_Sep2016_153,adrenal gland pheochromocytoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P18825,47
2196,-,Class A (Rhodopsin),small molecule,tolazoline,ada2c_human,ADRA2C,ASH_Sep2016_154,arthralgia,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P18825,47
2197,-,Class A (Rhodopsin),small molecule,ergoloid,ada2c_human,ADRA2C,ASH_Sep2016_155,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergoloid,P18825,47
2198,-,Class A (Rhodopsin),small molecule,labetalol,ada2c_human,ADRA2C,ASH_Sep2016_156,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P18825,47
2199,-,Class A (Rhodopsin),small molecule,methyldopa,ada2c_human,ADRA2C,ASH_Sep2016_157,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,methyldopa,P18825,47
2200,-,Class A (Rhodopsin),small molecule,ergotamine,ada2c_human,ADRA2C,ASH_Sep2016_158,migraine disorder,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P18825,47
2201,-,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada2c_human,ADRA2C,ASH_Sep2016_159,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P18825,47
2202,-,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada2c_human,ADRA2C,ASH_Sep2016_160,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P18825,47
2203,-,Class A (Rhodopsin),small molecule,mephentermine,ada2c_human,ADRA2C,ASH_Sep2016_161,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P18825,47
2204,-,Class A (Rhodopsin),small molecule,apraclonidine,ada2c_human,ADRA2C,ASH_Sep2016_162,glaucoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,apraclonidine,P18825,47
2205,-,Class A (Rhodopsin),small molecule,phentolamine,ada2c_human,ADRA2C,ASH_Sep2016_163,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,phentolamine,P18825,47
2206,-,Class A (Rhodopsin),small molecule,dipivefrin,ada2c_human,ADRA2C,ASH_Sep2016_164,glaucoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P18825,47
2207,-,Class A (Rhodopsin),small molecule,esmirtazapine,ada2c_human,ADRA2C,ASH_Sep2016_165,insomnia,Aminergic ,3.0,Phase III,Adrenoceptors,GPCR;Rhodopsin,established,esmirtazapine,P18825,47
2208,-,Class A (Rhodopsin),small molecule,guanabenz,ada2c_human,ADRA2C,ASH_Sep2016_166,bone neoplasm,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,guanabenz,P18825,47
2209,-,Class A (Rhodopsin),small molecule,dipivefrin,adrb1_human,ADRB1,ASH_Sep2016_167,glaucoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P08588,8
2210,-,Class A (Rhodopsin),small molecule,sotalol,adrb1_human,ADRB1,ASH_Sep2016_168,atrial fibrillation,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,sotalol,P08588,8
2211,-,Class A (Rhodopsin),small molecule,dopamine,adrb1_human,ADRB1,ASH_Sep2016_169,hypotension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dopamine,P08588,8
2212,-,Class A (Rhodopsin),small molecule,propafenone,adrb1_human,ADRB1,ASH_Sep2016_170,cardiac arrhythmia,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,propafenone,P08588,8
2213,-,Class A (Rhodopsin),small molecule,mephentermine,adrb1_human,ADRB1,ASH_Sep2016_171,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P08588,8
2214,-,Class A (Rhodopsin),small molecule,nebivolol,adrb2_human,ADRB2,ASH_Sep2016_172,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,nebivolol,P07550,86
2215,-,Class A (Rhodopsin),small molecule,albuterol,adrb2_human,ADRB2,ASH_Sep2016_173,chronic obstructive pulmonary disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,albuterol,P07550,86
2216,-,Class A (Rhodopsin),small molecule,levosalbutamol,adrb2_human,ADRB2,ASH_Sep2016_174,asthma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,levosalbutamol,P07550,86
2217,-,Class A (Rhodopsin),small molecule,metaproterenol,adrb2_human,ADRB2,ASH_Sep2016_175,asthma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,metaproterenol,P07550,86
2218,-,Class A (Rhodopsin),small molecule,carteolol,adrb2_human,ADRB2,ASH_Sep2016_176,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,carteolol,P07550,86
2219,-,Class A (Rhodopsin),small molecule,propafenone,adrb2_human,ADRB2,ASH_Sep2016_177,atrial fibrillation,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,propafenone,P07550,86
2220,-,Class A (Rhodopsin),small molecule,propranolol,adrb2_human,ADRB2,ASH_Sep2016_178,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,propranolol,P07550,86
2221,-,Class A (Rhodopsin),small molecule,dobutamine,adrb2_human,ADRB2,ASH_Sep2016_179,heart failure,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dobutamine,P07550,86
2222,-,Class A (Rhodopsin),small molecule,sotalol,adrb2_human,ADRB2,ASH_Sep2016_180,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,sotalol,P07550,86
2223,-,Class A (Rhodopsin),small molecule,pirbuterol,adrb2_human,ADRB2,ASH_Sep2016_181,obstructive lung disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,pirbuterol,P07550,86
2224,-,Class A (Rhodopsin),small molecule,isoetharine,adrb2_human,ADRB2,ASH_Sep2016_182,obstructive lung disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,isoetharine,P07550,86
2225,-,Class A (Rhodopsin),small molecule,bitolterol,adrb2_human,ADRB2,ASH_Sep2016_183,obstructive lung disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,bitolterol,P07550,86
2226,-,Class A (Rhodopsin),small molecule,esmolol,adrb2_human,ADRB2,ASH_Sep2016_184,tinnitus,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,esmolol,P07550,86
2227,-,Class A (Rhodopsin),small molecule,dipivefrin,adrb2_human,ADRB2,ASH_Sep2016_185,glaucoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P07550,86
2228,-,Class A (Rhodopsin),small molecule,mephentermine,adrb2_human,ADRB2,ASH_Sep2016_186,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P07550,86
2229,-,Class A (Rhodopsin),small molecule,carmoterol,adrb2_human,ADRB2,ASH_Sep2016_187,chronic obstructive pulmonary disease,Aminergic ,2.0,Phase II,Adrenoceptors,GPCR;Rhodopsin,established,carmoterol,P07550,86
2230,-,Class A (Rhodopsin),small molecule,batefenterol,adrb2_human,ADRB2,ASH_Sep2016_188,chronic obstructive pulmonary disease,Aminergic ,2.0,Phase II,Adrenoceptors,GPCR;Rhodopsin,established,batefenterol,P07550,86
2231,-,Class A (Rhodopsin),small molecule,bedoradrine,adrb2_human,ADRB2,ASH_Sep2016_189,asthma,Aminergic ,2.0,Phase II,Adrenoceptors,GPCR;Rhodopsin,established,bedoradrine,P07550,86
2232,-,Class A (Rhodopsin),small molecule,abediterol,adrb2_human,ADRB2,ASH_Sep2016_190,asthma,Aminergic ,2.0,Phase II,Adrenoceptors,GPCR;Rhodopsin,established,abediterol,P07550,86
2233,-,Class A (Rhodopsin),small molecule,azd3199,adrb2_human,ADRB2,ASH_Sep2016_191,chronic obstructive pulmonary disease,Aminergic ,2.0,Phase II,Adrenoceptors,GPCR;Rhodopsin,established,azd3199,P07550,86
2234,-,Class A (Rhodopsin),small molecule,carvedilol,adrb3_human,ADRB3,ASH_Sep2016_192,hypertension,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,carvedilol,P13945,116
2235,-,Class A (Rhodopsin),small molecule,isoproterenol,adrb3_human,ADRB3,ASH_Sep2016_193,asthma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,isoproterenol,P13945,116
2236,-,Class A (Rhodopsin),small molecule,carteolol,adrb3_human,ADRB3,ASH_Sep2016_194,glaucoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,carteolol,P13945,116
2237,-,Class A (Rhodopsin),small molecule,labetalol,adrb3_human,ADRB3,ASH_Sep2016_195,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P13945,116
2238,-,Class A (Rhodopsin),small molecule,mephentermine,adrb3_human,ADRB3,ASH_Sep2016_196,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P13945,116
2239,-,Class A (Rhodopsin),small molecule,dipivefrin,adrb3_human,ADRB3,ASH_Sep2016_197,glaucoma,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P13945,116
2240,-,Class A (Rhodopsin),small molecule,ergoloid,drd1_human,DRD1,ASH_Sep2016_198,cardiovascular disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P21728,10
2241,-,Class A (Rhodopsin),small molecule,pimozide,drd1_human,DRD1,ASH_Sep2016_199,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,pimozide,P21728,10
2242,-,Class A (Rhodopsin),small molecule,amoxapine,drd1_human,DRD1,ASH_Sep2016_200,unipolar depression,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P21728,10
2243,-,Class A (Rhodopsin),small molecule,droperidol,drd3_human,DRD3,ASH_Sep2016_201,vomiting,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,droperidol,P35462,24
2244,-,Class A (Rhodopsin),small molecule,haloperidol,drd3_human,DRD3,ASH_Sep2016_202,gastroparesis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol,P35462,24
2245,-,Class A (Rhodopsin),small molecule,trifluoperazine,drd3_human,DRD3,ASH_Sep2016_203,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,trifluoperazine,P35462,24
2246,-,Class A (Rhodopsin),small molecule,chlorpromazine,drd3_human,DRD3,ASH_Sep2016_204,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,chlorpromazine,P35462,24
2247,-,Class A (Rhodopsin),small molecule,thioridazine,drd3_human,DRD3,ASH_Sep2016_205,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,thioridazine,P35462,24
2248,-,Class A (Rhodopsin),small molecule,ergoloid,drd3_human,DRD3,ASH_Sep2016_206,cardiovascular disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P35462,24
2249,-,Class A (Rhodopsin),small molecule,loxapine,drd3_human,DRD3,ASH_Sep2016_207,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,loxapine,P35462,24
2250,-,Class A (Rhodopsin),small molecule,promazine,drd3_human,DRD3,ASH_Sep2016_208,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,promazine,P35462,24
2251,-,Class A (Rhodopsin),small molecule,pergolide,drd3_human,DRD3,ASH_Sep2016_209,parkinson's disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,pergolide,P35462,24
2252,-,Class A (Rhodopsin),small molecule,amoxapine,drd3_human,DRD3,ASH_Sep2016_210,unipolar depression,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P35462,24
2253,-,Class A (Rhodopsin),small molecule,pimozide,drd3_human,DRD3,ASH_Sep2016_211,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,pimozide,P35462,24
2254,-,Class A (Rhodopsin),small molecule,haloperidol decanoate,drd3_human,DRD3,ASH_Sep2016_212,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol decanoate,P35462,24
2255,-,Class A (Rhodopsin),small molecule,levomepromazine,drd3_human,DRD3,ASH_Sep2016_213,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,levomepromazine,P35462,24
2256,-,Class A (Rhodopsin),small molecule,haloperidol,drd4_human,DRD4,ASH_Sep2016_214,schizophrenia,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol,P21917,153
2257,-,Class A (Rhodopsin),small molecule,ergoloid,drd4_human,DRD4,ASH_Sep2016_215,cardiovascular disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P21917,153
2258,-,Class A (Rhodopsin),small molecule,bromocriptine,drd4_human,DRD4,ASH_Sep2016_216,growth hormone excess,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,bromocriptine,P21917,153
2259,-,Class A (Rhodopsin),small molecule,trifluoperazine,drd4_human,DRD4,ASH_Sep2016_217,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,trifluoperazine,P21917,153
2260,-,Class A (Rhodopsin),small molecule,ropinirole,drd4_human,DRD4,ASH_Sep2016_218,parkinson's disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,ropinirole,P21917,153
2261,-,Class A (Rhodopsin),small molecule,thioridazine,drd4_human,DRD4,ASH_Sep2016_219,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,thioridazine,P21917,153
2262,-,Class A (Rhodopsin),small molecule,chlorpromazine,drd4_human,DRD4,ASH_Sep2016_220,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,chlorpromazine,P21917,153
2263,-,Class A (Rhodopsin),small molecule,amoxapine,drd4_human,DRD4,ASH_Sep2016_221,unipolar depression,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P21917,153
2264,-,Class A (Rhodopsin),small molecule,pimozide,drd4_human,DRD4,ASH_Sep2016_222,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,pimozide,P21917,153
2265,-,Class A (Rhodopsin),small molecule,loxapine,drd4_human,DRD4,ASH_Sep2016_223,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,loxapine,P21917,153
2266,-,Class A (Rhodopsin),small molecule,droperidol,drd4_human,DRD4,ASH_Sep2016_224,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,droperidol,P21917,153
2267,-,Class A (Rhodopsin),small molecule,levomepromazine,drd4_human,DRD4,ASH_Sep2016_225,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,levomepromazine,P21917,153
2268,-,Class A (Rhodopsin),small molecule,pergolide,drd4_human,DRD4,ASH_Sep2016_226,parkinson's disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,pergolide,P21917,153
2269,-,Class A (Rhodopsin),small molecule,haloperidol decanoate,drd4_human,DRD4,ASH_Sep2016_227,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol decanoate,P21917,153
2270,-,Class A (Rhodopsin),small molecule,amoxapine,drd5_human,DRD5,ASH_Sep2016_228,unipolar depression,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P21918,374
2271,-,Class A (Rhodopsin),small molecule,ergoloid,drd5_human,DRD5,ASH_Sep2016_229,cardiovascular disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P21918,374
2272,-,Class A (Rhodopsin),small molecule,pimozide,drd5_human,DRD5,ASH_Sep2016_230,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,pimozide,P21918,374
2273,-,Class A (Rhodopsin),small molecule,pergolide,drd5_human,DRD5,ASH_Sep2016_231,parkinson's disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,pergolide,P21918,374
2274,-,Class A (Rhodopsin),small molecule,antazoline,hrh1_human,HRH1,ASH_Sep2016_232,atrial fibrillation,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,antazoline,P35367,9
2275,-,Class A (Rhodopsin),small molecule,tolazoline,hrh1_human,HRH1,ASH_Sep2016_233,cardiovascular disease,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,tolazoline,P35367,9
2276,-,Class A (Rhodopsin),small molecule,trimipramine,hrh1_human,HRH1,ASH_Sep2016_234,unipolar depression,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,trimipramine,P35367,9
2277,-,Class A (Rhodopsin),small molecule,acrivastine,hrh1_human,HRH1,ASH_Sep2016_235,allergy,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,acrivastine,P35367,9
2278,-,Class A (Rhodopsin),small molecule,pyrilamine,hrh1_human,HRH1,ASH_Sep2016_236,pruritus,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,pyrilamine,P35367,9
2279,-,Class A (Rhodopsin),small molecule,esmirtazapine,hrh1_human,HRH1,ASH_Sep2016_237,insomnia,Aminergic ,3.0,Phase III,Histamine receptors,GPCR;Rhodopsin,established,esmirtazapine,P35367,9
2280,-,Class A (Rhodopsin),small molecule,dexchlorpheniramine,hrh1_human,HRH1,ASH_Sep2016_238,sunburn,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,dexchlorpheniramine,P35367,9
2281,-,Class A (Rhodopsin),small molecule,histamine,hrh1_human,HRH1,ASH_Sep2016_239,migraine disorder,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,histamine,P35367,9
2282,-,Class A (Rhodopsin),small molecule,methantheline,hrh2_human,HRH2,ASH_Sep2016_240,digestive system disease,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,methantheline,P25021,188
2283,-,Class A (Rhodopsin),small molecule,tolazoline,hrh2_human,HRH2,ASH_Sep2016_241,arthralgia,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,tolazoline,P25021,188
2284,-,Class A (Rhodopsin),small molecule,pitolisant,hrh3_human,HRH3,ASH_Sep2016_242,parkinson's disease,Aminergic ,3.0,Phase III,Histamine receptors,GPCR;Rhodopsin,established,pitolisant,Q9Y5N1,147
2285,-,Class A (Rhodopsin),small molecule,bavisant,hrh3_human,HRH3,ASH_Sep2016_243,attention deficit hyperactivity disorder,Aminergic ,2.0,Phase II,Histamine receptors,GPCR;Rhodopsin,established,bavisant,Q9Y5N1,147
2286,-,Class A (Rhodopsin),small molecule,pf-03654764,hrh3_human,HRH3,ASH_Sep2016_244,allergic rhinitis,Aminergic ,2.0,Phase II,Histamine receptors,GPCR;Rhodopsin,established,pf-03654764,Q9Y5N1,147
2287,-,Class A (Rhodopsin),small molecule,pf-03654746,hrh3_human,HRH3,ASH_Sep2016_245,allergic rhinitis,Aminergic ,2.0,Phase II,Histamine receptors,GPCR;Rhodopsin,established,pf-03654746,Q9Y5N1,147
2288,-,Class A (Rhodopsin),small molecule,irdabisant,hrh3_human,HRH3,ASH_Sep2016_246,cognitive impairment,Aminergic ,1.0,Phase I,Histamine receptors,GPCR;Rhodopsin,established,irdabisant,Q9Y5N1,147
2289,-,Class A (Rhodopsin),small molecule,toreforant,hrh4_human,HRH4,ASH_Sep2016_247,asthma,Aminergic ,2.0,Phase II,Histamine receptors,GPCR;Rhodopsin,established,toreforant,Q9H3N8,447
2290,-,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,413,for treatment of cognitive dysfunction; for treatment of ADHD,Aminergic ,,approved,Trace amine receptors,GPCR;Rhodopsin,established,"c105, levo-amphetamine sulfate",Q96RJ0,124
2291,-,Class A (Rhodopsin),small molecule,azilsartan medoxomil,agtr1_human,AGTR1,ASH_Sep2016_248,hypertension,Peptide ,4.0,Phase IV,Angiotensin receptors,GPCR;Rhodopsin,established,azilsartan medoxomil,P30556,231
2292,-,Class A (Rhodopsin),small molecule,candesartan cilexetil,agtr1_human,AGTR1,ASH_Sep2016_249,hypertension,Peptide ,4.0,Phase IV,Angiotensin receptors,GPCR;Rhodopsin,established,candesartan cilexetil,P30556,231
2293,-,Class A (Rhodopsin),small molecule,olmesartan medoxomil,agtr1_human,AGTR1,ASH_Sep2016_250,cardiovascular disease,Peptide ,4.0,Phase IV,Angiotensin receptors,GPCR;Rhodopsin,established,olmesartan medoxomil,P30556,231
2294,-,Class A (Rhodopsin),small molecule,ema401,agtr2_human,AGTR2,MMAmay2016_0377,for treatment of peripheral neuropathic pain; post herpetic neuralgia,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,not established,ema401,P50052,596
2295,-,Class A (Rhodopsin),peptide,apelin,apj_human,APLNR,MMAjun2016_0045,Cardiovascular disorders; Insulin sensitivity,Peptide ,,in trial,Apelin receptors,GPCR;Rhodopsin,not established,apelin,P35414,148
2296,-,Class A (Rhodopsin),small molecule,anatibant,bkrb2_human,BDKRB2,177,for treatment of traumatic brain injury,Peptide ,,in trial,Bradykinin receptors,GPCR;Rhodopsin,established,anatibant,P30411,129
2297,-,Class A (Rhodopsin),small molecule,ceruletide,cckar_human,CCKAR,NRDD085,Diagnostic Agents,Peptide ,,approved,Cholecystokinin receptors,GPCR;Rhodopsin,established,-,P32238,392
2298,1974,Class A (Rhodopsin),small molecule,pentagastrin,gasr_human,CCKBR,NRDD418,Diagnostic Agents,Peptide ,,approved,Cholecystokinin receptors,GPCR;Rhodopsin,established,-,P32239,1502
2299,-,Class A (Rhodopsin),small molecule,ccx168,c5ar1_human,C5AR1,448,Anti-inflammatory agent; for treatment for autoimmune disease,Peptide ,,in trial,Complement peptide receptors,GPCR;Rhodopsin,not established,ccx168,P21730,383
2300,-,Class A (Rhodopsin),small molecule,tezosentan,ednra_human,EDNRA,ASH_Sep2016_251,heart failure,Peptide ,3.0,Phase III,Endothelin receptors,GPCR;Rhodopsin,established,tezosentan,P25101,112
2301,-,Class A (Rhodopsin),small molecule,tezosentan,ednrb_human,EDNRB,ASH_Sep2016_252,heart failure,Peptide ,3.0,Phase III,Endothelin receptors,GPCR;Rhodopsin,established,tezosentan,P24530,113
2302,-,Class A (Rhodopsin),small molecule,darusentan,ednrb_human,EDNRB,ASH_Sep2016_253,hypertension,Peptide ,3.0,Phase III,Endothelin receptors,GPCR;Rhodopsin,established,darusentan,P24530,113
2303,-,Class A (Rhodopsin),small molecule,ulimorelin,ghsr_human,GHSR,ASH_Sep2016_254,digestive system disease,Peptide ,3.0,Phase III,Ghrelin receptors,GPCR;Rhodopsin,not established,ulimorelin,Q92847,128
2304,-,Class A (Rhodopsin),protein,goserelin,gnrhr_human,GNRHR,ASH_Sep2016_255,Antineoplastic agent,Peptide ,4.0,Phase IV,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,goserelin,P30968,2
2305,-,Class A (Rhodopsin),protein,ganirelix acetate,gnrhr_human,GNRHR,ASH_Sep2016_256,infertility,Peptide ,4.0,Phase IV,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,ganirelix acetate,P30968,2
2306,-,Class A (Rhodopsin),small molecule,elagolix,gnrhr_human,GNRHR,ASH_Sep2016_257,endometriosis,Peptide ,3.0,Phase III,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,elagolix,P30968,2
2307,-,Class A (Rhodopsin),small molecule,relugolix,gnrhr_human,GNRHR,ASH_Sep2016_258,endometriosis,Peptide ,2.0,Phase II,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,relugolix,P30968,2
2308,1976,Class A (Rhodopsin),small molecule,danazol,gnrr2_human,GNRHR2,NRDD139,Antiendometriosis Agent; Antineoplastic agent,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,Q96P88,484
2309,-,Class A (Rhodopsin),small molecule,ngd-4715,mchr1_human,MCHR1,1408,Appetite suppressant,Peptide ,,in trial,Melanin-concentrating hormone,GPCR;Rhodopsin,not established,ngd-4715,Q99705,1190
2310,-,Class A (Rhodopsin),protein,modimelanotide,mshr_human,MC1R,ASH_Sep2016_259,acute kidney injury,Peptide ,2.0,Phase II,Melanocortin receptors,GPCR;Rhodopsin,not established,modimelanotide,Q01726,41
2311,1950,Class A (Rhodopsin),protein,corticotropin,acthr_human,MC2R,NRDD127,Diagnostic Agents,Peptide ,,approved,Melanocortin receptors,GPCR;Rhodopsin,established,-,Q01718,459
2312,-,Class A (Rhodopsin),protein,bremelanotide,mc3r_human,MC3R,ASH_Sep2016_260,sexual dysfunction,Peptide ,3.0,Phase III,Melanocortin receptors,GPCR;Rhodopsin,not established,bremelanotide,P41968,137
2313,-,Class A (Rhodopsin),protein,modimelanotide,mc3r_human,MC3R,ASH_Sep2016_261,acute kidney injury,Peptide ,2.0,Phase II,Melanocortin receptors,GPCR;Rhodopsin,not established,modimelanotide,P41968,137
2314,-,Class A (Rhodopsin),small molecule,ap-1034,mc4r_human,MC4R,189,Anti-obesity agent,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap1030,P32245,135
2315,-,Class A (Rhodopsin),peptide,ap214,mc5r_human,MC5R,2538,for treatment of post-surgical kidney injury,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,P33032,139
2316,-,Class A (Rhodopsin),small molecule,camicinal,mtlr_human,MLNR,ASH_Sep2016_262,gastroparesis,Peptide ,2.0,Phase II,Motilin receptors,GPCR;Rhodopsin,not established,camicinal,O43193,828
2317,-,Class A (Rhodopsin),small molecule,obinepitide,npy2r_human,NPY2R,2027,Anti-obesity agent,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"tm30338,obinepitide",P49146,1244
2318,-,Class A (Rhodopsin),small molecule,obinepitide,npy4r_human,PPYR1,2027,Anti-obesity agent,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"tm30338,obinepitide",P50391,1245
2319,-,Class A (Rhodopsin),small molecule,velneperit,npy5r_human,NPY5R,2144,Anti-obesity agent,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"velneperit, s-2367",Q15761,1976
2320,-,Class A (Rhodopsin),small molecule,odelepran,oprd_human,OPRD1,ASH_Sep2016_263,alcohol dependence,Peptide ,2.0,Phase II,Opioid receptors,GPCR;Rhodopsin,established,odelepran,P41143,31
2321,-,Class A (Rhodopsin),small molecule,cebranopadol,oprd_human,OPRD1,ASH_Sep2016_264,diabetic neuropathy,Peptide ,3.0,Phase III,Opioid receptors,GPCR;Rhodopsin,established,cebranopadol,P41143,31
2322,-,Class A (Rhodopsin),small molecule,hydrocodone,oprk_human,OPRK1,ASH_Sep2016_265,pain,Peptide ,4.0,Phase IV,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone,P41145,67
2323,-,Class A (Rhodopsin),small molecule,oxymorphone,oprk_human,OPRK1,ASH_Sep2016_266,opiate dependence,Peptide ,4.0,Phase IV,Opioid receptors,GPCR;Rhodopsin,established,oxymorphone,P41145,67
2324,-,Class A (Rhodopsin),small molecule,cebranopadol,oprk_human,OPRK1,ASH_Sep2016_267,diabetic neuropathy,Peptide ,3.0,Phase III,Opioid receptors,GPCR;Rhodopsin,established,cebranopadol,P41145,67
2325,-,Class A (Rhodopsin),small molecule,odelepran,oprk_human,OPRK1,ASH_Sep2016_268,alcohol dependence,Peptide ,2.0,Phase II,Opioid receptors,GPCR;Rhodopsin,established,odelepran,P41145,67
2326,-,Class A (Rhodopsin),small molecule,dihydrocodeine,oprm_human,OPRM1,ASH_Sep2016_269,pain,Peptide ,4.0,Phase IV,Opioid receptors,GPCR;Rhodopsin,established,dihydrocodeine,P35372,33
2327,-,Class A (Rhodopsin),small molecule,meperidine,oprm_human,OPRM1,ASH_Sep2016_270,pain,Peptide ,4.0,Phase IV,Opioid receptors,GPCR;Rhodopsin,established,meperidine,P35372,33
2328,-,Class A (Rhodopsin),small molecule,difenoxin,oprm_human,OPRM1,ASH_Sep2016_271,recurrent infection of the gastrointestinal tract,Peptide ,4.0,Phase IV,Opioid receptors,GPCR;Rhodopsin,established,difenoxin,P35372,33
2329,-,Class A (Rhodopsin),small molecule,axelopran,oprm_human,OPRM1,ASH_Sep2016_272,constipation,Peptide ,2.0,Phase II,Opioid receptors,GPCR;Rhodopsin,established,axelopran,P35372,33
2330,-,Class A (Rhodopsin),small molecule,cebranopadol,oprm_human,OPRM1,ASH_Sep2016_273,"osteoarthritis, knee",Peptide ,3.0,Phase III,Opioid receptors,GPCR;Rhodopsin,established,cebranopadol,P35372,33
2331,-,Class A (Rhodopsin),small molecule,methylsamidorphan,oprm_human,OPRM1,ASH_Sep2016_274,constipation,Peptide ,2.0,Phase II,Opioid receptors,GPCR;Rhodopsin,established,methylsamidorphan,P35372,33
2332,-,Class A (Rhodopsin),small molecule,odelepran,oprm_human,OPRM1,ASH_Sep2016_275,alcohol dependence,Peptide ,2.0,Phase II,Opioid receptors,GPCR;Rhodopsin,established,odelepran,P35372,33
2333,-,Class A (Rhodopsin),small molecule,cebranopadol,oprx_human,OPRL1,ASH_Sep2016_276,pain,Peptide ,3.0,Phase III,Opioid receptors,GPCR;Rhodopsin,not established,cebranopadol,P41146,1700
2334,-,Class A (Rhodopsin),small molecule,sb-649868,ox1r_human,HCRTR1,ASH_Sep2016_277,insomnia,Peptide ,2.0,Phase II,Orexin receptors,GPCR;Rhodopsin,established,sb-649868,O43613,81
2335,-,Class A (Rhodopsin),small molecule,lemborexant,ox1r_human,HCRTR1,ASH_Sep2016_278,insomnia,Peptide ,2.0,Phase II,Orexin receptors,GPCR;Rhodopsin,established,lemborexant,O43613,81
2336,-,Class A (Rhodopsin),small molecule,sb-649868,ox2r_human,HCRTR2,ASH_Sep2016_279,insomnia,Peptide ,2.0,Phase II,Orexin receptors,GPCR;Rhodopsin,established,sb-649868,O43614,82
2337,-,Class A (Rhodopsin),small molecule,lemborexant,ox2r_human,HCRTR2,ASH_Sep2016_280,insomnia,Peptide ,2.0,Phase II,Orexin receptors,GPCR;Rhodopsin,established,lemborexant,O43614,82
2338,-,Class A (Rhodopsin),small molecule,rigosertib,par1_human,F2R,ASH_Sep2016_281,refractory anemia with excess blasts,Peptide ,3.0,Phase III,Proteinase-activated receptors,GPCR;Rhodopsin,established,rigosertib,P25116,1676
2339,-,Class A (Rhodopsin),small molecule,atopaxar,par1_human,F2R,ASH_Sep2016_282,acute coronary syndrome,Peptide ,2.0,Phase II,Proteinase-activated receptors,GPCR;Rhodopsin,established,atopaxar,P25116,1676
2340,-,Class A (Rhodopsin),peptide,rusalatide,par3_human,F2RL2,2048,for treatment of diabetic foot ulcers,Peptide ,,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",O00254,1677
2341,-,Class A (Rhodopsin),peptide,rusalatide,par4_human,F2RL3,2048,for treatment of diabetic foot ulcers,Peptide ,,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",Q96RI0,1678
2342,-,Class A (Rhodopsin),small molecule,dg3173,ssr1_human,SSTR1,632,hormone replacement,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P30872,525
2343,-,Class A (Rhodopsin),protein,lanreotide,ssr2_human,SSTR2,ASH_Sep2016_283,Antineoplastic agent,Peptide ,4.0,Phase IV,Somatostatin receptors,GPCR;Rhodopsin,established,lanreotide,P30874,277
2344,-,Class A (Rhodopsin),protein,octreotide,ssr3_human,SSTR3,ASH_Sep2016_284,growth hormone excess,Peptide ,4.0,Phase IV,Somatostatin receptors,GPCR;Rhodopsin,established,octreotide,P32745,1490
2345,-,Class A (Rhodopsin),protein,octreotide,ssr4_human,SSTR4,ASH_Sep2016_285,growth hormone excess,Peptide ,4.0,Phase IV,Somatostatin receptors,GPCR;Rhodopsin,not established,octreotide,P31391,527
2346,-,Class A (Rhodopsin),small molecule,bim23a760,ssr5_human,SSTR5,358,Antineoplastic agent; treatment for acromegaly,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,bim23a760,P35346,278
2347,-,Class A (Rhodopsin),small molecule,tradipitant,nk1r_human,TACR1,ASH_Sep2016_286,alcohol dependence,Peptide ,2.0,Phase II,Tachykinin receptors,GPCR;Rhodopsin,established,tradipitant,P25103,164
2348,-,Class A (Rhodopsin),small molecule,orvepitant,nk1r_human,TACR1,ASH_Sep2016_287,unipolar depression,Peptide ,2.0,Phase II,Tachykinin receptors,GPCR;Rhodopsin,established,orvepitant,P25103,164
2349,-,Class A (Rhodopsin),small molecule,saredutant,nk2r_human,TACR2,1810,Anti-depressant; anxiolytic,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"saredutant, sr 48968",P21452,1692
2350,-,Class A (Rhodopsin),small molecule,"mle4901,  azd4901",nk3r_human,TACR3,MMAapril2016_0263,for Polycystic Ovarian Syndrome,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"mle4901,  azd4901",P29371,1048
2351,-,Class A (Rhodopsin),protein,selepressin,v1ar_human,AVPR1A,ASH_Sep2016_288,septic shock,Peptide ,2.0,Phase II,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,selepressin,P37288,149
2352,-,Class A (Rhodopsin),peptide,desmopressin,v1br_human,AVPR1B,1537,for treatment of incontinence,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ox 19, sublingual desmopressin",P47901,508
2353,-,Class A (Rhodopsin),small molecule,conivaptan,v2r_human,AVPR2,519,for treatment of hyponatremia,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"conivaptan, ym-087,vaprisol",P30518,457
2354,-,Class A (Rhodopsin),small molecule,retosiban,oxyr_human,OXTR,ASH_Sep2016_289,premature birth,Peptide ,3.0,Phase III,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,retosiban,P30559,366
2355,-,Class A (Rhodopsin),protein,barusiban,oxyr_human,OXTR,ASH_Sep2016_290,infertility,Peptide ,2.0,Phase II,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,barusiban,P30559,366
2356,-,Class A (Rhodopsin),small molecule,epelsiban,oxyr_human,OXTR,ASH_Sep2016_291,premature ejaculation,Peptide ,2.0,Phase II,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,epelsiban,P30559,366
2357,-,Class A (Rhodopsin),small molecule,ccx832,cml1_human,CMKLR1,451,Anti-inflammatory agent; for treatment for autoimmune disease,Protein ,,in trial,Chemerin receptor,GPCR;Rhodopsin,not established,ccx832,Q99788,387
2358,-,Class A (Rhodopsin),small molecule,ccx354,ccr1_human,CCR1,450,Anti-inflammatory agent; DMARD,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx354,P32246,385
2359,-,Class A (Rhodopsin),small molecule,cenicriviroc,ccr2_human,CCR2,ASH_Sep2016_292,hiv-1 infection,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,cenicriviroc,P41597,224
2360,-,Class A (Rhodopsin),antisense oligo,tpi-asm8,ccr3_human,CCR3,2049,Anti-Asthmatic Agents,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,tpi-asm8,P51677,1882
2361,-,Class A (Rhodopsin),antibody,mogamulizumab,ccr4_human,CCR4,MMAjun2016_0001,Antineoplastic agent,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,mogamulizumab,P51679,1055
2362,-,Class A (Rhodopsin),small molecule,cenicriviroc,ccr5_human,CCR5,ASH_Sep2016_293,hiv-1 infection,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,established,cenicriviroc,P51681,349
2363,-,Class A (Rhodopsin),small molecule,vercirnon,ccr9_human,CCR9,ASH_Sep2016_294,crohn's disease,Protein ,3.0,Phase III,Chemokine receptors,GPCR;Rhodopsin,not established,vercirnon,P51686,381
2364,-,Class A (Rhodopsin),small molecule,navarixin,cxcr1_human,CXCR1,ASH_Sep2016_295,chronic obstructive pulmonary disease,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,navarixin,P25024,719
2365,-,Class A (Rhodopsin),small molecule,ladarixin,cxcr1_human,CXCR1,ASH_Sep2016_296,bullous pemphigoid,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,ladarixin,P25024,719
2366,-,Class A (Rhodopsin),small molecule,danirixin,cxcr2_human,CXCR2,ASH_Sep2016_297,chronic obstructive pulmonary disease,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,danirixin,P25025,720
2367,-,Class A (Rhodopsin),small molecule,ladarixin,cxcr2_human,CXCR2,ASH_Sep2016_298,bullous pemphigoid,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,ladarixin,P25025,720
2368,-,Class A (Rhodopsin),small molecule,navarixin,cxcr2_human,CXCR2,ASH_Sep2016_299,chronic obstructive pulmonary disease,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,navarixin,P25025,720
2369,-,Class A (Rhodopsin),small molecule,elubrixin,cxcr2_human,CXCR2,ASH_Sep2016_300,ulcerative colitis,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,elubrixin,P25025,720
2370,-,Class A (Rhodopsin),antibody,"alx- 0651, biparatopic nanobody",cxcr4_human,CXCR4,MMAmay2016_0267,Antineoplastic agent,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"alx- 0651, biparatopic nanobody",P61073,99
2371,2000,Class A (Rhodopsin),protein,choriogonadotropin alfa,fshr_human,FSHR,NRDD099,Fertility Agents,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945,410
2372,-,Class A (Rhodopsin),protein,"gonadotropin, chorionic",lshr_human,LHCGR,ASH_Sep2016_301,infertility,Protein ,4.0,Phase IV,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"gonadotropin, chorionic",P22888,213
2373,1998,Class A (Rhodopsin),protein,thyrotropin alfa,tshr_human,TSHR,NRDD522,Diagnostic Agents,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P16473,1845
2374,-,Class A (Rhodopsin),small molecule,"tak-875, fasiglifam",ffar1_human,FFAR1,MMAmay2016_0580,Antidiabetic; type II diabetes,Lipid ,,in trial,Free fatty acid receptors,GPCR;Rhodopsin,not established,"tak-875, fasiglifam",O14842,1779
2375,-,Class A (Rhodopsin),small molecule,glpg0974,ffar2_human,FFAR2,MMAmay2016_0156,Anti-inflammatory agent; neutrophil driven inflammation; ulcerative colitis,Lipid ,,in trial,Free fatty acid receptors,GPCR;Rhodopsin,not established,glpg0974,O15552,728
2376,-,Class A (Rhodopsin),small molecule,amelubant,lt4r1_human,BLT1,ASH_Sep2016_302,chronic obstructive pulmonary disease,Lipid ,2.0,Phase II,Leukotriene receptors,GPCR;Rhodopsin,not established,amelubant,Q15722,1680
2377,-,Class A (Rhodopsin),small molecule,cinalukast,cltr1_human,CYSLTR1,NRDD106,Anti-Asthmatic Agents,Lipid ,,in trial,Leukotriene receptors,GPCR;Rhodopsin,established,-,Q9Y271,423
2378,-,Class A (Rhodopsin),small molecule,am-152,lpar1_human,LPAR1,144,Anti-inflammatory agent; antifibrotic agent,Lipid ,,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,am-152,Q92633,103
2379,-,Class A (Rhodopsin),small molecule,mc-1,lpar4_human,LPAR4,1227,cardioprotectant,Lipid ,,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,mc-4232,Q99677,943
2380,-,Class A (Rhodopsin),small molecule,mc-1,lpar6_human,LPAR6,1227,cardioprotectant,Lipid ,,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,mc-4232,P43657,944
2381,-,Class A (Rhodopsin),enzyme,asfotase alfa,s1pr1_human,S1PR1,ASH_Sep2016_303,hypophosphatasia,Lipid ,4.0,Phase IV,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,asfotase alfa,P21453,57
2382,-,Class A (Rhodopsin),small molecule,siponimod,s1pr1_human,S1PR1,ASH_Sep2016_304,chronic progressive multiple sclerosis,Lipid ,3.0,Phase III,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,siponimod,P21453,57
2383,-,Class A (Rhodopsin),small molecule,ibipinabant,cnr1_human,CNR1,ASH_Sep2016_305,type ii diabetes mellitus,Lipid ,2.0,Phase II,Cannabinoid receptors,GPCR;Rhodopsin,established,ibipinabant,P21554,53
2384,-,Class A (Rhodopsin),small molecule,drinabant,cnr1_human,CNR1,ASH_Sep2016_306,schizophrenia,Lipid ,2.0,Phase II,Cannabinoid receptors,GPCR;Rhodopsin,established,drinabant,P21554,53
2385,-,Class A (Rhodopsin),small molecule,ajulemic acid,cnr2_human,CNR2,2361,Analgesics;neuropathic pain,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"ip 751, ct-3",P34972,54
2386,-,Class A (Rhodopsin),small molecule,vsn16r,gpr55_human,GPR55,MMAmay2016_0803,Antispasmodics;  for spatisity related to multiple sclerosis,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,vsn16r,Q9Y2T6,2000
2387,-,Class A (Rhodopsin),small molecule,apd597,gp119_human,GPR119,2469,Antidiabetic,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,apd597,Q8TDV5,143
2388,-,Class A (Rhodopsin),small molecule,vidupiprant,pd2r_human,PTGDR,ASH_Sep2016_307,asthma,Lipid ,2.0,Phase II,Prostanoid receptors,GPCR;Rhodopsin,not established,vidupiprant,Q13258,105
2389,-,Class A (Rhodopsin),small molecule,fevipiprant,pd2r2_human,GPR44,ASH_Sep2016_308,asthma,Lipid ,2.0,Phase II,Prostanoid receptors,GPCR;Rhodopsin,not established,fevipiprant,Q9Y5Y4,104
2390,-,Class A (Rhodopsin),small molecule,setipiprant,pd2r2_human,GPR44,ASH_Sep2016_309,seasonal allergic rhinitis,Lipid ,3.0,Phase III,Prostanoid receptors,GPCR;Rhodopsin,not established,setipiprant,Q9Y5Y4,104
2391,-,Class A (Rhodopsin),small molecule,vidupiprant,pd2r2_human,GPR44,ASH_Sep2016_310,asthma,Lipid ,2.0,Phase II,Prostanoid receptors,GPCR;Rhodopsin,not established,vidupiprant,Q9Y5Y4,104
2392,-,Class A (Rhodopsin),small molecule,azd1981,pd2r2_human,GPR44,ASH_Sep2016_311,asthma,Lipid ,2.0,Phase II,Prostanoid receptors,GPCR;Rhodopsin,not established,azd1981,Q9Y5Y4,104
2393,-,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r1_human,PTGER1,29,dental ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P34995,3
2394,-,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r2_human,PTGER2,29,periodontal ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P43116,4
2395,-,Class A (Rhodopsin),small molecule,misoprostol,pe2r3_human,PTGER3,ASH_Sep2016_312,hemorrhage,Lipid ,4.0,Phase IV,Prostanoid receptors,GPCR;Rhodopsin,established,misoprostol,P43115,5
2396,-,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r4_human,PTGER4,29,periodontal ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P35408,6
2397,-,Class A (Rhodopsin),small molecule,latanoprostene bunod,pf2r_human,PTGFR,ASH_Sep2016_313,increased intraocular pressure,Lipid ,3.0,Phase III,Prostanoid receptors,GPCR;Rhodopsin,established,latanoprostene bunod,P43088,281
2398,-,Class A (Rhodopsin),small molecule,ralinepag,pi2r_human,PTGIR,ASH_Sep2016_314,pulmonary hypertension,Lipid ,2.0,Phase II,Prostanoid receptors,GPCR;Rhodopsin,established,ralinepag,P43119,26
2399,-,Class A (Rhodopsin),small molecule,"boxaban, hepatoren, vasculan, ifetroban",ta2r_human,TBXA2R,MMAjun2016_0011,Treatment of asystemic scleroderma; hepatorenal syndrome; asthma,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"boxaban, hepatoren, vasculan, ifetroban",P21731,295
2400,-,Class A (Rhodopsin),small molecule,agomelatine,mtr1a_human,MTNR1A,87,Anti-depressant,Melatonin ,,in trial,Melatonin,GPCR;Rhodopsin,established,"agomelatine, ago178c, s-20098,valdoxan, thymanax",P48039,51
2401,-,Class A (Rhodopsin),small molecule,agomelatine,mtr1b_human,MTNR1B,86,Anti-depressant,Melatonin ,,in trial,Melatonin,GPCR;Rhodopsin,established,"agomelatine , ago178c, s-20098,valdoxan, thymanax",P49286,48
2402,1989,Class A (Rhodopsin),small molecule,adenosine,aa1r_human,ADORA1,2267,Analgesics;postoperative pain,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P30542,27
2403,-,Class A (Rhodopsin),small molecule,apadenoson,aa2ar_human,ADORA2A,ASH_Sep2016_315,atrial fibrillation,Nucleotide ,3.0,Phase III,Adenosine receptors,GPCR;Rhodopsin,established,apadenoson,P29274,28
2404,-,Class A (Rhodopsin),small molecule,pentoxifylline,aa2br_human,ADORA2B,ASH_Sep2016_316,irritable bowel syndrome,Nucleotide ,4.0,Phase IV,Adenosine receptors,GPCR;Rhodopsin,established,pentoxifylline,P29275,29
2405,-,Class A (Rhodopsin),small molecule,caffeine,aa2br_human,ADORA2B,ASH_Sep2016_317,coronary artery disease,Nucleotide ,4.0,Phase IV,Adenosine receptors,GPCR;Rhodopsin,established,caffeine,P29275,29
2406,-,Class A (Rhodopsin),small molecule,theophylline,aa3r_human,ADORA3,ASH_Sep2016_318,asthma,Nucleotide ,4.0,Phase IV,Adenosine receptors,GPCR;Rhodopsin,established,theophylline,P0DMS8,30
2407,-,Class A (Rhodopsin),small molecule,caffeine,aa3r_human,ADORA3,ASH_Sep2016_319,atherosclerosis,Nucleotide ,4.0,Phase IV,Adenosine receptors,GPCR;Rhodopsin,established,caffeine,P0DMS8,30
2408,-,Class A (Rhodopsin),small molecule,cf101,aa3r_human,ADORA3,ASH_Sep2016_320,keratoconjunctivitis sicca,Nucleotide ,3.0,Phase III,Adenosine receptors,GPCR;Rhodopsin,established,cf101,P0DMS8,30
2409,-,Class A (Rhodopsin),small molecule,mc-1,p2ry1_human,P2RY1,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,P47900,945
2410,-,Class A (Rhodopsin),small molecule,denufosol,p2ry2_human,P2RY2,614,for treatment of cystic fibrosis,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,"denufosol tetrasodium, ins37217 respiratory",P41231,500
2411,-,Class A (Rhodopsin),small molecule,mc-1,p2ry4_human,P2RY4,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,P51582,952
2412,-,Class A (Rhodopsin),small molecule,gc021109,p2ry6_human,P2RY6,MMAfeb2016_0055,for treatment of Alzheimer's disease,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,gc021109,Q15077,724
2413,-,Class A (Rhodopsin),small molecule,mc-1,p2y11_human,P2RY11,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q96G91,947
2414,2015,Class A (Rhodopsin),small molecule,cangrelor,p2y12_human,P2RY12,428,antithrombotic,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,"cangrelor, ar69931",Q9H244,353
2415,-,Class A (Rhodopsin),small molecule,mc-1,p2y13_human,P2RY13,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q9BPV8,949
2416,-,Class A (Rhodopsin),small molecule,mc-1,p2y14_human,P2RY14,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q15391,950
2417,-,Class A (Rhodopsin),small molecule,int-767,gpbar_human,GPBAR1,MMAapril2016_0196,Treatment of liver fibrosis,Steroid ,,in trial,Bile acid receptors,GPCR;Rhodopsin,not established,int-767,Q8TDU6,806
2418,-,Class A (Rhodopsin),small molecule,ari-3037mo,hcar2_human,HCAR2,226,Vitamin B analog; for treatment for hyperlipidemia,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,ari-3037mo,Q8TDS4,170
2419,-,Class A (Rhodopsin),small molecule,ari-3037mo,hcar3_human,HCAR3,226,Vitamin B analog; for treatment for hyperlipidemia,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,ari-3037mo,P49019,171
2420,-,Class A (Rhodopsin),small molecule,pa101b,gpr35_human,GPR35,MMAmar2016_0133,for treatment of autoimmune diseases,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,pa101b,Q9HC97,1472
2421,-,Class A (Rhodopsin),small molecule,glpg1205,gpr84_human,GPR84,MMAapril2016_0323,for ulcerative colitis; IBS,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,glpg1205,Q9NQS5,729
2422,-,Class A (Rhodopsin),protein,nu206,lgr4_human,LGR4,2528,for treatment of gastrointestinal disease,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,"nu206, r-spondin1",Q9BXB1,1239
2423,-,Class A (Rhodopsin),protein,nu206,lgr5_human,LGR5,2528,for treatment of gastrointestinal disease,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,"nu206, r-spondin1",O75473,1240
2424,-,Class A (Rhodopsin),peptide,"txa127, angiotensin (1-7)",mas_human,MAS1,MMAmay2016_0617,for stem cell engraftment and thrombocytopenia,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,"txa127, angiotensin (1-7)",P04201,1948
2425,-,Class A (Rhodopsin),small molecule,mc-1,p2ry8_human,P2RY8,1227,cardioprotectant,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,mc-4232,Q86VZ1,954
2426,-,Class A (Rhodopsin),small molecule,mc-1,p2y10_human,P2RY10,1227,cardioprotectant,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,mc-4232,O00398,946
2427,-,Class B1 (Secretin),protein,calcitonin salmon recombinant,calcr_human,CALCR,ASH_Sep2016_321,osteitis deformans,Peptide ,4.0,Phase IV,Calcitonin receptors,GPCR;Secretin,established,calcitonin salmon recombinant,P30988,350
2428,-,Class B1 (Secretin),protein,pramlintide acetate,calcr_human,CALCR,ASH_Sep2016_322,type ii diabetes mellitus,Peptide ,4.0,Phase IV,Calcitonin receptors,GPCR;Secretin,established,pramlintide acetate,P30988,350
2429,-,Class B1 (Secretin),protein,calcitonin salmon,calcr_human,CALCR,ASH_Sep2016_323,postmenopausal osteoporosis,Peptide ,4.0,Phase IV,Calcitonin receptors,GPCR;Secretin,established,calcitonin salmon,P30988,350
2430,-,Class B1 (Secretin),protein,calcitonin human,calcr_human,CALCR,ASH_Sep2016_324,parathyroid disease,Peptide ,4.0,Phase IV,Calcitonin receptors,GPCR;Secretin,established,calcitonin human,P30988,350
2431,-,Class B1 (Secretin),protein,davalintide,calcr_human,CALCR,ASH_Sep2016_325,obesity,Peptide ,2.0,Phase II,Calcitonin receptors,GPCR;Secretin,established,davalintide,P30988,350
2432,-,Class B1 (Secretin),small molecule,telcagepant,calrl_human,CALCRL,ASH_Sep2016_326,migraine disorder,Peptide ,3.0,Phase III,Calcitonin receptors,GPCR;Secretin,not established,telcagepant,Q16602,115
2433,-,Class B1 (Secretin),small molecule,ubrogepant,calrl_human,CALCRL,ASH_Sep2016_327,migraine disorder,Peptide ,2.0,Phase II,Calcitonin receptors,GPCR;Secretin,not established,ubrogepant,Q16602,115
2434,-,Class B1 (Secretin),protein,davalintide,calrl_human,CALCRL,ASH_Sep2016_328,obesity,Peptide ,2.0,Phase II,Calcitonin receptors,GPCR;Secretin,not established,davalintide,Q16602,115
2435,-,Class B1 (Secretin),small molecule,rimegepant,calrl_human,CALCRL,ASH_Sep2016_329,migraine disorder,Peptide ,2.0,Phase II,Calcitonin receptors,GPCR;Secretin,not established,rimegepant,Q16602,115
2436,-,Class B1 (Secretin),small molecule,emicerfont,crfr1_human,CRHR1,ASH_Sep2016_330,irritable bowel syndrome,Peptide ,2.0,Phase II,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,emicerfont,P34998,0
2437,-,Class B1 (Secretin),small molecule,pexacerfont,crfr1_human,CRHR1,ASH_Sep2016_331,anxiety,Peptide ,3.0,Phase III,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,pexacerfont,P34998,0
2438,-,Class B1 (Secretin),peptide,corticotropin-releasing factor,crfr2_human,CRHR2,528,for treatment of peritumoral brain edema,Peptide ,,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"corticotropin-releasing factor,xerecept",Q13324,461
2439,-,Class B1 (Secretin),small molecule,akl-0707,ghrhr_human,GHRH,96,hormone replacement,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"akl-0707, ghrh analog",Q02643,56
2440,-,Class B1 (Secretin),peptide,mar701,gipr_human,GIPR,1217,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,not established,mar701,P48546,938
2441,-,Class B1 (Secretin),protein,dulaglutide,glp1r_human,GLP1R,ASH_Sep2016_332,type ii diabetes mellitus,Peptide ,4.0,Phase IV,Glucagon receptor family,GPCR;Secretin,established,dulaglutide,P43220,59
2442,-,Class B1 (Secretin),peptide,elsiglutide,glp2r_human,GLP2R,2464,Antidiuretic Agents,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,zp1846,O95838,593
2443,-,Class B1 (Secretin),small molecule,mk-0893,glr_human,GCGR,ASH_Sep2016_333,type ii diabetes mellitus,Peptide ,2.0,Phase II,Glucagon receptor family,GPCR;Secretin,established,mk-0893,P47871,730
2444,-,Class B1 (Secretin),protein,glucagon hydrochloride recombinant,glr_human,GCGR,ASH_Sep2016_334,hypoglycemia,Peptide ,4.0,Phase IV,Glucagon receptor family,GPCR;Secretin,established,glucagon hydrochloride recombinant,P47871,730
2445,-,Class B1 (Secretin),peptide,rg1068,sctr_human,SCTR,1749,for treatment of autism,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"rg1068, synthetic secretin,secreflo",P47872,1652
2446,-,Class B1 (Secretin),small molecule,768974,pth1r_human,PTH1R,10,Anti-osteoporotic agent,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"768974, parathyroid hormone analog",Q03431,1
2447,-,Class B1 (Secretin),protein,alx1-11,pth2r_human,PTH2R,1646,Anti-osteoporotic agent,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,preos,P49190,101
2448,-,Class B1 (Secretin),peptide,vasoactive intestinal peptide,vipr1_human,VIPR1,288,for treatment of erectile dysfunction,Peptide ,,in trial,VIP and PACAP receptors,GPCR;Secretin,not established,"aviptadil,invicorp",P32241,1970
2449,-,Class B1 (Secretin),peptide,vasoactive intestinal peptide,vipr2_human,VIPR2,288,for treatment of erectile dysfunction,Peptide ,,in trial,VIP and PACAP receptors,GPCR;Rhodopsin,not established,"aviptadil,invicorp",P41587,1971
2450,-,Class C (Glutamate) ,small molecule,adx71441,gabr2_human,GABBR2,MMAmay2016_0244,for treatment of neurologic disorders,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,adx71441,O75899,40
2451,2004,Class C (Glutamate) ,small molecule,cinacalcet,casr_human,CASR,NRDD105,Calcimimetics,Ion ,,approved,Calcium-sensing receptors,GPCR;Glutamate,established,-,P41180,421
2452,-,Class C (Glutamate) ,small molecule,adx71441,gabr1_human,GABBR1,MMAmay2016_0243,for treatment of neurologic disorders,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,adx71441,Q9UBS5,39
2453,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm1_human,GRM1,MMAmar2016_0121,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q13255,636
2454,-,Class C (Glutamate) ,small molecule,pomaglumetad methionil,grm2_human,GRM2,ASH_Sep2016_335,schizophrenia,Amino acid ,3.0,Phase III,Metabotropic glutamate receptors,GPCR;Glutamate,not established,pomaglumetad methionil,Q14416,38
2455,-,Class C (Glutamate) ,small molecule,decoglurant,grm2_human,GRM2,ASH_Sep2016_336,unipolar depression,Amino acid ,2.0,Phase II,Metabotropic glutamate receptors,GPCR;Glutamate,not established,decoglurant,Q14416,38
2456,-,Class C (Glutamate) ,small molecule,pomaglumetad methionil,grm3_human,GRM3,ASH_Sep2016_337,schizophrenia,Amino acid ,3.0,Phase III,Metabotropic glutamate receptors,GPCR;Glutamate,not established,pomaglumetad methionil,Q14832,239
2457,-,Class C (Glutamate) ,small molecule,decoglurant,grm3_human,GRM3,ASH_Sep2016_338,unipolar depression,Amino acid ,2.0,Phase II,Metabotropic glutamate receptors,GPCR;Glutamate,not established,decoglurant,Q14832,239
2458,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm4_human,GRM4,MMAmar2016_0125,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14833,641
2459,-,Class C (Glutamate) ,small molecule,dipraglurant,grm5_human,GRM5,ASH_Sep2016_339,parkinson's disease,Amino acid ,2.0,Phase II,Metabotropic glutamate receptors,GPCR;Glutamate,established,dipraglurant,P41594,7
2460,-,Class C (Glutamate) ,small molecule,mavoglurant,grm5_human,GRM5,ASH_Sep2016_340,obsessive-compulsive disorder,Amino acid ,2.0,Phase II,Metabotropic glutamate receptors,GPCR;Glutamate,established,mavoglurant,P41594,7
2461,-,Class C (Glutamate) ,small molecule,basimglurant,grm5_human,GRM5,ASH_Sep2016_341,fragile x syndrome,Amino acid ,2.0,Phase II,Metabotropic glutamate receptors,GPCR;Glutamate,established,basimglurant,P41594,7
2462,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm6_human,GRM6,MMAmar2016_0125,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,O15303,642
2463,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm7_human,GRM7,MMAmar2016_0124,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14831,639
2464,-,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm8_human,GRM8,MMAmar2016_0125,for treatment of attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,O00222,643
2465,-,Class F (Frizzled),antibody,omp-18r5,fzd7_human,FZD7,2457,Antineoplastic agent,Protein ,,in trial,Frizzled,GPCR;Frizzled,not established,omp-18r5,O75084,1387
2466,-,Class F (Frizzled),small molecule,patidegib,smo_human,SMO,ASH_Sep2016_342,primary myelofibrosis,Protein ,2.0,Phase II,Frizzled,GPCR;Frizzled,established,patidegib,Q99835,470
2467,-,Class F (Frizzled),small molecule,glasdegib,smo_human,SMO,ASH_Sep2016_343,Antineoplastic agent,Protein ,2.0,Phase II,Frizzled,GPCR;Frizzled,established,glasdegib,Q99835,470
2468,-,Class F (Frizzled),small molecule,tak-441,smo_human,SMO,ASH_Sep2016_344,basal cell carcinoma,Protein ,1.0,Phase I,Frizzled,GPCR;Frizzled,established,tak-441,Q99835,470
